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Abstract 
In the last years nanotechnology is strongly influencing the progresses of medicine, in 
particular against cancer, both for diagnostic and therapeutic purposes. 
Nanostructures can be planned with properties useful for a specific application. 
However, the same nanostructure can be synthesized also for more diagnostic 
techniques. In addiction, one can also plan these nanostructures for what is called 
multiplexing, namely the presence in the same diagnostic signal of information 
related to many analytes at the same time. The nanostructures can be synthesized for 
obtaining targeting, which increases the ability of discriminating different type of 
tumour associated antigens or, in the case of therapeutic purposes, for the ability of 
being directed to a specific site. 
In the present thesis, nanostructures have been synthesized for their applications in 
particular with two techniques like surface enhanced Raman spectroscopy (SERS) 
and magnetic resonance imaging (MRI), which are complementary techniques for 
imaging. The nanostructures have been functionalized also with antibodies for 
targeting antigens.  
SERS exploits the huge enhancement of electromagnetic fields of plamonic 
nanostructures. It is shown that this technique can be used for quantitative 
measurements of clinically interesting anticancer drugs, with a linear range response 
in the order of nanomole per millimetre square of SERS active area, which is 
appropriate also for clinical purposes. It is also demonstrated how molecules with a 
poor Raman cross section could be revealed with the help of a protocol, called 
Reactive-SERS, which considers a simple photoactivated reaction. 
Nanoparticles are obtained with laser ablation and they are found easy to 
functionalize due to their unique naked surface. It is shown that their properties are 
useful in laser desorption ionization mass spectrometry. Used as a matrix, they are 
compared with chemically produced particles and with a widely used organic matrix 
and they always show the lowest background especially in the low mass region under 
500 Da, which is important for the identification of small molecules. 
Multiplexing analysis are carried out with gold nanoparticles (AuNP) functionalized 
with different dyes, as SERS reporters, associated to different antibodies. The library 
of optimized thiolated reporters is increased and makes possible to investigate more 
complex biological samples. This application is also translated to the cultural heritage 
research field for the characterization of paint stratigraphic samples. 
Multimodal contrast agents are developed, coupling the SERS activity, typical of dye 
functionalized gold nanoparticles, with magnetic sensitive moieties, like iron atoms in 
alloy nanoparticles or with Gd3+ ions linked to gold nanoparticles. A new polymer, 
called SuperDOTA, is synthetized for achieving high Gd3+ loadings on the surface of 
nanoparticles. Preliminary results show that AuNPs, functionalized with both a SERS 
reporter dye and SuperDOTA-Gd, have useful properties for in vivo MRI tumour 
analysis and ex-vivo SERS imaging. 
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Riassunto 
Negli ultimi anni le nanotecnologie stanno fortemente influenzando i progressi della 
medicina, in particolare contro il cancro, sia per quanto riguarda la diagnostica che la 
terapia. 
Le nanostrutture possono essere pianificate con proprietà utili per specifiche 
applicazioni. Ad ogni modo, la stessa nanostruttura può essere sintetizzata anche per 
più tecniche diagnostiche. In aggiunta, si possono ottenere nanostrutture per quel che 
viene chiamato multiplexing, ovvero la presenza nello stesso segnale diagnostico di 
informazioni relative a più analiti simultaneamente. Le nanostrutture possono essere 
sintetizzate per ottenere targeting, che aumenta l’abilità di discriminare differenti tipi 
di antigeni associati a tumori o, nel caso di obiettivi terapeutici, per l’abilità di 
raggiungere un sito specifico. 
Nella presente tesi, le nanostrutture sono state sintetizzate per applicazioni con due 
particolari tecniche come la spettroscopia Raman amplificata da superfici (SERS) e 
l’imaging per risonanza magnetica (MRI), che sono tecniche di imaging 
complementari. Le nanostrutture sono state altresì funzionalizzate con anticorpi per il 
riconoscimento di antigeni. 
Il SERS sfrutta l’enorme amplificazione dei campi elettromagnetici di una 
nanostruttura plasmonica. Viene mostrato che questa tecnica può essere usata per 
misure quantitative di farmaci antitumorali di interesse clinico, con un range di 
risposta lineare nell’ordine delle nanomoli per millimetro quadrato di superficie SERS 
attiva, che risulta appropriato anche per applicazioni cliniche. Viene in oltre 
dimostrato come molecole con una bassa sezione d’urto Raman possano essere 
rivelate con l’aiuto di un protocollo, chiamato Reactive-SERS, che sfrutta una 
semplice reazione fotoattivata. 
Le nanoparticelle sono ottenute per ablazione laser e risultano quindi facili da 
funzionalizzare a causa della loro peculiare purezza superficiale. Viene mostrato che 
le loro proprietà sono utili per la spettrometria di massa a ionizzazione per 
desorbimento laser. Usate come matrice, sono state confrontate con particelle prodotte 
chimicamente e con una matrice organica largamente utilizzata e  hanno sempre 
mostrato un rumore di fondo inferiore, specialmente nella zona dei bassi pesi 
molecolari, sotto i 500 Da, che è una zona importante per l’identificazione di piccole 
molecole. 
L’analisi in multiplexing viene fatta con nanoparticelle di oro (AuNP) funzionalizzate 
con differenti coloranti, come SERS reporters, associati a differenti anticorpi. La 
libreria di coloranti tiolati ottimizzati è stata incrementata e rende possibile 
investigare campioni biologici più complessi. Questa applicazione è stata anche 
traslata alla ricerca applicata ai beni culturali per la caratterizzazione di campioni 
pittorici stratigrafici. 
Sono stati sviluppati agenti di contrasto multimodali, accoppiando l’attività SERS, 
tipica delle particelle di oro funzionalizzate con coloranti, e agenti sensibili a campi 
magnetici, come atomi di ferro in nanoparticelle di lega o ioni Gd3+ legati alle 
nanoparticelle di oro. Un nuovo polimero, chiamato SuperDOTA, è stato sintetizzato 
per raggiungere alte concentrazioni di Gd3+ sulla superficie delle nanoparticelle. 
Risultati preliminari mostrano che queste AuNP, funzionalizzate sia con coloranti 
SERS reporter che con SuperDOTA-Gd, hanno proprietà utili per analisi in vivo di 
tumori con MRI ed imaging ex vivo con SERS. 
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1. Introduction 
 
 “I want to build a billion tiny factories, models of each other, which are 
manufacturing simultaneously… The principles of physics, as far as I can see, do not 
speak against the possibility of manoeuvring things atom by atom. It is not an attempt 
to violate any laws; it is something, in principle, that can be done; but in practice, it 
has not been done because we are too big.” 
Richard P. Feynman (1918-1988), Noble Prize in Physics in 1965 
 
During “There’s Plenty of Room at the Bottom”, a lecture at the American Physical 
Society meeting at Caltech in 1959, Richard P. Feynman inspired the concepts of 
nanotechnology. He concluded his talk with two challenges: the fist was the 
construction of a nanomotor, the second was the writing of the content of a book page 
at the scale of 1/25000. Both the challenges were won in 1960 and 1985, respectively. 
At present time, reaching the nanometre scale is no more a challenge. 
Nanotechnology is becoming important in many fields and is finding new applications 
every day in energetics, informatics and health care. 
Noble Metal Nanoparticles as Plasmonic Substrates 
Especially for metals, scaling from the bulk materials to nanometre size particles, 
strongly influences their electronic configuration and, as a consequence, their 
physico-chemical properties. 
The metallic behaviour of long ordered materials breaks down into size-dependent or 
quantum confinement effects, when the particles size falls to nanometre range.1 
Techniques based on X rays are very helpful in understanding this evidences, like X-
ray diffraction (XRD).  
Starting from clusters of few hundreds to few thousands of Au atoms, in the range 
particles of 1-2 nm, Cleveland et al. performed computational analysis to understand 
which geometrical arrangement could be favoured.2 They report that there are three 
preferential stable gold nanocrystallites that could be practically synthetized in this 
range. These nanoparticles were synthesized and they were characterized with mass 
spectrometry. Their core masses were found to be 14k, 22k and 28k (k = 1000au or 
5.08 Au atoms, so the three populations are made of about 70, 110 and 140 Au 
atoms).2 They also registered XRD spectra of these AuNPs clusters and compared 
them with those calculated for the predicted structures. The favourite geometrical 
arrangements, from the energetic point of view, are the Marks Decahedra (m-Dh), as 
show in Figure 1.1. 
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Figure 1.1: Energies of structurally 
optimized AuN (N≤ 520). N represent 
the number of gold atoms in each 
cluster. !! =3.93eV represents the 
cohesive energy of atoms in bulk 
gold. The stable m-Dh clusters, 
compared with experimental data, 
are denoted with filled stars with the 
indices (m,n,p) as in the inset figure. 
From Ref.  2. 
 
 
The comparisons between the experimental XRD pattern and the predicted ones for 
different geometrical arrangements are shown in Figure 1.2. 
We can see that only the m-Dh motif has a reasonable similarity with the 
experimental data for all the nanoparticles studied. The signals observed at large s 
(the x coordinate in Figure 1.2), giving information on the internal atomic structure, 
recall the fcc structure of bulk gold.2 Especially for the Au14k nanoparticles (the first-
top graph in Figure 1.2), the Marks Decahedral configuration in which the apical 
atoms were removed, overlaps perfectly with the experimental data. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.2: The comparison of the 
experimental (“Exp.”) XRD pattern with the 
calculated ones for different geometrical 
arrangement of Au atoms. s = 2 !"# ! ! , 
where !  is the scattering angle and ! = 
1.5405 Å . The bottom bars represent the 
predicted scattering pattern for bulk gold. 
On the top, the experimental XRD for Au14k, 
at the centre for Au22k and at the bottom for 
Au28k. Form Ref.  2.  
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Increasing the nanoparticles size, the diffraction pattern of fcc bulk gold become 
clear.3 Petkov at al. synthetized three populations of particles of 3, 15 and 30 nm.3 
The XRD patterns of these samples show essentially the same Bragg feature of  bulk 
gold, but the signals become more broadened decreasing the size. As expected, 
reducing the lattice dimension, the peculiar long order of bulk crystals is lost and a 
large number of defects grow up. 
In fact, comparing XRD data of Figure 1.2 and Figure 1.3, we found a progressively 
broadening of the diffraction signals decreasing the size of nanoparticles. This 
indicates that the lattice is no more regular as in the bulk material. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.3: XRD pattern for bulk 
gold and 3 nm particles in water 
(a) and for the three population of 
nanoparticles studied by Petkov et 
al. (b). From Ref.  3. 
 
The authors used the atomic Pare Distribution Function (PDF) to compute some 
interesting data regarding the defects of the crystal lattices in nanoparticles. 
PDF is another way to represent diffraction data. It is a Fourier transform of the 
experimentally observable structure function, that explains the coherent part of the 
total scattering intensity.3 In a first approximation, peaks represent the interaction 
with the nearest neighbour atoms. 
The first important consideration, coming from Figure 1.4, is that the bulk gold 
expresses well defined structural features extending at long distance, but, for all 
nanoparticles, it vanishes at distance smaller than the nanoparticles size. 
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 Figure 1.4: Experimental atomic 
PDFs for bulk gold and the three 
populations of AuNPs studied by 
Petkov et al. (a). At bottom (b), the 
first peak for the bulk gold 
(continuous line) is sharper than 
for the nanoparticles (symbols). 
From Ref. 3. 
 
 
For all the studied nanoparticles, the first peak is always approximately at 2.85Å, that 
is the average interatomic distance in gold, but the bands are broader than for bulk 
gold (Figure 1.4b). This fact reflects a sort of distribution in the first neighbour atomic 
distances in nanoparticles, and remains almost constant changing the nanoparticles 
dimension. The authors concluded that the structural disorder, and not the 
nanoparticles size, is responsible for the limitation of coherence in the studied gold 
nanostructures.3 
In nanoparticles, the numbers of total atoms to surface atoms ratio decreases in 
smaller particles, explaining why the X-ray diffraction pattern becomes broader 
decreasing the nanoparticles size. The cores of nanoparticles maintain the fcc 
structure of bulk gold, but the lattice become less regular approaching the surface, 
affecting the distribution in interatomic distances. 
Considering the electronic configuration of a bulk metal, we find an extended 
delocalization of orbitals over the entire crystal lattice. This gives the peculiar high 
electron mobility of metals, reflected in physical properties like electrical and thermal 
conductivity. 
In particles approaching the nanometre size, this orbital delocalization is limited by 
the particle dimension, falling into discrete electronic band structures in the case of 
the smaller particles.1 In this case the nanoparticle physical properties become 
strongly influenced by size, shape, environment and surface coverage. 
For the compound [Au55(PPh3)12Cl6], for example, it was found a discrete band gap of 
170 meV, attributed to the Au55 core. 1 
In Figure 1.5 the Differential Pulse Voltammetry (DPV) for clusters of Au147 and 
Au38, both capped with hexanethiols, are shown. 15 oxidation states were found for 
the Au147 cluster. Different states and also a well defined HOMO-LUMO band gap is 
1. Introduction 
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present for the Au38. This example shows how the delocalization in a metal crystal 
lattice vanishes when the particle size decreases to nanometre scale. 
 
 
Figure 1.5: Differential Pulse Voltammetry (DPV) for Au147 (upper) and Au38 (down) 
capped with hexanethiol. The electronic level spacing increases while decreasing the 
particle size. From Ref. 1. 
 
Compared to bulk metal, physical and optical properties of nanoparticles have 
consistent variations only when the energy level spacing exceed kBT. Therefore, in 
metal nanostructures bigger than 0.5-1.0 nm still remains a consistent electronic 
mobility. The interaction with electromagnetic fields, in this situation, could be 
explained with a classical approach, taking into account a mechanical collective 
oscillation of the electron gas. 1, 4, 5 This excitation is called plasmon. 
These oscillations take place when exited near the electron plasma frequency, that is 
related to the electron density of material. At the surface of bulk metals, plasmons 
take the form of surface plasmon polaritons, also simply called surface plasmon (SP).4 
The SP, optically exited, propagate on the material surface, but, when the surface 
plasmon is confined into a particle with dimension comparable to the incident 
wavelength, all the particle’s free electron participate to the collective oscillation. The 
surface plasmons located in nanoparticles, or other confined structures, are called 
localized surface plasmons (LSPs). 4 
 
Figure 1.6: A cartoon representing the surface plasmon polaritons in bulk metals (a) 
and the localized surface plasmon in nanoparticles (b). From Ref.  4. 
 
Gustav Mie was a physician that solved analytically the Maxwell equation for the 
scattering and absorption of light by spherical particles. At the beginning of the 20th 
century, he proposed an exhaustive explanation for the localized surface plasmon 
effect based on the principles of classical electromagnetic theory. 
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The expressions, calculated by the Mie theory, of the total scattering (!!"#), extinction 
(!!"#) and absorption (!!"#) cross section are the follow: 4 
 !!"# = 2!! ! 2! + 1 !! ! + !! !!!!!  
…Equation 1.1 
 !!"# = 2!! ! 2! + 1 !" !!! + !!!!!!!  
…Equation 1.2 
 !!"# = !!"# − !!"# 
…Equation 1.3 
 
Where k is the incoming field wave vector, L are integers representing the dipole and 
higher multipoles of the scattering. aL and bL are parameters given by the Riccati-
Bessel functions, representing the particle and environment refractive indexes. 4 
When the particle size is much smaller than the incident wavelength, the electron 
oscillation acts principally as a simple dipole and the Mie equations 1.1 and 1.2 could 
be approximated to: 4 
 !!"# = 32!!!!! !!!! !! − !! ! + !! !!! + 2!! ! + !! ! 
…Equation 1.4 
 !!"# = 18!!!! !!! !! !!! ! + 2!! ! + !! ! ! 
…Equation 1.5 
Where: !! = !!! 
…Equation 1.6 
 
 !! = !!! − !!! 
…Equation 1.7 
 
 !! = 2!!!! 
…Equation 1.8 
 
nm is the environment refractive index, nR and nI are the real and imaginary part of the 
particle refractive index, so ! represent the dielectric function of the medium (!!) and 
of the particle (!!  !"#  !). 
This approximation takes into account particles smaller than 10 nm, but the 
predictions was found reasonably correct also for bigger particles 4, up to 100nm. 
When !! !!"#$ = −2!!  the extinction cross section is maximized, reaching the 
resonant condition with the localized plasmon of the particle. 
1. Introduction 
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This explains two important evidences. The first is that only the materials with 
negative values of dielectric function !! can reach the resonance conditions. For noble 
metals this is verified into the visible region. For gold nanoparticles in water, the 
predicted localized surface plasmon resonance is located at 520 nm, well in agreement 
with experimental results.  
The second fact is the dependence of the localized surface plasmon from the 
environment, like the solvent or molecules bound to the surface of the nanoparticle. 
This dependence is also expressed by the slope of the real part of the dielectric 
function in Figure 1.7. 
 
 
Figure 1.7: The real (a) and imaginary (b) part of dielectric function for gold (yellow 
line) and silver (grey line). In (c) are reported an absorption spectra of colloidal gold 
nanoparticle. From Ref. 4. 
 
The Mie theory, complemented by the Gans theory, which takes into account also 
spheroidal particles, can be used to fit experimental absorption spectra of gold 
nanoparticles.6 Instead of expensive and more demanding techniques, like 
transmission electron microscopy, this fitting allows the routine evaluation of 
colloidal gold nanoparticles, giving information on size, shape, aspect ratio and total 
absorption cross section of the nanoparticles.6 
LSPs have also some other important properties. First of all, the electromagnetic field 
near to the nanostructure surface is greatly enhanced, with a strong distance 
dependence from the surface.4 Second, the nanostructure extinction coefficient has a 
maximum at the plasmon resonance frequency. For example, a single silver 
nanoparticle of 80 nm scatters light with a cross section a million times greater then 
the fluorescence cross section of fluorescein molecule, or thousands times greater 
than a fluorescein loaded nanoparticles of the same dimension.5 
Taking into account the sensitivity to the dielectric environment and the field 
enhancement due to the localized surface plasmons, it does not surprise the great 
interest that can be found for the functionalization of such a nanomaterials for sensing 
tools development.5 
Relativistic effects help to understand the chemistry of gold atoms, both in the case 
they are linked to other gold atoms or on the surface of nanostructures. 
The relativistic effect induces the contraction of most penetrating atomic orbitals, e.g. 
the s and p shells, affecting the consequent expansion of d and f shells.7 The 
relativistic contraction of 6s has its maximum effect at Z=79, corresponding to gold.7 
It reflects in three main aspects. First, the atomic radius of neutral gold is similar to 
silver, and the ionic radius for the first oxidized cation Au(I) is smaller than that for 
Ag(I). Second, the relativistic contraction of 6s influence also the 5d orbital, enabling 
the easy hybridization to sd orbitals and, therefore, their linking to neighbour atoms. 
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Third, the so called aurophilic effect, that is the weak 5d – 5d interaction that 
becomes important for the formation of complexes with Au(I)-Au(I) bonds.7 
The ubiquitous ligand used for the functionalization of the gold surface is the thiol 
group, even though the nature of the thiol-gold interaction has been systematically 
investigated only in recent yeas.7-9 
Jadzinsky at al. prepared in 2007 gold nanoparticles covered with p-mercaptobenzoic 
acid (p-MBA). 8 One of the most interesting highlight of their research is the 
extremely narrow size distribution of the particles [Au102MBA44], allowing them to 
obtain nanoparticle crystals and to perform X-ray crystal structure analysis.  
Their results show that the gold atoms effectively assume a Marks decahedron 
geometry, consistent with the fcc crystal structure. In addiction they observed that 
gold atoms up to 5.5Å from the centre of the particle do not bound any sulphur. 
Atoms between 6 and 6.3Å bound one sulphur and gold atoms in the shell between 
7.5 and 8Å bound two sulphur atoms.8 This observation implies the formation of S-
Au-S and Au-S-Au bridges, both observed also in other studies.7-9 
The sulphur atoms appear to be hybridized as sp3, with two orbital engaged with gold 
atoms, one with the rest of the molecule and the last as lone pair electrons. The 
sulphur also acts as a chiral centre and optical activity was found in thiol 
functionalized gold nanoparticles.7, 8 
The thiolate-gold bond has a strength close to that for gold-gold bond, so it strongly 
influences the lattice structure at the particle-environment interface.7 Surface gold 
atoms can in fact be extracted from the crystal lattice due to the formation of Au-S-
Au-S-Au chains.7-9 This extracted atoms are called adatoms and was found of crucial 
importance in the formation of self assembled monolayer at the low coverage regime, 
as shown in Figure 1.8.7 
The adatom and vacancies migration allows changes between gold-sulphur bond 
conformations and, moreover, translations of thiolated molecules on the metal 
surface.7, 9  
 
 
 
Figure 1.8: (a) The STM image of a self assembled CH3SH over a pure gold 
substrate. (b-d) and (c-e) The close-up image of the same sample on the situation of 
cis-trans and tran-trans assembling and relative atomic models. In (e-f) is shown the 
peculiar Au-S-Auadatom-S-Au chain with the tetrahedral geometry of sulphur molecular 
orbitals. From Ref.  7. 
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Raman Spectroscopy and SERS 
In 1930 C. V. Raman received the Noble Prize in Physics on “his work on the 
scattering of the light and for discovery the effect named after him”. 
The Raman effect is the inelastic scattering of radiation by molecules or crystals in a 
solid, liquid or gas sample. 10 
Every species has its own electronic configuration which assumes a stable electronic 
spatial distribution that could be perturbed by an incident electromagnetic field. The 
response of the electronic system is called polarizability.  
An electromagnetic field interacting with a chemical species, in a non-absorptive 
process, induces an oscillating dipole governed by the polarizability. The scattered 
light shows three main contributions, one from the scattered field at the same 
frequency of the incoming one (Rayleigh scattering), and two at  slightly smaller 
(Stokes Raman scattering) or larger (anti-Stoke Raman scattering) frequencies than 
that of the original field. Reyleigh scattering effect is usually several order of 
magnitude more intense than Raman scattering.11 
Raman scattering frequencies are usually related to a variation of the molecular 
polarizability induced by vibrational normal coordinates. Therefore, Raman 
spectroscopy is considered a vibrational spectroscopy although other degrees of 
freedom, like for example those of electron spins, can induce other features in the 
inelastic scattered light. 
One of the main difference between IR and Raman spectroscopy are the different 
selection rules, that makes these two techniques complementary, especially when the 
analysed species have an inversion centre. In this case the active modes in IR and in 
Raman are mutually exclusive.11 The second main difference is that Raman 
spectroscopy allows to obtain vibrational spectra exiting the sample at different 
frequencies.10 This possibility allows to avoid problems related to the presence of 
fluorescence in the scattered light. 
The advent of lasers made this technique more suitable for routine analysis by using 
monochromatic and intense radiation sources. 
The Raman scattering cross sections are usually very small, but the overall signal can 
be enhanced by several order of magnitude in particular situations, like when the laser 
excitation is close to an absorption band (called Resonance Raman Spectroscopy, 
RRS)10 or/and when the molecules are close to a plasmonic surface (called Surface 
Enhanced Raman Scattering, SERS).12-15 
In RRS, only the vibrations related to the chromophore are usually enhanced. 
Therefore, the vibrations not involved in the enhancement result to be almost invisible 
in the spectra.10 The RRS has the advantage to selectively amplify the spectrum of 
molecules or chromophores according to their absorption properties, although in these 
cases it can lack of all the vibrational information given by normal Raman spectra. 
In Figure 1.9 are reported two RRS spectra of pyrene obtained by exciting at different 
frequencies, in resonance with different excited states. As a function of the exited 
transition, different peaks become dominant because of their different coupling to the 
excited states. 
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Figure 1.9: Resonance Raman spectra 
of pyrene at 229 nm excitation (A) and 
257 nm excitation (B). The two spectra 
show many  differences in particular as 
relative intensities of peaks.  
From Ref. 10. 
 
 
Some problems are, however, related to RRS. The first is a technical one, because 
there are a finite number of laser systems which are commercially available for 
excitation. The second is the possible photodamaging of samples occurring and at 
resonance conditions. The third is the fluorescence, which is larger in resonance 
situations and that is often much more intense than Resonance Raman scattering.10 
The use of plasmonic nanostructures as substrate for Raman spectroscopy has the 
advantage of quenching the fluorescence and, much more important, increasing the 
Raman  intensities over several order of magnitude.10, 13-18 
This amplification effect is called “surface enhanced Raman scattering” (SERS). 
The first proposal of enhancements, up to 106, can be found in the ‘80s, measuring 
rhodamine 6G adsorbed over silver.15 The SERS cross section was found comparable 
to that of fluorescence, foreseeing the possibility of single molecule SERS, as it was 
possible with fluorescence. 
The mechanism involved into the surface enhancement is partially understood but it 
can be still considered an open issue. 
However there is a fixed point to take into account, the molecule has to be close to the 
metallic surface.13-15, 18 
A first proposed enhancement mechanism is called “chemical enhancement” (CE). By 
this effect, the molecule has to be physically or chemically absorbed over the metal 
surface and new resonances take place due to one or more of the following states: 
metal-ligand complex formations, creation of new charge transfers states 
(understandable with coordination chemistry) or transient hot electrons or electron-
hole pairs formation between metal and adsorbed molecule.15 
In a recent review, Moskovits, reports some excellent studies on the SERS 
enhancement factor calculations, comparing computational and experimental results 
that look at the enhancement mechanisms of SERS.15 He concludes that only 
chemical enhancement is not sufficient to understand the huge amplification 
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(sometimes over 10 order of magnitudes) provided by SERS. For the author, the 
complex formation could not result in amplifications up to one order of magnitude, 
unless it acts with the opening of new resonances, as charge transfer states. In this 
case, most theories evaluated the coupling of the adsorbate vibrations with the 
plasmon of the metal surface, considering that a metal hot electron, or a hole, or both 
are present on the adsorbate. Then, these return to the metal with information on the 
vibrations of the adsorbate.15 
At present time, it is widely accepted that the chemical enhancement gives a 
contribution to the SERS enhancement up to the order of 102.14, 15, 18 
The second, much more important, amplification mechanism is the “electromagnetic 
enhancement” (EE), almost exclusively due to the plasmon resonance. The EE theory 
states that SERS arises from the concentration of the electromagnetic field due the 
collective oscillations of a localized surface plasmon.14, 15 In SERS, the nanostructures 
behave as receiving and radiating antennae, concentrating light and exciting the 
molecule in close proximity to them.15 
Therefore, the SERS effect originates primarily from the metal structures since the 
enhancement factor is a property of the plasmonic substrate.15 
Usually observed electromagnetic enhancement factor vary from 104 to 106.15, 18 
Obviously, the chemical and the electromagnetic enhancement are present 
simultaneously, but the contribution of the second one is dominant. 
Since the EE mainly derives from the collective oscillation of electrons in plasmons, 
configurations allowing positive interferences of such enhanced electromagnetic 
fields creates further near field amplifications. Tips, junctions and roughly surfaces 
are only some examples of situations which are called “hot spots”. 
It is reported that in a plasmonic substrate, where less than 100 sites over 106 are hot 
spots, the 24% of the entire signal comes from these few hot sites.15 
In Figure 1.10 are shown some calculation based on discrete-dipole approximation 
(DDA) performed by Amendola at al. on the electromagnetic enhancement factor of 
gold nanoparticles alone and in dimer form.18 The results show an increase of 
enhancement between 2 and 3 orders of magnitude in the hot spots with respect to the 
nanoparticles alone. 
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Figure 1.10: Discrete-dipole approximation (DDA) calculation of electromagnetic 
enhancement factor for gold nanoparticle between about 10 and 30 nm, for isolated 
particles or for dimers. The results show bigger enhancement within junctions . From 
Ref . 18. 
 
Nuclear Magnetic Resonance as Imaging 
Technique 
The interaction of matter with an external magnetic field primarily involves the 
electron and nuclei spins which change their state energies. Different populations on 
these states produces a magnetization of the sample. An electromagnetic field 
interacting with the spin states causes a perturbation of the state populations, and  the 
net magnetization changes its orientation. Most techniques based on these interactions 
look at the spin nuclei and, for practical applications like magnetic resonance imaging 
(MRI), protons present in water are considered. Since the dynamic of the excited spin 
states depends on the nuclei environment, different responses can be observed in 
different tissues. This is the rationale of the MRI investigations in medicine. 
The electromagnetic radiation used in MRI is in the radiowave spectral region and is 
considered a safe radiation. Usually the contrast in the recorded images is poor and 
contrast agents are needed for its enhancement. Nanosized optimized contrast agents, 
are very important for these applications.19-23 
Compared to the optical spectroscopy, where a continuous scanning of the radiation 
frequency is performed, in magnetic resonance spectroscopy a single pulse, or a 
sequence of  radiofrequency pulses, are applied.24 
The pulse has the effect to induce a temporary perturbation of the system, that returns 
to the initial equilibrium state in a time also depending on the environment conditions. 
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The entire phenomenon is represented in Figure 1.11. The z axis is along the direction 
of the static magnetic field B0. The nuclear net magnetization is aligned to the field, 
along the z axis. The radiofrequency pulse (RF in the figure) has the effect to change 
the orientation of the magnetization vector. Frequently used pulses rotate the 
magnetization on the xy plane, so they are called “π/2 pulses”. This means that the 
population of the two spin states becomes equivalent (magnetization projection over z 
axis equal to zero) and that a magnetization appears in the xy plane .  
At the end of the pulse, the orientation induced by the electromagnetic field relaxes to 
the initial state along the z axis.  
 
 
Figure 1.11: Cartoon representing the effect of the external magnetic field B0 and the 
effect of the radiofrequency pulse RS in a magnetic resonance experiment.  
 
The signal decreasing in time domain in the xy plane, called “Free Induction Decay”, 
is the observable in magnetic resonance spectroscopy experiments. 
There are two main mechanisms involved in such relaxation, both expressed in term 
of time required to re-establish the equilibrium after the radiofrequency pulse.  
The first is known as longitudinal relaxation and is called T1, the second is the 
transverse relaxation, called T2. 
As a first approximation, the longitudinal relaxation is related to the restoring of 
population ratio between the two spin states, so it is mostly related to the recovery of 
the projection of the magnetization on the z axis. 
The T1 relaxation in biological samples is mostly due to the rotational and 
translational degree of freedom of molecules (especially water). If the tumbling 
frequency of protons matches the Larmor frequency, spin re-equilibration is favourite 
and so a short T1 is shown.25 For solid and slowly moving structures, the molecular 
tumbling frequency is too low. For unstructured tissues and fluids it is high. An 
intermediate situation is found on moderately sized proteins and fatty tissues and, for 
these situations, T1 is shorter than for the other one.25  
The transverse relaxation T2 is the dephasing of the spin states in the xy plane 
affecting therefore the magnetization in this plane. After the π/2 pulse, the maximum 
magnetization in the xy plane comes from an initial phase coherence of the individual 
spin protons. In amorphous structures, mobile molecules are not constrained and they 
exhibits long T2, while water molecules in hydration layers or in solid non-moving 
structures have very short T2 values.25 
1. Introduction 
 16 
Since the longitudinal and the transverse relaxation take into account the mobility of 
protons for the restoring of the equilibrium state, tissues showing long T1 often show 
also long T2 and vice versa. 
The Magnetic Resonance Imaging (MRI) is a diagnostic technique in which tissues 
are subject to a strong magnetic field and are irradiated with electromagnetic waves in 
the radiofrequencies. The differences in term of relaxation times, T1 and T2, due to the 
different responses exhibited by protons in different environments, are used to map 
the samples. 
The magnetic resonance imaging is a powerful diagnostic technique because it uses 
high penetrative and save radiation for biological tissues. 
Simply changing the pulse programme, different tissues are empathized measuring T1 
or T2. 
The advent of magnetic contrast agents allowed to overcome the not trivial 
discrimination of tissues that appear similar in MRI, as it will be reported in 
subsequent paragraphs. 
Synthesis of Noble Metal Nanoparticles by Laser 
Ablation 
The Laser Ablation Synthesis in Solution (LASiS) is a top down method for colloidal 
nanoparticle preparation starting directly from bulk materials.6, 26, 27 This method has 
extensively been used for this thesis work. 
The approaches to the nanoparticle synthesis can be classified according to the 
methodologies used, namely growing particles from atomic precursors (bottom up 
approach) or “extracting” them from a bulk macroscopic target (top down approach). 
The first one involves wet chemistry techniques, which often needs also reagents 
which can be toxic and can produce by-products and wastes.1 LASiS is simple, 
produce naked particles 28 and respects the 12 principles of green chemistry.26, 27 
 
 
Figure 1.12: The main feature of a laser ablation set-up and the principal parameters 
to take into account are represented schematically. From Ref. 26. 
 
The ablation set-up consists of a pulsed laser focused on the surface of the target. 
Usually, the ablation process is performed in a gas atmosphere, 27 but in the present 
work the target was ablated at the bottom of a flask, filled with a solvent, usually 
water. 
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The parameters to take into account in a LASiS synthesis are several, from the laser 
parameters, to the solution and, certainly, the target composition. 
Some general practical remarks have to be made. Since it is important that the largest 
possible fraction of laser energy reaches the target, the excitation wavelength has to 
be carefully chosen. In particular, the absorption of the laser by the solvent or by the 
produced nanoparticles has to be avoided. 
The nanoparticle synthesis follows some processes that are well characterized, but 
several details still remain not yet completely understood. 
Amendola and Meneghetti published a recent comprehensive review focused on this 
topic.27 
Considering, as starting time, the moment in which the pulse hits the target surface, 
the first phenomenon to occur is the linear and nonlinear absorption of the laser 
energy. 
The detachment of the ablated material starts at a timescale between 1-100ps. The 
high energy absorbed causes a large temperature gradient between the irradiated spot 
and the surrounding material. Accepted theories, regarding this detachment process, 
talk about three main mechanisms: the vaporization, the “coulombic explosion” and 
the “explosive boiling”.27 
The “explosive boiling” is believed to be the main mechanism involved with ns laser 
pulses.27 It occurs when the irradiated material is superheated up to the 
thermodynamic critical temperature, then a spinodal decomposition takes place and 
nanomaterial homogeneously nucleate.27 
The ablated material is highly concentrated in space and contains highly ionized 
species. At this stage, the so called “plasma plume” is observed.  
When the pulse duration is between 100 ps to 1 ns, there is a temporal and spatial 
overlaps between the pulse and the plasma plume. The laser irradiates the plasma, 
increasing its lifetime, its energy and its homogeneity. The phenomenon is known as 
“plasma shielding” and it is particularly important in laser ablation with ns pulses, 
where sharper size distribution of nanoparticles is observed with respect to those 
observed for ps or fs pulses.27 
 
Figure 1.13: The crater on the irradiated target spot area in gas-phase laser ablation. 
The differences using fs (A), ps (B) or ns pulses (C) are evident, mostly involving the 
increasing predominance of thermal process while increasing the pulse duration time. 
From Ref. 27. 
 
The mean lifetime of the plasma plume is between 100ps and 100ns depending also 
on the solvent above the bulk material. In LASiS, the plasma is confined close to the 
crater area by the solvent, where the plasma plume progressively transfer its thermal 
energy (temperatures about 103 K) both to the solution and to the target. 
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These huge energies were proved to initiate chemical processes involving the solvent 
and the ablated material. For example, organic solvents, especially toluene, degrade 
into a carbon graphitic-like shell over the surface of gold nanoparticles.29 
In laser ablation of gold in NaCl aqueous solution at micromolar concentration, the 
influence of the solvent and solute was found fundamental for the colloidal stability.  
Gold nanoparticles obtained in aqueous solutions show a little percentage of surface 
atoms (3-7%) with negative charges.26 Gold oxidation states of (I) and (III) were 
found through XPS and the presence of Au-O species was also revealed with 
vibrational spectroscopies.26 It is believed that the high energy of the plasma plume 
determines a partial oxidation of the gold nanoparticle surface and that both Cl- than 
OH- help to develop Au-O- negative charges.6, 27  
This effect produces a coulombic repulsion between nanoparticles, which gives 
stability to the aqueous AuNP colloid without any added surface coverage. 
Other phenomena related to the laser ablation can be understood as shockwaves and 
cavitation bubbles determined by the high pressure and temperature present in the 
ablation process.6, 27 Figure 1.14 summarizes the main processes occurring in LASiS. 
 
 
Figure 1.14: Cartoon representing the temporal evolution and the steps involved on 
the nanomaterial (NMs) formation during the laser ablation in solution.  
From Ref. 27. 
 
The main pros of LASiS, compared to wet chemistry nanoparticle synthesis, are the 
versatility, since different starting materials and different solvents can be used; the 
easy experimental set up, that remains almost unchanged for the synthesis of different 
particles, the cheapness of the synthesis, and last but not least, the ablation is waste 
free, the target unused can be re-used simply by changing the upper solution. 
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As drawbacks, one should recall that the nanoparticles size distribution is often 
broader than that obtained with chemical synthetic methods and that it is not trivial to 
obtain non-spherical particles, due to the nature of ablation process. 
Application in Cancer Treatment and Diagnosis 
In recent times cancer surpassed heart diseases as leading cause of death in US 
population for which data are available.30 
Cancer is the term used for the irregular proliferation of cells, that sometimes can 
diffuse into other sites through the vascular system. These cells are not foreigner, but 
come from the same organism. Sometimes, during cell replication, or caused by 
external agents, the DNA could be damaged. Most often such modifications cause the 
death of the cell, but there is the possibility that the cell is able to survive, and 
continue to replicate with its modified DNA. In such a situation, a population of 
cancer cells grew up. The tissue formed by these cells is called tumour.11 
Nanomedicine indicates that nanotechnology is involved in the treatment and/or 
diagnosis of diseases.30, 31 This implies the knowledge of the properties of materials 
by changing their size, shape, structure, or by modifying the surface with ligands. 
Nanoparticles can integrate different functions also for improving cell targeting, 
which is useful for imaging or for therapy.31 
From a therapeutic point of view, because of poor pharmacokinetic profiles and broad 
mechanism of action, small drug molecules have often a poor specificity for the target 
diseased tissue and other healthy ones.32 Using nanoparticles, consistent variation in 
pharmacokinetics are found. Their high potential stays in reducing the off-target 
toxicity and improving the therapeutic index of carried active moieties. 
Looking at the diagnosis, nanotechnology offers the possibility to improve efficient 
and multiple contrast agents for optical, magnetic, radio and acoustic imaging.19, 20, 31 
A general strategy for the preparation of multifunctional particles for nanomedicine 
has to take into account as many as possible points among the following: 
• Stealth features have to be improved to evade the immune system and prevent 
opsonization.20, 32, 33 
• A protective layer has to be designed to prevent the degradation of sensible 
loaded drugs, protein, DNA and so on.32 
• Targeting moiety for assisting the enhanced permeability and retention effect 
(EPR) on tumour, increasing selectivity and accumulation.30, 32, 33 
• Considering membrane permeation features and intracellular targeting 
moieties, or taking into account endosome escape mechanisms, improve the 
efficacy to specific intracellular targets.32 
• Designing imaging agents also for obtaining information on the efficiency of 
delivery and dose/effect responses.32 
• A planned drug-release behaviour. This could be a target-dependent assembly 
or disassembly, like pH sensible structures or enzyme cleavable moieties.11, 32 
Theranostic is a treatment that combines therapy and diagnostic into the same 
material, a challenge easier to be achieved through nanotechnology.20 
An excellent example of multifunctional nanomedicine, with unusual in vivo targeting 
approach, was provide by Von Maltzahn et al.34 They used a two steps targeting 
mechanism. In the first step, gold nanorods covered by polyethylene glycol 
accumulate to the tumour thanks to the EPR effect.  Then infrared irradiation is used 
to cause a temperature increase in the tumour tissues, where gold nanorods are 
accumulated. As a consequence, a biological coagulation cascade occurs and a second 
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type of nanoparticles, functionalized with targeting peptides for such an enzymatic 
cascade, reach the tumour. These second targeted nanoparticles are iron oxide 
nanostructures, providing MRI contrast, or drug loaded liposomes. The authors show 
a 40 fold drug response increase using both these “communicating” nanoparticles 
instead of the drug loaded liposomes alone.34 
Despite the clear advantages provided by sophisticated multifunctional nanoparticles, 
their longer and more complex synthesis reflects over the costs of the products.32 
In 2011, any of the therapeutic nanoparticle formulations at advanced clinical trials, 
or just approved by FDA, present an active targeting moiety.32  
The enhanced accumulation yield, due only to the enhanced permeability and 
retention effect, and the higher drugs loading provided by nanosystems are just some 
of the important improvements that can be obtained.  
New functionalities add new variables too. For example, adding targeting features 
could compromise the stealth properties. In fact, it was shown that the same non-
targeting particles have longer circulating lifetime.32 Furthermore, the dynamic nature 
of tumour markers affect the efficacy of active targeting. For example it was shown 
that the Her2/neu receptor density decreases by 40% after the treatment with 
Trastuzumab conjugated nanoparticles.32 
 
 
Figure 1.15: List of passive targeted nanoparticle formulations in advanced clinical 
trials in 2011. The status “approved” is referred to the approval for clinical practice 
by the American Food and Drug Administration (FDA). From Ref. 32. 
 
 
Figure 1.16: List of active targeted nanoparticle formulation in advanced clinical 
trials in 2011. From  Ref . 32. 
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Therapeutic Drug Monitoring 
The advantages provided by nanotechnology in developing targeted therapies are 
important to reduce size effects due to the systemic diffusion of active drugs. 
However, this is not sufficient when taking into account the individually variability of 
drug responses concerning efficacy, tolerability and toxicity. Such variables depend 
on patients factors, such sex, age, genetic background, and also depend on 
environmental factors like concomitant medications, smoking, diet and the personally 
belief in treatment and cure.35 
Statistic studies show that over 2 million of US patients support serious drug side 
effects per years, with 100 000 patients dying.35 
The therapeutic drug monitoring (TDM) is based on the idea that the concentration of 
a drug in the plasma, or in the blood, reflect the concentration of the drug at the target 
site better than the given dose.35 
Monitoring the drug concentration in patients allow to adjust the dosage in prolonged 
therapies and helps in understanding the pharmacokinetic and pharmacodynamics 
related to individual factors. 
A disease where TDM could be particularly useful is cancer. Cytotoxic drugs are 
characterized by very narrow therapeutic interval, that is the range in which the 
concentration is higher enough to have clinical effects, but not too high to be toxic.35, 
36 
Nussbaumer at al. published an extensive review on the analytical performances for 
the quantification of anticancer drugs in biological and environmental samples. 36 The 
authors reported that the highest sensibility is achieved by mass spectrometry coupled 
to liquid chromatography, frequently reaching the limit of detection of the order of ng 
per mL. 
In clinical practise, almost every drug is measured using chromatographic 
techniques.36  
Perspectives for the therapeutic drug monitoring could not escape the development of 
new point-of-care (POC) analytical methods. 
In principles, a POC device has to be easy to use, portable, cheap and, of course, it 
must provide robust analytical measurements in term of selectivity and sensitivity.  
Using POC for TDM allows patients to monitor the efficacy of their therapy at their 
own home, or allows doctors to personalize and adjust drug doses in function of 
individual therapeutic response. 
Paper based POC devices found really promising applications. Paper is cheap, light 
weigh, biocompatible and easy to use, dispose, store, transport and modify. 37 
The most popular application of a POC based on paper sampling tool is for the 
glycemic index monitoring in blood, but for cancer the issue seems to be more 
complicated. 
Both for treatment and diagnosis, a single marker measurement is not sufficient for 
cancer. Therapies often involve formulation of multiple drugs 11 and a correct 
diagnosis have to take into account different biological features as selected proteins 
concentration level and the presence of particular DNA or RNA sequences or of 
circulating tumour cells.38 
The analytical technique used for cancer POC devices has to be capable to distinguish 
and measure multiple analytes simultaneously. 
Mass spectrometry was used as analytical tool by Espy at al.. They defined a new 
protocol which required only 60 seconds between sampling and the output of 
results.39 The protocol uses a drop of blood, adsorbed on a paper, and alum for its 
coagulation. The paper is than connected to a high voltage field and few tens of 
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microliter of solvent are added at the edge of the paper. The solvent migrates to the 
other edge of the paper and, due to the high voltage, is sprayed into the mass 
spectrometer. Limits of detection and quantification ranges are shown to be 
compatible with clinical applications for eight different anticancer drugs.39 
The surface enhanced Raman spectroscopy, due to the fingerprint signature provided 
by vibrational transitions and the high sensitivity provided by the localized surface 
plasmon amplifications, can be a valid alternative for the TDM field. 
Since the SERS is a surface technique, the interaction and the distribution of the 
analytes on the plasmonic surface have to be taken into account.  
In the case of molecules with reasonable Raman cross sections, and that effectively 
adsorb on the surface of plasmonic substrates, SERS is a very effective  technique 
because many molecules can be recognized by their own Raman spectra with only 
one measurement.13 
Quantitative SERS evaluations have to consider some issues like the reproducibility 
of signals, principally due to the SERS substrate. The surface enhancement acts only 
on molecules very close to the plasmonic surface, and even the fluorescence 
quenching act in the same way. This could be counterintuitive, but lowering the 
amount of analytes often results in an increase of the signal to noise ratio. 13 
Homogeneous and reproducible distribution of hot-spots is needed for reproducibility, 
since the highest percentage of the collected signals come from these points.15 
Instrumental parameters, such as excitation wavelength, laser power and time 
exposure are crucial variables to consider for maximizing the scattering and 
preventing photo-decomposition, especially in resonance Raman conditions. 
Farquharson et al. reported quantitative estimation of 5-fluoruracil anticancer drug by 
SERS on less than 1mL of saliva and in less than 5 minutes.40 The SERS substrate 
used by the authors were silver nanoparticles embedded in a sol-gel matrix. The limit 
of detection was reached at 150ng/mL. 
Song et al. used core-shell Fe3O4@AuNP and Fe3O4@AgNP as SERS substrate for 
the quantification of thiram (a fungicide). The authors first mixed the nanoparticles 
with the analyte solution, then used the magnetic susceptibility of the iron oxide core 
to concentrate the particles in a spot where the SERS signals were than acquired. A 
linearity regime is reported up to 0.5 micromolar concentration of thiram.41 
A different approach was exploited by Hidi at al., using a microfluidic device to 
transport methotrexate solutions (an antibiotic) over silver nanostructure.42 SERS 
quantitative evaluation shows a linearity range between 0.2 and 2 ! M of 
methotrexate, with a detection limit of about 0.17 !M. 
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Advanced Diagnostic Tools 
In most patients, by the time the cancer is detected, metastasis already occurred. In the 
case of lung cancer, the percentage of metastatic patients at the time of the diagnosis 
is more than 80%.33, 43 
The enhanced permeability and retention effect, present in many solid tumours, is 
effective only when the tissue is larger than about 5mm in diameter.33 
 
 
Figure 1.17: An image representing the preferred arrival sites and relative 
probabilities for some of the most diffuse tumours. The light blue areas are the 
starting location of tumours. From Ref . 33. 
 
Taking into account these evidences, the development of nanotechnology for high 
contrast imaging or high theragnostic efficiency, but still with nanoparticles 
accumulation in tumour only by EPR effects, seems to be suitable only at an advanced 
stage of the disease. 
Contrast agents for in vivo imaging of tumour remain of absolute importance, 
especially approaching its surgical operation. 
Magnetic resonance imaging (MRI) is one of the most powerful total-body imaging 
technique used in medicine. The reason is that MRI combines safe and high 
penetrative radiation with an huge variety of information given by specific responses 
of tissues to the magnetic field. Moreover, where the sample appears too much 
homogeneous, the advent of contrast agents (CAs) overcome such lack in selectivity, 
as in the case of soft tissues differentiation.20 
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The most used imaging techniques based on MRI are T1 or T2 weighted signals. 
As just mention in a previous paragraph, T1 and T2 are related to the spin relaxation 
times of the spin populations.  
CAs help in shortening these two relaxation times, but the effect, for a single agent, 
will be stronger for one of the two. Therefore, a CA could be referred preferentially as 
a T1 or T2 contrast agent. 
A common property has to be the high magnetic moment of the CA. T1 contrast 
agents are generally paramagnetic metallic cations with a high number of unpaired 
electrons. Gd(III), for example, have a S8 ground state.19,21 The longitudinal relaxation 
is strongly influenced by dipole-dipole interactions or spin couplings, so water 
molecules coordinated to the paramagnetic metal strongly interact and their protons 
relaxed at shorter times.19, 21 
In comparison, the transversal relaxation mechanism is affected by field 
inhomogeneity. Iron oxide nanoparticles (FeOxNPs) have a high concentration of 
paramagnetic centres (iron cations). Their magnetic moment is than very intense, 
creating important field inhomogeneity that involved a large number of water 
molecules, also at the outer coordination spheres.19 FeOxNPs are most known as T2 
contrast agents. 
A significant limitation of MRI CAs is their low sensitivity. At least micromolar 
concentration of paramagnetic agent have to be present to improve an image 
contrast.32 This makes often necessary the validation with other diagnostic 
techniques.19 
FeOxNPs as T2 CAs are often more sensitive than other T1 CAs like Gd(III) 
complexes, but improves only a negative contrast in T2 weighted images.19 
The general strategies to improve the efficacy of T1 CAs involved the increment in 
coordinated water molecules or the synthesis of macromolecule containing more 
metallic cations.19, 21  
However, a really advance is provided by the synthesis of a new class of materials, 
incorporating the better advantages of MRI and of other complementary imaging 
techniques, the so called multimodal contrast agents (MCAs).19 
Magnetic resonance imaging is a total-body technique and shows spatial resolution of 
the order of tens of micron in the best cases.19, 21 Optical techniques can be considered 
complementary techniques because, although they do not have a great body 
penetration, they can use much more sensitive contrast agents (at nanomolar or less 
for SERS), and show sub-micron spatial resolution. Furthermore they also show the 
possibility of multiplexing analysis, in particular in the case of SERS.13 
Kircher at al. proposed triple multimodality MRI-photoacoustic-SERS nanoparticles 
for in vivo passive targeting and imaging of tumour.22 They functionalized 60 nm gold 
nanoparticles with a Raman active dye. Then they covered the AuNP with a sol-gel 
matrix and functionalized the external surface with a DOTA-Gd(III) complex. The in 
vivo model was a mice with an implanted brain tumour. The authors reported the pre-
surgical MRI imaging and photoacoustic and SERS imaging during the surgery for a 
better removal of tumour margins. 
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Figure 1.18: Representation of the nanoparticles and protocol used by Kircher at al. 
for multimodal contrast agents imaging. From Ref. 22. 
 
The early diagnosis of cancer is the second main issue on the prevention of 
metastasis. 
About 60% of patients with ovarian cancer just present metastasis by the time of the 
diagnosis. Therapies at such advanced state are often not very effective, with a 
survival at 5 years of about 30-40%. By contrast, the same survival percentage rise to 
95% if the cancer is detected when it is still confined to the ovary.43 
After free DNA was found in the serum of cancer patients, a special attention was 
focused on circulating biomarkers for the diagnosis and prognosis of cancer. Despite 
free DNA is released in plasma also by healthy patients, the progressive 
differentiation of tumour from normal tissues causes discrete clinically relevant 
peculiar characteristic, as in the case of specific proteins expression.32, 43 
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Figure 1.19: Common tumor biomarkers that can potentially be used as targets for 
nanoparticle. PSMA, prostate-specific membrane antigen; PCLA, prostate cancer 
lipid antigen; MUC1, mucin-1; VCAM-1, vascular cell adhesion molecule 1; VEGFR, 
vascular endothelial growth factor receptor; Tem1, tumor endothelial marker 1; 
TAMs, tumor-associated macrophages; TAFs-FAP, tumor-associated fibroblasts–
fibroblast activation protein; TEMs, Tie-2–expressing monocytes; APA, 
aminopeptidase A. From Ref. 32. 
 
Most of actually used tests, approved for disease detection, are protein-based assay.43, 
44 Probably, the most popular one is the enzyme-linked immunosorbent assay 
(ELISA). In a classical simple protocol, the bottom of a well is functionalized with a 
specific antibody. The relative antigen, if present on the sample, is than recognized 
and fixed. A second antibody is finally added for the detection. This second antibody 
is coupled with a peroxidase, that reacts with a colorimetric reagent developing a 
colour whose intensity is proportional to present antigen. The ELISA test is robust, 
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linear and is considered an immunological analytical tool. In this way an effective 
high number of clinically relevant biomarkers could be quantified in biological fluids, 
such as serum, urine or saliva. 
The real issue for the early diagnosis of cancer is reaching the adequate detection 
limits. 
Surface enhanced laser desorption ionization (SELDI) is a promising ionization 
source for mass spectrometry, usually coupled with time-of-flight, used in proteomic 
studies.43, 44 
This technique has the same immunological selection of ELISA, ea. by an antibody 
functionalized surface, but the second step consists in the addition of an organic 
matrix and in the irradiation with a laser for the desorption of the antigen ions to the 
mass analyser.43 
 
 
Figure 1.20: Serum concentration of selected proteins. The cancer type attribution 
come from SELDI-TOF studies. Form Ref. 44. 
 
Quantitative SELDI-TOF studies found higher prostate specific antigens 
concentrations in patients with prostate cancer with respect to healthy ones. Data 
regression analysis resolved discrete patterns of SELDI peaks attributed to prostate 
cancer instead of benign prostate signatures.43 Despite such  impressive results, some 
crucial drawbacks related to measurement reproducibility was remarked by 
Diamandis.44 This author attributes these effect to non uniformly data acquisition and 
computational treatments, in addition to case variability in immunological 
procedures.44 
The discovery of new clinically relevant biomarkers remains one of the most crucial 
challenges. 
In this field, the analysis of representative tumour tissues is essential, but it could be 
sometimes difficult to obtain, as for example in the case of patients with non small-
cell lung cancer (NSCLC) where the surgery is frequently not a component of the 
treatment.45 
Even in cases where primary tissue is available, the tumour sample could not be 
representative, if long time and therapies passed from the diagnosis to the biopsy. In 
other cases, like for the prostate, the disease is often indolent for 10-15 years and the 
metastasis are often located in bones, from where a fresh biopsy is difficult.45 
Backman at al. reported the characterization of cancer epithelia cells based on the 
nucleus dimensions.46 Cancer cells show a nucleus large up to 20 !m, instead of 5-10 
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!m for non-dysplastic cells. The measurements were provided in vivo on endoscopic 
screening by scattered light carried on with optical fibre. 
Even at the early stage of cancer, few metastatic cells could be found in blood. These 
circulating tumour cells (CTCs) could be collected from blood draws and are 
considered well representative of the state of the disease.45 
The American Food and Drug Administration approved the use of CellSearch® as 
clinical protocol for the extraction and enumeration of CTCs from blood.45, 47 
It is an immunologic based method in which magnetic nanoparticles are 
functionalized with an anti epithelial cell adhesion molecule (EpCAM) antibody. This 
step serves to enrich the sample with EpCAM expressing cells, followed by 
immunological fixation for the confirmation of presence of cytokeratin and the 
absence of leukocyte marker CD45.45 
The extracted cells are epithelial cancer cells, demonstrated to be prognostic for 
several cancer types.45 
A second diffuse procedure for CTCs speciation is the CTC-chip technology, based 
on !-EpCAM antibody functionalized microfluidic channels. 
Punnoose at al. published a comparative study between CellSearch® and CTC-chip 
on their efficacy in capturing CTCs.45 The authors tested these two methods with 
spiked samples and with real samples of blood from human patients. They found that 
both CellSearch® than CTC-chip have over 70% efficiency in capturing cells 
expressing high EpCAM levels, but the percentage falls down to about 50% on low 
EpCAM expression. In some cases CTC-chip also showed efficiency over 100%, 
attributed probably to non-specific interactions and so in false-positive events.  
Most remarkably, the author used CTCs of different cancer types and, after the 
analysis with the two procedures, submitted the isolated CTC to other histological 
tests. The authors confirmed the clinical relevance of CTCs as tumour biomarkers and 
evaluated a minimum number of 3 CTCs/mL of blood (ea. 3 cells over millions) as 
statistical relevant index of tumour presence, for sample homogeneity and minimal 
assay error. Finally the authors marked the potentially upgrade provided by targeting 
these CTCs with more than one antibody, both for false-negative recovering and for 
more complete speciation of the sample.45 
Gold nanoparticles functionalized with a SERS active dye and a peptide sensible to 
the epidermal grow factor (EGF) receptor were used by Wang et al. for the detection 
of 1-720 CTCs/mL of blood.47 The authors reported clear fingerprint spectra of their 
SERS labels over the CTCs and successfully used their protocol to monitoring the 
evolution of the disease. A patient that had 11 CTCs/mL was than threated with usual 
chemotherapy for 2 month. At the end no more CTCs were detected. 
The improvement of SERS labels on this kind of application provides some important 
advantages due to the vibrational high sensitivity character of the technique. Sharp 
Raman signals are suitable for multiplexing analysis.  
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Applications in Cultural Heritage 
In the field of Cultural Heritage, the development of non-destructive, or at least 
micro-destructive techniques have a relevant importance. 
By this point of view, Raman spectroscopy provides clear advantages. The technique 
is non-destructive and can be performed in-loco using a series of new generation 
portable Raman spectrometers.48 
The high spatial resolution, intrinsic of this optical technique, offers the possibility to 
obtain chemical maps of the sample. In addition, since it is a vibrational spectroscopy, 
Raman spectra give chemical speciation both for organic and inorganic components, 
even if they are present in  mixture.48 
For this kind of applications, near infrared laser excitation is frequently used, due to 
the low fluorescence generally reported into this spectral range. However, the Raman 
scattering efficiency decreases with the fourth power of wavenumber, and the usual 
detector efficiencies also decrease in the near-infrared, so that longer acquisition 
times, are sometimes needed.48 
The discrimination of the same anion in different compounds is a clear demonstration 
of the usefulness of Raman spectroscopy. For example, different carbonate based 
minerals have informative frequency shifts: CaCO3 has a symmetric C=O stretching 
at 1086cm-1, whereas CaMg(CO3)2 has the analogue band at 1094cm-1 and MgCO3 at 
1117cm-1.48 
Taking into account biological materials, Edwards at al. analysed the skin of an 
ancient egyptian mummy from the twelfth dynasty (about 2000 a.C.).48 They found 
well defined amide I and associated proteins modes at 1660, 1450 and 1240cm-1, 
revealing that the skin was well preserved. In addition, other bands at lower 
frequencies revealed the presence of residual chemicals coming from the 
mummification process, ea. the sodium sulphate from the natron used as desiccant.48 
Despite the large number of information provided by Raman spectroscopy, only the 
species with sufficient Raman cross section could be easily measured, but 
differentiations among very similar macromolecules, such as different proteins, is not 
trivial. As the building blocks are essentially the same, in principle they show the 
same bands.  
An important upgrade, overcoming this issue, was provided by Sciutto et al. for the 
characterization of a paint stratigraphy.49 They used gold nanoparticles functionalized 
with an ovalbumin specific antibody and a Raman active dye. Their results showed 
positive targeting of the ovalbumin present in the artwork allowing also the 
simultaneous chemical identification of  the inorganic materials present in the 
stratigraphy. 
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2. Aims of the Project 
During my Ph.D. I focused my attention on the development of new nanomaterials 
and protocols for the characterization of clinical relevant samples, both in vitro and in 
vivo. 
Gold nanoparticles were always used as the basis of the studied nanosystems. Raman 
was extensively employed because of its higher analytical potential and, exploiting 
together the plasmonic nanoparticles and Raman spectroscopy, the surface 
enhancement effect (SERS) was used to improve the analytical sensitivity of analysis. 
The gold nanoparticles, which were obtained by laser ablation synthesis in solution 
(LASiS), were used also as substrate for laser desorption ionization mass 
spectrometry. We tested AuNP for different low weight molecules, including 
interesting cytotoxic and anticancer analytes. Our results show the possibility of  
upgrading this technique to the low mass region, where the signals from the 
commonly used organic matrix predominate. 
The quantitative determination of four clinically used anticancer drugs was explored 
with SERS experiments. Reference solutions reveal detection limits up to ng per 
millimetre square of SERS active area, useful for the actual clinical requirements. 
Moreover, advanced statistical models were applied for recognizing a drug, 
Irinotecan, and its active metabolite. 
The limitations provided by molecules with intrinsic low Raman cross section was 
investigated and potentially solved with a new protocol for analyte derivatization and 
analysis, called Reactive SERS. 
Nanomaterials were synthetized for multiplexing targeting and analysis of proteic 
samples. The main applications were developed in nanomedicine, with the 
identification of cancer cells, but the protocols have been applied also in the cultural 
heritage field with the characterization of ancient paint stratigraphic samples. 
The organic synthesis of new optimized Raman active dyes was pursued to extend the 
potential complexity of SERS multiplexing analysis. 
The development of new software helped in a complete automatization of the SERS 
measurements protocols. Interactive algorithms were developed for working in 
synergy with the micro-Raman instrument and provided lowering of the data 
acquisition and manipulation times. 
The new optimized dye library was used for the selection of the most efficient dyes 
for in vivo diagnosis of tumour using innovative multimodal contrast agents. A gold-
iron nanoalloy nanoparticles were used for magnetic resonance, computed 
tomography and SERS imaging. 
A new class of polymer was also planned and synthetized, as  a potent T1 MRI 
contrast agent. This molecule has multiple branches, bonding DOTA-Gd(III) residues, 
and a thiol for a stable linkage to the gold nanoparticle surface. It is called 
SuperDOTA and it was just characterized and associated to SERS tags as another  
generation of multimodal contrast agents. 
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3. Therapeutic Drug Monitoring 
Among the new therapeutic strategies against cancer, a special issue is that of the  
personalization of therapies. 
Individual dose/response effects have to be monitored to adjust the treatment at 
optimum dosage, where the drug has maximum effect, still remaining non toxic. 
The best analytical performances for anticancer drugs monitoring are usually obtained 
with chromatographic techniques coupled with mass spectrometry.36 
Exploration of solutions for problems related to the therapeutic drug monitoring are 
part of the present work. First, a possible solution to the limitations of the laser 
assisted ionization mass spectrometry was analyzed,28 since this technique has high 
sensitivities, but shows problems in analysing low molecular weight molecules. 
Second, another approach, alternative to the use of mass spectrometry, was 
considered for revealing four widely clinically used anticancer drugs using a high 
sensitive quantitative evaluation based on surface enhanced Raman scattering.12 This 
technique is very sensitive and suitable, in principle, for measurement at single 
molecule level.17 Third, new reactions and analyses were developed for detecting 
molecules with low Raman and SERS cross sections.  
Gold Nanoparticle assisted LDI for mass 
spectrometry at low molecular weight 
In mass spectrometry there are two fundamental building blocks regarding the 
measurement: the ion source and the mass analyser.  
In general, one obtains the mass distribution and the relative abundance of the 
components extracted by the sample. 
The ion source provides the the different components of the sample as ions. Then, 
they are accelerated within the mass analyser by high voltage electric field. In Time-
of-Flight (TOF) mass analyser the ions are accelerated through a linear or curved 
trajectory. Since the external electric field is constant, ions with different mass over 
charge (m/z) ratios acquire different accelerations, arriving at the end of the trajectory 
at different times. The time of arrival to the detector for every single ion is correlated 
to its m/z ratio and the signal intensities represent their relative abundance. An 
efficient and effective ionization of samples is, therefore, of crucial importance. 
The ionization of the sample can occur at different levels. For example the inductively 
coupled plasma (ICP) decompose every species to atomic level, giving information 
on elemental composition.  
The laser desorption ionization (LDI) is considered, on the other hand, a soft ion 
source, meaning that molecules remain integer, or fragmentations takes place in small 
amounts.50 In LDI there is an ablation process on the surface of a solid sample, due to 
a laser irradiation. The ablated material is than directed into the mass analyser. 
To optimise the absorption of the laser and the consequent desorption of the sample, 
highly absorptive organic molecules (referred to as matrix) are added in large excess 
to the sample. The analytes have to be dispersed into the matrix crystals. These 
crystals absorb the laser radiation and sublime, carrying the sample ions, so the 
technique is known as matrix assisted LDI (MALDI).50 
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An important drawback of this approach is, clearly, the abundance of matrix signals in 
mass spectra. For this reason, molecules under 500-800 Da are not usually 
investigated with the MALDI-TOF mass spectrometry.28, 50 
Nevertheless, MALDI-TOF is the elected technique for peptides and polymers.28, 50  
Mass spectrometry is a well known high sensitive analytical technique, but before 
using MALDI for the therapeutic drug monitoring with low mass molecules, we had 
to overcome the problem of the low mass region. 
Due to the localized surface plasmon resonance (LSPR), gold nanoparticles (AuNPs) 
emerged as suitable inorganic matrixes for LDI.51, 52 Their high surface area allows a 
high loading and the LSPR band is usually broad, especially when the nanoparticles 
aggregate, and covers the visible region. 
Therefore, visible pulsed lasers can be used for NPs assisted LDI. This can be 
important for preventing photoblenching of molecules sensible to UV or near-UV 
irradiation.51 
Nanoparticles can also be functionalized for  selective reactions with analytes present 
in a complex solution. A simple centrifugation is than sufficient to separate the 
nanoparticles and their loading for subsequent MALDI analysis.51 
Nevertheless, the use of capping agents, needed to stabilize commercial AuNPs, still 
remains a strong interference for the analysis of the low mass region. 
Gold nanoparticles obtained by laser ablation synthesis in solution (LASiS) have, in 
principle, the sufficient high surface purity to provide mass analysis of lightweight 
molecules. 
The nanoparticle size is another important variable for the desorption yield. In first 
approximation, smaller NPs have higher specific area (involving great matrix to 
analyte molar ratio) and, with the same excitation wavelength, the temperature 
reached by laser irradiation increases in decreasing particles size.28, 51, 53  
We have studied AuNPs, obtained by LASiS, as matrix for LDI, in comparison with 
commercial AuNPs and 2′,6′-Dihydroxyacetophenone (DHAP), an organic matrix 
usually employed in MALDI. Commercial AuNP are synthesised by citrate based wet 
chemistry.51 
The gold nanoparticles obtained by LASiS have usually a broader dimensional 
dispersion than NPs produced by wet chemistry.26, 27 To account a reliable 
comparison against the citrate-AuNP, we used a size selected LASiS-AuNP. The size 
selection was performed by centrifugal gradient, as reported in literature.54 
In Table 3.1 and Table 3.2 are reported all the matrixes used, and the studied analytes. 
 
Table 3.1: Inorganic and organic matrixes used for MALDI-TOF mass spectrometry 
experiments. All the nanoparticles solutions were prepared with similar gold atoms 
concentration. The DHAP solution is  saturated in acetonitrile with 0.1% of TFA. 
Matrixes 
LASiS- 
AuNP-I 
LASiS- 
AuNP-II 
Citrate- 
AuNP-I 
Sigma Aldrich 
Citrate- 
AuNP-II 
BBI international 
DHAP-TFA 
Sigma Aldrich 
10.6nm ±22% 18.6nm ±35% 10.2nm ±12% 19.6nm ±8% - 
2.1∙10-7 M  
in [AuNP] 
3.2∙10-8 M 
in [AuNP] 
2.1∙10-7 M 
in [AuNP] 
2.6∙10-8 M 
in [AuNP] 
0.263 M 
in [DHAP] 
2.6 mg/mL 
in [Au] 
2.6 mg/mL 
in [Au] 
2.6 mg/mL 
in [Au] 
2.6 mg/mL 
in [Au] 
40 mg/mL 
in [DHAP] 
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Table 3.2 Analytes used for testing the AuNP assisted MALDI . 
Analytes 
name / structure molecular weight 
stock solution 
concentration 
analysed 
quantity skills 
L-arginine 
 
174.20 
g/mol 
1.1∙10-3 M 
in water 
100 ng 
574 pmol 
polar  
aminoacid 
D(-)fructose 
 
180.16 
g/mol 
1.1∙10-3 M 
in water 
100ng 
555 pmol 
natural 
monosaccharide 
Atrazine 
 
215.68 
g/mol 
2.3∙10-4 M 
in MeOH:water 
1:1 
25ng 
116 pmol herbicide 
Anthracene 
 
178.23 
g/mol 
1.9∙10-3 M 
in MeOH:water 
2:1 
175ng 
981 pmol 
apolar aromatic 
molecule 
Paclitaxel 
 
853.91 
g/mol 
1.3∙10-4 M 
in MeOH:water 
1:1 
57.5ng 
67 pmol anticancer drug 
 
As a first step, we acquire the mass spectra of the pure matrixes, in Figure 3.1. 
Especially in the range below 500Da the LASiS-AuNP-I and II show negligible 
background, with few and low intense signals. 
 
 
Figure 3.1: LDI-TOF mass spectra of the pure matrixes. From Ref . 28. 
 
All colloidal solutions were pre-concentrated to the same atomic gold concentration. 
Dialysis membranes were used before depositing the particles, for the purification of 
the nanoparticle solutions. In this way we removed the largest amount of free citrate 
and other molecules, like tannic acid or sodium azide, present in the commercial 
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solution as reported in the specification sheet. However, a consistent amount of 
capping agents still remain over the Citrate-AuNPs, populating the background into 
the low mass range of mass spectra. 
The supernatant, taken by the dialysis membrane of Citrate-AuNP-I, were mixed with 
LASiS-AuNP-I and than analysed by MALDI-TOF. As expected, high signals grew 
up into the low mass range. 
 
 
Figure 3.2: Mass spectrum of LASiS-AuNP-I, on the left. It presents negligible 
signals. On the right, the mass spectrum of LASiS-AuNP-I after the addition of the 
Citrate-AuNP-I supernatant, obtained by the dialysis membrane. In this case, lots of 
signals are present under 600 Da. From Ref.  28. 
 
This feature makes LASiS-AuNP interesting for analysis of molecules under 500 Da. 
Five different analytes with different  characteristics were chosen, to analyze the 
performances one can obtain with the LASiS-AuNP. 
Arginine is a polar, basic aminoacid. It has amines and a carboxylate functional 
group, which show good affinity with the gold nanoparticles surface. 
In Figure 3.3, the LASiS-AuNP-II matrix performs better than the Citrate-AuNP-II. 
The molecular peak, relative to the addition of a proton ([M+H]+ =175.29 m/z), is the 
base peak and the sodium and potassium adducts are also clear and intense. The 
spectra relative to the Citrate-AuNP shows much more peaks. In the case of the 
organic matrix DHAP, the peak at 175.29 m/z is very intense, but the same peak is 
found also for the matrix alone, making the attribution unsafe. 
 
3. Therapeutic Drug Monitoring 
 37 
 
Figure 3.3: LDI-TOF mass spectra of selected AuNPs and DHAP with Arginine. The 
black spectra at the bottom are those of the matrixes alone. The clearest attribution 
are provided by LASiS-AuNP. From Ref. 28. 
 
Fructose is a natural monosaccaride. It is water soluble, but it does not present highly 
polar functional groups. In Figure 3.4 are reported the mass spectra using LASiS-
AuNP, Citrate-AuNP and DHAP as matrixes. Also in this case the laser ablated 
nanoparticles performs better than the Citrate-AuNPs. The [M+Na]+ peak, at 203.24 
m/z in LASiS-AuNP-II, is also present with Citrate-AuNP-II but its intensity is much 
lower. The spectra of Fructose with DHAP is again ambiguous  since the only signal 
with a m/z corresponding to the analyte is also present as background ( [M+K]+ at 
219.32 m/z). 
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Figure 3.4: LDI-TOF mass spectra of selected AuNPs and DHAP with Fructose. The 
black spectra at the bottom are those of the matrixes alone. From Ref 28. 
 
Atrazine is an aromatic heterocyclic compound. It is used as fungicide and its 
secondary amines do not contribute to a consistent polarity. The molecule is slightly 
water soluble. In Figure 3.5, the mass spectra with the LASiS-AuNP, the [M+Na]+ 
peak at 239.43 m/z is the only signal in the range of interest. The same peak is evident 
also with the Citrate-AuNP and with DHAP, but the spectra is rich of other signals, 
partially due to the matrix and partially probably due to Atrazine fragmentations. 
 
 
Figure 3.5: LDI-TOF mass spectra of selected AuNPs and DHAP with Atrazine. The 
black spectra at the bottom are those of the matrixes alone. From Ref. 28. 
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Anthracene is an apolar aromatic molecule. It is very slightly soluble in water. In this 
case, all the matrixes are not very efficient for this molecule. The molecular ion signal 
is present using LASiS-AuNP and the [M+Na]+ is present with Citrate-AuNP at 
201.22 m/z. Any peak relative to Anthracene can be found using the organic DHAP 
matrix. 
 
 
Figure 3.6: LDI-TOF mass spectra of selected AuNPs and DHAP with Anthracene. 
The black spectra at the bottom are those of the matrixes alone. Any signal from the 
analyte is recorded with the DHAP matrix. From Ref. 28. 
 
Paclitaxel is a widely used anticancer drug, belonging to the family of Taxanes.36 It is 
approved for a broad spectrum of human malignancies and is characterized by a slight 
solubility in water.36, 55 
Paclitaxel is a relatively heavy molecule, in comparison to the other molecules. Its 
sodium adduct ion [M+Na]+, at 876.42 m/z for the LASiS-AuNP-I, falls outside the 
critical range of the low masses. Therefore, it is well defined for all the tested 
matrixes , with a negligible background in all cases, as could be seen at Figure 3.7.  
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Figure 3.7: LDI-TOF mass spectra of selected AuNPs and DHAP with Paclitaxel. The 
black spectra at the bottom are those of the matrixes alone. The mass range of 
interest falls outside the critical low mass region, so negligible backgrounds were 
found with all matrixes. From Ref. 28. 
 
With this study we concluded, therefore, that gold nanoparticles are suitable to extend 
the mass range of the LDI-TOF mass spectrometry under 200 Da, but attention has to 
be made to the surface coverage of such nanoparticles. LASiS-AuNPs give better 
performances compared to Citrate-AuNPs, mostly due to the fact that LASiS 
produces naked nanoparticles, since only water and bulk gold, are used for their 
synthesis. 
Citrate-AuNPs were dialysed before their deposition, but also in this case a consistent 
amount of citrate still remains over the nanoparticle surface. For LASiS-AuNPs  the 
nanoparticles are produced with a surface negative charge which stabilizes the 
solution by electrostatic repulsion, and no other molecules are needed for their 
colloidal stability.26, 27 The clean surface is believed to allow analytes to stay closer to 
the nanoparticles, resulting in a more efficient laser induced ionization. 
We also observed that smaller nanoparticles, ea. LASiS-AuNP-I and Citrate-AuNP-I, 
often give better signals with respect to the bigger ones, as also reported in the 
literature.51-53 The results suggest that the surface chemistry of nanoparticles plays the 
major role in the ionization yield and therefore for the quality of mass spectra, 
especially in the low mass region. 
Considering the different characteristics of the studied analytes , polar molecules 
show the clearest signals, while anthracene is the case in which, because of solubility 
and of low polarity, the recorded peaks are very weak. Our results confirm the general 
understanding of the importance of the polarity of the molecules and of the matrix. 
Figure 3.8 reports the results for Paclitaxel in particular for the signal reproducibility 
and linearity. Interestingly, LASiS-AuNP-I, performs better in term of correlation 
coefficient and sensibility.  
 
3. Therapeutic Drug Monitoring 
 41 
 
Figure 3.8. Log-log calibration curve of [M+Na]+ signal of Paclitaxel on different 
matrixes and different sample deposition amounts. The error bars represent the 
standard deviation over three different acquisitions. From Ref. 28. 
Quantitative determination of chemotherapy drugs 
with Surface Enhancement Raman Scattering 
The surface enhanced Raman Scattering was considered for a quantitative 
determination for three clinically relevant anticancer drugs: Sunitinib, Paclitaxel and 
Irinotecan. For the last one, also its active metabolite SN-38 was considered. 
Sunitinib malate is a small molecule active on several targets as inhibitor for tyrosine 
kinases such as c-KIT, fms-like tyrosine kinase 3 (FLT3), platelet-derived growth 
factor receptor (PDGFR) and vascular endothelial growth factor receptor (VEGFR).56, 
57 All these receptors play important roles in tumour grow and angiogenesis, 
regulating cell proliferation, differentiation, and survival. 
The therapeutic practice for the administration of Sunitinib requires dose of 25 mg 
once daily for 4 weeks every 6 weeks. The steady state concentration is reached after 
4 weeks of daily dosing with a plasma concentration of 32 ng/mL (80 nM).57  
Paclitaxel is the second wide spread anticancer drug used in clinics. It acts against a 
broad spectrum of tumours, as breast cancer, ovarian carcinoma and lung cancer. Its 
mechanism of action regards the stabilization of dysfunctional microtubules, that are 
structural intracellular moieties. Paclitaxel is involved in inhibition of cell replication, 
and induction of cell death. The minimum plasma concentration of Paclitaxel required 
for of clinical activity is about 40 ng/mL (50nM).55 
Irinotecan, also known as CPT-11, is a semisynthetic derivative of the natural 
alkaloid camptothecin.58, 59 It is used in cancer therapy against a large variety of solid 
tumours and for metastatic colorectal cancer.59, 60 CPT-11 presents a complex 
metabolism. In fact, its pharmacologic activity is mostly due to its active metabolite 
SN-38. It is reported to be cytotoxic and a potent selective inhibitor of Topoisomerase 
I, a nuclear enzyme responsible for relaxation of supercoiled DNA during replication 
and transcription.58, 59 The mechanism of action of CPT-11 involves a reversible 
complex between SN-38 and DNA/topoisomerase I, causing a single strand break in 
DNA. Irinotecan is usually submitted to patients with a 30-90 minutes infusion every 
three weeks.59, 60 Pharmacokinetics studies show a plasma concentration peak of 
Irinotecan and SN-38 respectively of 35.5 and 7 ng/mL (60.5 and 17.9 nM).59 While 
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the steady state plasma concentration during the therapy reach 25 ng/mL (42.7nM) for 
Irinotecan and 5.8 ng/mL (14.9nM) for SN-38.59 
We explored the reliability of a SERS based quantitative determination protocol for 
these three drugs and for the active metabolite SN-38. 
Before acquiring calibration curves, we evaluated the best experimental condition for 
the SERS measurement. 
 
Table 3.3: The analysed drugs  
Drug Name (CAS number) 
Chemical Formula (Molecular Weight) 
IUPAC Name 
Chemical Structure 
Sunitinib (CAS 341031-54-7) 
C22H27FN4O2 · C4H6O5 (532.56 g/mol) 
N-[2-(Diethylamino)ethyl]-5-[(Z)-(5-fluoro-
1,2-dihydro-2-oxo-3H-indol-3-
ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-
carboxamide (2S)-2-hydroxybutanedioic 
acid (1:1) salt 
 
Irinotecan (CAS 100286-90-6) 
C33H38N4O6 · HCl (623.14 g/mol) 
(S)-4,11-diethyl-3,4,12,14-tetrahydro-4-
hydroxy-3,14-dioxo-1H-
pyrano[3′,4′:6,7]indolizino[1,2-b]quinolin-
9-yl ester  
SN-38 (CAS 86639-52-3) 
C22H20N2O5 (392.40 g/mol) 
(4S)-4,11-Diethyl-4,9-dihydroxy-1H-
pyrano[3′,4′:6,7]indolizino[1,2-
b]quinoline-3,14(4H,12H)dione  
Paclitaxel (CAS 33069-62-4) 
C47H51NO14 (853.91 g/mol) 
(1S,2S,3R,4S,7R,9S,10S,12R,15S)-4,12-
bis(acetyloxy)-1,9-dihydroxy-15-{[(2R,3S)-
2-hydroxy-3-phenyl-3-
(phenylformamido)propanoyl]oxy}-
10,14,17,17-tetramethyl-11-oxo-6-
oxatetracyclo[11.3.1.0^{3,10}.0^{4,7}]hept
adec-13-en-2-yl benzoate 
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Exploring best measurement conditions 
First we determined the best experimental conditions for recording the best SERS 
signals.  
Both the excitation wavelength and the nature of the SERS substrate were 
investigated. For comparison, we also used  Doxorubicin, an anticancer drug active as 
a DNA intercalating agent,11 since it is known as efficient SERS analyte.61, 62 
 
Table 3.4: Doxorubin used as reference SERS analyte. From Ref 12. 
Doxorubicin (CAS 25316-40-9) 
C27H29NO11 · HCl  (579.98 g/mol) 
(7S,9S)-7-[(2R,4S,5S,6S)-4-amino-5-
hydroxy-6-methyloxan-2-yl]oxy-6,9,11-
trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-
8,10-dihydro-7H-tetracene-5,12-dione  
 
Klarite substrates, a commercial SERS substrate, were used with excitation 
wavelengths at 488, 633 and 785nm.  
Klarite is a silicon slide uniformly covered with gold. The SERS active area is a 4x4 
mm2 surface where ordered gold pyramids are present, as shown in Figure 3.9 and 
3.10. Enhanced fields can be found at the edges and at the tops of the pyramids (hot 
spots).  
 
 
 
 
 
Figure 3.9: A picture representing a Klarite substrate. The SERS active area is the 
4x4mm square where the pyramids provide hot-spot features. 
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Figure 3.10: SEM image of a Klarite 
substrate. From Ref. 13. 
 
 
 
 
 
 
 
 
1!g of each drug was spotted over Klarite substrates simply drying a drop of the 
relative solution. A home-made Viton mask with a cylindrical hole was used to limit 
deposition surface to a 1.8 mm2. 
Raman measurements were acquired with the substances deposited over a pure silicon 
slide to prove that the Raman spectra originated from SERS. 
The same results obtained with the non-SERS silicon surface was obtained with the 
Klarite substrate using the 488 nm excitation, showing that in this configuration there 
was not a SERS enhancements. The observed intensities, when exciting at 785 nm on 
Klarite, were too low to be used for a quantitative analysis. 
SERS spectra of Doxorubicin, Sunitinib, SN-38 and CPT-11, deposited on Klarite 
substrates, were obtained exciting at 633 nm. In particular, Doxorubicin spectra 
showed a maximum at 1230-1250 cm-1, Sunitinib at 1280-1330cm-1 and at 1570cm-1, 
whereas Irinotecan and its metabolite SN-38 have a similar spectra characterized by a 
series of peaks in the 1350-1600 cm-1 range. 
Any appreciable signal was detected for Paclitaxel exciting at 633nm, even for long 
acquisition times. 
Doxorubicin, as expected, shows the higher intensities, about two hundred times more 
than the second better performer, Sunitinib.  
The Raman scattering efficiency can be explained in terms of the absorption 
characteristics of the analytes. In Figure 3.11 one can see the distance between the 
maximum absorption band of the compounds and the excitation wavelengths used for 
the experiments. Considering that gold substrates show their activity in the red 
spectral region,15 one observes that closer are the drug’s maximum absorption to the 
excitation wavelength, higher are their Raman bands.12  
The main absorption band of Doxorubicin is the nearest to the 633 nm exciting line, 
whereas for Paclitaxel it is the farthest. Therefore, Doxorubicin benefits of both the 
contribution of SERS and of the pre-resonance electronic situation. 
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Figure 3.11: The optical extinction cross sections of the molecules studied (b) and 
their SERS spectra obtained from 1!g of substance at 633nm excitation over a Klarite 
substrate (a). From Ref. 12. 
 
Table 3.5: A resume of the signals obtained with different excitation wavelengths and 
SERS substrates. 
SERS Substrate 
Laser Wavelength Klarite Si 
488nm No signals No signals 
633nm Suitable for quantification No signals 
785nm Too low for quantifications No signals 
 
The second step was that of identifying the better SERS substrate among the 
commercial Klarite and other substrates obtained by drying plasmonic nanoparticles 
in cylindrical aluminium wells. The nanoparticles considered were laser ablated gold 
and silver nanoparticles (AuNPs-LASiS and AgNPs-LASiS) and commercially 
available AuNPs and AgNPs. The nanoparticles size was 30 nm for the LASiS 
particles and 60 nm for the commercial ones. 
The performances were compared measuring 1!g of Sunitinib at 633 nm excitation 
and are reported in Figure 3.12. 
 
Figure 3.12: signals of the most intense Raman band of Sunitinib (at 1320cm-1) 
acquired with 633 nm excitation over different SERS substrates. Error bars represent 
the standard deviation for a set of 10 measurements recorded in random points.  
From Ref . 12.   
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Despite the highest intensities obtained with laser ablated silver nanoparticles, the 
Klarite substrate shows less point-to-point variability. 
Nevertheless, laser ablated nanoparticles perform better than the corresponding ones 
obtained by wet chemistry. This reflects the higher surface purity of the nanoparticles 
obtained by LASiS. 
The above measurements show that the better conditions for SERS measurements are 
obtained with the Klarite substrate and the 633nm laser excitation. 
Calibration curves for chemiodrugs 
We measured the intensity (counts per second, c.p.s.) variation of representative 
Raman bands for each drug, by changing the amount deposited over Klarite 
substrates. 
We used the band at 1322cm-1 for Sunitinib and at 1385cm-1 for both Irinotecan and 
SN-38. The mass range explored varied between 10 and 103 ng. For this reason we 
found useful to express the calibration curves in a logarithmic scale. 
In a typical measurement procedure (see Appendix A4), we dried 6!L of drug 
solution over a surface of about 1.8 mm2 of Klarite active substrate. We recorded the 
Raman spectra in 133 points within this area. The acquisition time for every spectra 
varied with the drug concentration in the range of 15-120 seconds. These times 
correspond to measurement time between 30 minutes to 4 hours for a single sample. 
For limit of quantification (LQ) we mean the lowest amount of drug at which the 
logarithm of Raman intensity is linearly correlated to the logarithm of analyte mass. 
Therefore, LQ is larger than limit of detection (LD), which is the lower amount of 
analyte clearly identified above the noise.  
In Figure 3.13, we report the Raman bands intensities as a function of both the total 
mass of analyte deposited and the mass per unit area.  
 
Figure 3.13: Continue… 
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Figure 3.13: Calibration curves of SERS intensity as a function of deposited drug 
mass or mass to spotted surface ratio. The most characterizing Raman band is taken 
for each drug: 1322 cm-1 for Sunitinib, 1385 cm-1 for Irinotecan and SN-38.  
From Ref. 12. 
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We choose to express the total spotted mass, or the mass/area ratio, because SERS is a 
surface techniques and the active surface involved could be a more sensitive 
parameter than the bulk analyte quantity. This implies that LQ and LD can be 
improved by reducing the deposition area with the same  analyte mass. For example, 
we used 6!L of solution over a 1.8 mm2, but if you dry just 100 !L over 0.5 mm2 one 
can  increase the sensibility by a factor of 60. 
In Table 3.6 the main results for Sunitinib, Irinotecan and SN-38 are shown. 
The LQ for all the three drugs falls in the order of 102 pmol/mm2. Despite the three 
analytes are different and have different SERS efficiency (this is reflected on the 
curve slopes), this effect could be explained by the fact that the largest amount of 
SERS signal comes from few structural features, called hot-spots. 13-15  
In the upper limit of the curves, we observed the saturation of the Raman intensity for 
1-4∙103 pmol/mm2. This is probably related to the saturation of the hot spots.13 
 
Table 3.6: Main results from the calibration curves of Sunitinib, Irinotecan and SN-
38. From Ref. 12. 
 Slope Linearity range Limit of Detection 
 c.p.s   /ng 
c.p.s.  
/(ng 
/mm2) 
c.p.s.  
/(nmol 
/mm2) 
ng ng /mm2 
pmol 
/mm2 ng 
ng 
/mm2 
pmol 
/mm2 
Sunitinib 1.06 ±0.09 
1.88 
±0.16 
748 
±60 
88 - 
1872 
50 - 
1059 
125 - 
2657 18 - 26 11 - 15 26 - 37 
Irinotecan 0.751 ±0.004 
1.327 
±0.007 
778 
±5 
198 - 
4032 
112 - 
2280 
191 - 
3886 60 - 70 34 - 40 58 - 68 
SN-38 0.86 ±0.09 
1.52 
±0.15 
598 
±60 
107 - 
1092 
60 - 
620 
153 - 
1580 20 - 50 11 - 28 29 - 72 
 
Taking into account the concentration levels required for clinical practice, about 32 
ng/mL for Sunitinib, 25 ng/mL for Irinotecan and 6 ng/mL for  SN-38, our actual 
measurement protocol will require the deposition of several millilitre of sample to 
reach the linearity regime. 
Nevertheless, the scope of this study was to verify the feasibility of SERS as an 
analytical tool for therapeutic drug monitoring (TDM) with the aim of developing a 
point-of-care (POC) device. 
Klarite substrates have the lower signal variability, but laser ablated AgNP showed 
more than three times higher SERS efficiency (see Figure 3.12). The optimization of 
AgNP based SERS substrates, mostly in term of structural homogeneity, could result 
in consistent analytical reproducibility improvement. 
In conclusion, quantitative determination of anticancer drugs with SERS is an 
interesting open issue for the development of TDM-POC devices. 
Speciation between Irinotecan and SN38 by PCA 
Irinotecan has a complex metabolism that transforms it into the active SN-38, as just 
recalled above. Therefore, monitoring therapies involving Irinotecan cannot avoid the 
concomitant quantification of SN-38. 
Raman spectroscopy and SERS, due to the fingerprint features provided by 
vibrational transitions, are usually a powerful qualitative techniques. 13 Nevertheless, 
Raman spectra of Irinotecan and SN-38 show very small differences, especially in the 
region between 1350 and 1650cm-1, where the most intense bands are located. 
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In such a frequency region, vibrational transitions due to molecular structures with 
extended delocalized electrons occur.63 In fact, comparing their molecular structure in 
Table 3.3, Irinotecan differs from SN-38 only in a non conjugate moiety. 
We spotted 1!g of each solution, and the same amount of a mixture of Irinotecan and 
SN-38, over the active area of a Klarite substrate. Than we mapped the entire 4x4 
mm2 surface at a resolution of less than 100 !m between adjacent points (more than 
1900 spectra acquired). As for the previous experiments, SERS spectra were collected 
with the 633 nm excitation. 
The white-light photograph of the Klarite is reported in Figure 3.14a. By a 
macroscopic point of view, SN-38 dry as small crystals while Irinotecan as an 
amorphous deposit. The mixture solution presented both these characteristics. 
The entire surface was mapped, but as a reference spectrum for each deposition, we 
took only the measurements at the centre of the three spots. The spectra obtained by 
the average of these points are shown in Figure 3.14c. 
 
 
Figure 3.14: The optical microscope image of the drugs dried over the active surface 
of a Klarite substrate (a). The picture is collected mounting several snapshots with 
the instrument software. In (b) are shown the acquisition points used to obtain the 
average spectra of the pure drugs and mixture, in (c).  
 
Distinguishing between Irinotecan, SN-38 and mixture simply by the spectra in 
Figure 3.14-c is not trivial, since the only slight difference, found with naked eye, is 
the double peak at 1450 cm-1.  
Principal Component Analysis (PCA) is a statistical analysis that takes into account 
all possible correlations between the variables describing a dataset of samples. In this 
case every spectra is a sample and every frequency is a variable. PCA computes such 
correlations, between intensities at every frequency along every spectra, considering 
them as describing the same kind of information. 
In this way, the multivariate analysis is more sensitive to small differences in a dataset 
by quantitatively accounting for the Raman fingerprint.  
PCA results in a set of mutually independent new variables called principal 
components (PCs). Every PC expresses a particular spectral feature redundant through 
the dataset in such a way that the firsts PCs represent the most recurring ones. As a 
result, every spectra has its own peculiar coefficient (called PC’s score) for every PC. 
 
Irinotecan SN-38 
Mixture 
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Figure 3.15: false colour maps of PC’s scores for the first six principal components. 
Each point in the maps represents an acquisition point. Spectra with intensity lower 
than 100 c.p.s. were not considered, giving the empty holes. PC1, 2, 4, 5 and 6 do not 
provide differences between the three spots, but along PC3 the pure drugs assume 
opposite values. From Ref. 12. 
 
The scores for PC 1, 2, 4, 5 and 6 of every spectra of the dataset have similar values 
for both Irinotecan, SN-38 and the mixture. These PCs only provides a good contrast 
between the deposition area and the free zone of the substrate (see Figure 3.15).  
Instead, PC3 is a good distinctive element between the two drugs, as indicated by the 
opposite average score of 0.29±0.10 for Irinotecan and of -0.95±0.16 for SN-38 (see 
Table 3.7). In the mixture spot, as expected, the PC3’s score assumes an intermediate 
value, close to zero at -0.10±0.08. 
 
Table 3.7: The average PC’s scores are calculated for the areas shown in Figure 
3.14-b, giving numerical information for every spotted solution of pure drugs and 
mixture. From Ref. 12. 
Principal  
Component 
Variance 
Explained (%) 
Irinotecan  
Mean Score 
(Zone 1) 
SN-38  
Mean Score 
(Zone 2) 
Mixture  
Mean Score 
(Zone 3) 
PC1 27.8 -0.50 ± 0.39 0.67 ± 0.66 -0.92 ± 0.25 
PC2 10.5 0.67 ± 0.24 0.12 ± 0.27 0.23 ± 0.18 
PC3 4.5 0.29 ± 0.10 -0.95 ± 0.16 -0.10 ± 0.08 
PC4 3.1 0.03 ± 0.12 -0.43 ± 0.22 -0.12 ± 0.14 
PC5 2.0 -0.03 ± 0.11 0.12 ± 0.18 -0.01 ± 0.11 
PC6 1.2 -0.28 ± 0.06 -0.03 ± 0.09 0.15 ± 0.05 
 
When the score map of PC3 is overlapped to the image of the substrate, there is a 
good contrast passing through each different spots (Figure 3.16).  
Therefore, the PCA of SERS spectra can be used as a systematic and operator-
independent approach for the discrimination of Irinotecan and its active metabolite 
SN-38. 
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Figure 3.16: The PC3’s score map overlapped to optical microscope image of the 
Klarite. The different score values well follow the boundaries between each spot. SN-
38 assumes negative values for PC3, while Irinotecan has positive score and the 
mixture shows an intermediate value, close to zero. 
Reactive SERS 
The application of surface enhanced Raman scattering to the quantitative 
determination of small molecules, like drugs, was found very useful and effective. 
Portable Raman spectrometers can be purchased from several company and the time 
required for analysis is consistent with routinely applications. 
Despite the potential of SERS based analysis to any substance, because of the 
vibrational nature of the Raman effect, in practise the range of allowed analytes is 
strongly limited by molecules with high Raman scattering cross section. This is 
particularly true approaching the low concentration regime. 
For example, Nie and Emory published a study on the single-molecule detection with 
SERS.17 They used silver nanoparticles excited at 514 nm. The probe molecule was 
Rhodamine 6G. Such a result is very impressive, but a crucial remark regards the 
Raman scattering cross section of Rhodamine 6G. When excited at 514 nm, the cross 
section of its most intense Raman band at 604 cm-1 is about 3 million times grater 
than the CO stretching vibration at 1020 cm-1 of methanol.15 
To extend the potential of SERS, as a quantitative technique, to molecules with small 
Raman scattering efficiency, a new  protocol was developed.  
The idea is that of using gold nanoparticles functionalized with a molecule which can 
react with a specific functional group present in the target analyte. Therefore, a 
chemical reaction can occur at the surface of the gold nanoparticles, associated to a 
measurable variation of the SERS spectra of the original reagent, as schematically 
shown in Figure 3.17. We called this approach  Reactive-SERS. 
 
SN-38 Irinotecan 
Mixture 
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Figure 3.17: The key steps of the Reactive-SERS protocol. Gold nanoparticles are 
functionalized with a molecule which can react with the target analyte. The chemical 
reaction occurring between the reactive and the analyte vary the Raman spectra in a 
quantitative way. 
The reactive substrate and the photoreaction involved 
Bis[2-(4-azidosalicylamido)ethyl] disulphide (called ASAES2, see Figure 3.18) is a 
commercially available reactive substrate used especially in biochemistry as cross 
linker.64-66 
 
 
Figure 3.18: Molecular structure of Bis[2-(4-azidosalicylamido)ethyl] disulphide 
 
It consists of two identical aromatic azide moieties linked by a sulphur bridge. 
Since the synthesis of the first organic azide, phenyl azide, by Peter Grieß in 1864, 
this functional group found a great attention and several field of applications.66-68 
Many azide containing compounds are instable because of the possible release of 
molecular nitrogen, occurring also in explosive reactions.68 
The resonance structures reported in Figure 3.19 help to understand why the nitrogen 
release is favoured. These resonances structures also provide information about the 
chemistry of the azide. In fact electrophiles usually attack the first nitrogen atom, the 
closest to the R group in Figure 3.19, while nucleophiles go to the third nitrogen.68 
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Figure 3.19: Limit resonance structures for the azide group. The release of molecular 
nitrogen leaves the electron deficient group R-N: . 
 
The most popular reaction involving azides is the Huisgen cycloaddiction, that, in its 
classical form, takes place with an alkyne. More discussions regarding the Huisgen 
reaction could be found in Chapter 5. 
In Reactive-SERS we are interested into the photochemistry of the aromatic azide 
group. 
Upon high temperature or irradiation into the near UV region (typically under 400 
nm), the release of molecular nitrogen occurs, leaving a singlet nitrogen atom.67-70 
In Figure 3.20 are summarized the principal structural pattern that phenyl azide 
follows after UV irradiation, as currently accepted by the literature.67, 70 
 
 
 
 
 
 
 
Figure 3.20: The 
dynamic of phenyl azide 
after UV irradiation. 
 
 
 
 
 
 
 
It was found that the photochemistry of phenyl azide in solution is temperature 
dependent. At ambient temperature the singlet phenylnitrene undergoes  
rearrangement to the cyclic ketenimine. At temperature below 180 K the inter system 
crossing (ISC) drives the molecule to triplet state of phenylnitrene and the coupling 
with another triplet phenylnitrene, or an unreacted phenyl azide, yield preferentially 
di-azo compounds.67 
All of these derivatives of the phenyl nitrene were found reactive toward insertion 
into multiple bonds, intramolecular cyclization and addition to heteroatom like 
phosphorous, sulphur and nitrogen.67, 68, 70 
Polar solvents enhance the reaction rate of orto-azidophenol,69 while para-
azidophenol transforms preferentially to para-aminophenol using acetonitrile instead 
of water.71 
In biochemistry, ASAES2 is found useful as photoactivate coupling agent, due to the 
reactivity of the aromatic azide toward amines. This cross-linkage could eventually be 
cleaved by the reduction of the sulphur bridge.64-66 
To test the chemistry of ASAES2 we used diethylamine (DEA) in acetonitrile.67, 68, 70 
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Figure 3.21: The reaction scheme of the photoreaction of ASAES2 with diethylamine. 
 
Three reaction mixtures were prepared according to Table 3.8. The reaction mixture A 
was used as reference whereas the reaction B and C were in double excess of ASAES2 
and in stoichiometric amount, respectively. 
 
Table 3.8: The proportions between ASAES2 and DEA tested in photoreactions with 
acetonitrile as solvent. 
 ASAES2 (mM) DEA (mM) 
Molar ratio  
(molDEA / molASAES2) 
A 3.15 - 0 
B 3.15 4.32 0.5 
C 3.15 8.65 1.1 
 
All the reagents were dissolved in acetonitrile. The photoreaction was activated under 
irradiation with a common UV lamp for 10 minutes. 
The reaction products were than characterized by MALDI-TOF mass spectrometry 
(see Figure 3.22). 
 
Table 3.9: Molecular structure and mass assignment for the reaction products 
between ASAES2 and DEA. 
 Calculated mass peaks 
 
ASAES2 = 474.09 Da 
[M+H]+ = 475 m/z 
[M+Na]+ = 497 m/z 
[M+K]+ = 513 m/z 
 
mono-adduct = 519.17 Da 
[M+H]+ = 520 m/z 
[M+Na]+ = 542 m/z 
[M+K]+ = 558 m/z 
 
di-adduct = 564.26 Da 
[M+H]+ = 565 m/z 
[M+Na]+ = 587 m/z 
[M+K]+ = 603 m/z 
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Figure 3.22: MALDI-TOF spectra of the reaction between ASAES2 and DEA. The 
matrix used was DHAP+TFA 0.1%. 
 
Peaks present for the reaction mixture A show the products without the presence of 
DEA. The mass spectra of reaction B and C show intense signals related to the mono 
and the bis-adduct. The mono-adduct [M+H]+ is observed at mass 494.0 m/z, whereas 
[M+Na]+ at 520.0 m/z both for reaction B and C. The bis-adduct has its [M+H]+ and 
[M+Na]+ peaks at 565.0 and 587.0 m/z are also observed both for reaction B and C. 
The mass spectra of reaction C still shows a consistent abundance of the mono-adduct 
The reaction showed, therefore, to be effective within few minutes of irradiation using 
a common UV lamp. 
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Stability of ASAES2 toward reduction 
The scheme of Reactive SERS needs the reactive molecule bound to the nanoparticles 
surface.  
However, using ASAES2 as reactive substrate, it is not possible to reduce the 
disulphide to obtain a thiol which is highly reactive with AuNP, since almost every 
reducing agent reduces also the azide group. This was observed with molecular 
hydrogen, hydrides as NaBH4, other thiols as dithiothreitol (DTT) and phosphine 
groups. 64, 68, 72 
For this reason, the scheme was adjusted, as reported in Figure 3.23. The first step is 
the photoreaction, as in the precedent paragraph. The second step is the reduction of 
both the disulphide bond, and the unreacted azides, with the tris-(2-carboxyethyl) 
phosphine (TCEP). The final step is the reaction of the thiols with the gold 
nanoparticles surface. 
 
 
Figure 3.23: The Reactive SERS protocol adapted for ASAES2 
 
The use of TCEP, instead of other soft reducing agents such as DTT for example, 
allow the entire protocol to be made in a single batch and without any purification. 
During the synthesis all thiols are added and the gold nanoparticles can be mixed 
directly with the crude reaction mixture. 
TCEP is a well known reducing agent for disulphide bonds64, 72 and the reaction with 
an azide group is known as Staudinger reaction.68 
The mechanism involved in reduction of azides by phosphines starts from the 
addiction of the azide to the phosphor atom. Than molecular nitrogen is released and 
the phosphine is oxidized in presence of water. 
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Figure 3.24: The mechanism 
involved in Staudinger 
reaction.  
Adapted from Ref. 68. 
 
We tested the reduction of ASAES2 with TCEP with different excess of reagents. We 
used the proportion of TCEP:ASES2 of 1:20, 1:1 and 10:1. The solvent used was 
acetonitrile. The reaction was carried out at ambient temperature under mechanical 
agitation for 1 hour. Then, the reaction mixtures were analysed by MALDI-TOF mass 
spectrometry. 
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Figure 3.25: MALDI-TOF analysis of the reaction between TCEP and ASAES2. The 
matrix used was DHAP+TFA 0.1%. 
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Table 3.10: Molecular structures and attribution of the MALDI-TOF in Figure 3.25. 
 Calculated mass peaks 
ASAES2 
M = 474.09 Da 
[M+H]+ = 475 m/z 
[M+Na]+ = 497 m/z 
[M+K]+ = 513 m/z 
TCEP 
M = 250.06 Da 
[M+H]+ = 251 m/z 
[M+Na]+ = 273 m/z 
[M+K]+ = 289 m/z 
TCEPO 
M = 266.06 Da 
[M+H]+ = 267 m/z 
[M+Na]+ = 289 m/z 
[M+K]+ = 305 m/z 
 
M = 422.11 Da 
[M+H]+ = 423 m/z 
[M+Na]+ = 445 m/z 
[M+K]+ = 461 m/z 
 
M = 212.06 Da 
[M+H]+ = 213 m/z 
[M+Na]+ = 236 m/z 
[M+K]+ = 251 m/z 
 
M = 238.05 Da 
[M+H]+ = 239 m/z 
[M+Na]+ = 261 m/z 
[M+K]+ = 277 m/z 
 
At the highest dilution of TCEP (1:20), the reduction occurs slightly, nevertheless the 
peaks of the reduced azide at 422.9 and 448.9 m/z are present, while any signals 
referred to ASAES were found. For the stoichiometric reaction (1:1) both the feature 
of the reduced azide in ASAES2 and in ASAES are present. In the mass spectra of the 
reaction with an excess of TCEP (10:1) only complete reduction occurs and the only 
peaks found are from the reduced ASAES. 
These results also show a preferential reduction of the azide group before that of the 
disulphide group. 
Quantification of DEA with Reactive-SERS as a proof of 
principle 
As a proof of principle, we used the entire protocol reported in Figure 3.23 for the 
three solutions of Table 3.8, namely for the reaction of diethylamine (DEA) with 
ASAES2. 
After the reduction of the three solution with TCEP, gold nanoparticles were added to 
the reaction mixtures. The thiolated ASAES and ASAES-DEA are expected to bound 
preferentially to the nanoparticles surface, due to the strong reaction of thiols with 
gold. 
The functionalized AuNPs were purified by centrifugation and the SERS spectra were 
acquired with the 633 nm excitation. We normalized the SERS spectra to the band at 
1460 cm-1 for a  quantitative evaluation. 
The results reported in Figure 3.26a, show that the band at 1325cm-1 is sensible to the 
amount of DEA and its intensity results to be linearly correlated to the initial 
concentration of DEA (see Figure 3.26b) and, therefore, although an assignment of all 
the bands was not obtained, to the concentration of the molecular adduct ASAES-
DEA. 
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These results show the possibility of obtaining the concentration of a molecule like 
DEA, which does not show a SERS spectrum, by using its reaction with a molecule 
which change its SERS spectrum after the reaction. The scheme, which is shown here 
for a molecule with an amine group can be clearly extended to other molecules with 
other groups provided the identification of a Reactive-SERS molecule which reacts 
with these groups.  The scheme can be therefore useful also for the quantification of 
paclitaxel when the appropriate Reactive-SERS molecule is found.  
 
 
 
         (a)      (b) 
 
Figure 3.26: On the left, the SERS spectra acquired over AuNP surface for the 
ReactiveSERS protocol at different amount of DEA, the spectra were normalized at 
the band at 1460 cm-1. On the right, the normalized intensity of the band at 1325 cm-1 
well follow the increment of DEA concentration through the three reaction studied. 
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4. Advanced Diagnostic Tools, part 1 
In the introduction chapter the so called Circulating Tumour Cells (CTCs) were 
recalled as emerging powerful cancer diagnostic signals. These cells originate from 
tumours even at their early growing stages. Their counting and their phenotypization 
are technological and clinical challenges, because CTCs, at early tumour stages, are 
present in blood only in very low amount. 
Immunological analytical protocols, coupled with surface enhanced Raman scattering 
as detection technique, were recently shown to give impressive results in this field.47, 
73 Despite various strategies and nanotechnological architectures that could be 
adopted, the main features of a useful nanostructure, which must be functionalized 
with a targeting units, like an antibody, are water solubility and presence of strong 
SERS signals.47, 73, 74 Such a nanosytems show specific interactions with antigens 
usually present on the cell membrane.47, 73, 74 Therefore, recording SERS spectra of 
each cell, with a conventional micro-Raman instrument, one identifies the presence of 
an antigen when the SERS spectrum of the reporter, present in the nanostructure, is 
observed.  
A relevant advantage provided by the SERS spectra is multiplexing, namely the 
simultaneously detection of multiple analytes with a limited spectral detection 
window. For example, the simultaneous detection of two different nanosystems, 
coupled with each own targeting moiety and Raman reporter, required an optical 
window of only 92 nm using 633 nm as excitation wavelength.74 This is because 
Raman spectroscopy is a vibrational technique, so different molecules could be 
recognised by their fingerprint signals, that usually stay between zero and 2000 cm-1. 
It results into an optical window of 52, 92 and 146 nm, exciting respectively at 488, 
633 or 785 nm. However, much smaller spectral windows are usually needed because 
vibrational bands show widths of the order of 1 nm or less. If compared to 
fluorescence, SERS provides a superior and trustfully chemical attributions into a 
smaller wavelength range and with comparable signal intensities.13-15, 17 
AuNP, synthetized by laser ablation in solution, were used as SERS substrate for the 
synthesis of two different SERS-tags, sensitive to different prostate cancer antigens. 74 
Antibodies specific for PSMA (prostate specific membrane antigen) and PSCA 
(prostate stem cell antigen) were used for the two different nanostructures. We used 
these two dyes as SERS reporters, TR-SH (Texas-Red functionalized with a thiol 
function) and MG-SH (Malachite Green functionalized with a thiol function). They 
were chosen because of their absorption band near the 633 nm excitation wavelength, 
where also the surface plasmon resonance of AuNPs is present. To guarantee better 
enhancement performances, AuNP were first aggregated by a centrifugation. This 
operation has the double effect of  generating a localised surface plasmon resonance 
in the near infrared and to produce a nanostructure, rich in nanoparticles junctions 
where the incident electromagnetic field is strongly enhanced (hot spots). TR-SH was 
associated to the nanostructure with the anti-PSMA antibody and MG-SH for the 
nanostructure with the anti-PSCA antibody. 
We used these nanostructures in cancer cell antigen detection. Four different cell 
types were used, two expressing only one of the two selected antigens, PSMA and 
PSCA, one expressing both and one expressing none of them. 
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Every cell culture was fixed and treated with a mixture of both SERS-nanostructures,. 
After incubation, cells were washed with PBS solution and micro-Raman 
measurements were obtained for each cell. 
 
 
Figure 4.1: a) LNCap cells show preferential interaction with TR-SH SERS-tag, 
meaning that they express the associated PSMA antigen. In b) PC3-PSCA cells act in 
the same way, but with the PSCA antigen, reflecting in high MG-SH signals. In c) 
both the Raman reporters were present, since cells express both the antigens. In d) a 
representative Raman spectrum, from the cell number 15 in c), shows both the bands 
associated to TR-SH and MG-SH (multiplexing). From Ref. 74. 
 
Although all the cells were incubated with both nanostructures, the cells expressing 
PSMA (LNCaP in Figure 4.1a) correctly showed the SERS bands of TR-SH, which 
was present in the nanostructure functionalized with the anti-PSMA antibody. In the 
case of PC3-PSCA cells, expressing PSCA (Figure 4.1b), the SERS signals were 
those of MG-SH, because of the antibody for PSCA and MG-SH were associated 
together. The almost equivalent abundance of the two SERS signals in LNCaP-PSCA 
cells showed the presence of both antigens on the cell membrane, as expected. The 
fourth cell culture (not shown), not expressing any of the two antigens, showed very 
small  signals only in few cases. 
The ability to perform multiplexing analysis at cellular level was, therefore, fully 
verified, but the number of analytes observed in the SERS spectra can be greatly 
enhanced adding more different SERS-tags. 
A library of new SERS tags is therefore important. 
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Raman active dyes library 
In the following, new dyes were selected and modified to become optimized Raman 
reporters for SERS  multiplexing analysis using AuNP. These molecules show the 
following characteristics: 
o at least one thiol moiety is present for a covalent binding to AuNP, which 
allows to obtain a stable structure also in an aggressive environment like a 
biological environment; 
o the optical absorption  has to be in resonance, or preresonance, with the 
excitation wavelengths used for the registration of the SERS spectra, namely 
633 nm or 785 nm; 
o the SERS spectrum shows few sharp intense bands, different from those of 
other SERS-tags for multiplexing analysis; 
o soluble in water because this is the solvent of election for biological samples. 
The two dyes used for the above recalled work were TR-SH and MG-SH (Figure 4.2), 
optimized for 633 nm excitation wavelength. 
 
 
Figure 4.2: molecular structures of the two Raman reporters just present in our dye 
library. 
 
Part of my work was that of functionalizing three new Raman reporters. While one of 
them was found good for both 633 and 785 nm excitations, the other two were found 
to be best performer only at 785 nm. 
The experimental procedures are reported in Appendix A7.  
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Lipoic Nile Blue 
Nile Blue A (NB) is an aromatic dye used in photodynamic therapy.75 It is also a 
SERS active dye over silver electrode when excited at 488nm.76 
The molecule was conjugated with a lipoic acid according to the reaction scheme 
reported by Ho et al.77, and reported in Figure 4.3. 
 
 
Figure 4.3: the reaction scheme for the conjugation of Nile Blue A with Lipoic Acid. 
 
The mixture was purified by phase chromatography and characterized by ESI-TOF. 
The absorption pattern of LipNB, seemingly to NB, is sensitive to environment 
polarity and acidity.77, 78 The absorption spectrum of LipNB in acetonitrile is show in 
Figure 4.4. 
 
Figure 4.4: UV-vis-NIR molar extinction coefficient for LipNB in acetonitrile. 
 
To test its efficiency for SERS, AuNP were functionalized with LipNB and purified 
with centrifugation. 
In Figure 4.5 the same solution of LipNB 1.12 !M in water was analysed with Raman 
spectroscopy before and after the addition of AuNPs. The analysis of supernatant, 
obtained by the nanoparticles purification steps, shows that LipNB was quantitatively 
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linked to AuNPs. While fluorescence dominates the spectra of free LipNB in solution, 
intense and sharp Raman peaks rise after the conjugation with plasmonic gold 
nanoparticles. 
 
 
Figure 4.5: A solution of LipNB before and after gold nanoparticles are added. The 
SERS effect quenches the fluorescence and increases the Raman signals.  
 
The same experiment with AuNP, but carried out with NB, show consistent spectra 
differences if compared to AuNP-LipNB, especially in the 1100-1600 cm-1 region 
(see Figure 4.6), where bands related to amines and amides are found.76  
 
Figure 4.6: SERS spectra of gold nanoparticles functionalized with NB or LipNB. The 
intensities are normalized to the peak at 594 cm-1. Great differences are evident 
especially in the 1100-1600cm-1 region. 
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The stability of LipNB vs pH was also studied to exclude the release of the dye at 
extreme acid or basic conditions. We modified the pH solutions of a LiNB with HCl 
or NaOH from pH 1 to pH 10.  The same overall intensity pattern was found at all pH, 
showing the stability of the molecule. Some small changes were only observed at pH 
higher than 7, as shown in Figure 4.7, in particular for the bands at 1184, 1382, 1490 
cm-1. The results are in good agreement with those previously reported by Ni et al. for 
NB on silver electrode excited at 488 nm.76 
 
 
Figure 4.7: Raman spectra of the same solution of AuNP-LipNB at different pH show 
the sensitivity of this dye to the environment acidity. 
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Thiolated Cyanine-7 
In the field of infrared optical probes, cyanine-7 dyes plays an important role. 
Moreover, some interesting recent studies show their applications also as SERS-tags 
for in vivo79, 80 and in vitro81 detection of cancer cells. 
The commercially available IR783 was found to react with thiols.82 According to the 
reaction scheme of Figure 4.8, the thiol derivative (Cy7SH) was obtained in 
stoichiometric amount of dithiothreitol (DTT) in dichloromethane (DCM) and in 
presence of tri-ethylamine (TEA). 
 
Figure 4.8: The reaction scheme between IR783 and dithiothreitol to produce Cy7SH 
dye. 
 
The reaction was purified by liquid phase extraction and the product crystallized in 
saturated NaCl aqueous solution. 
A little amount of the dark green solid was dissolved in methanol and characterized 
by MALDI-TOF mass spectrometry.  
 
Figure 4.9: UV-vis-NIR molar extinction cross section of Cy7SH in methanol. 
 
The absorption behaviour of Cy7SH shows that a resonance condition occurs with the 
785 nm laser line. 
The SERS spectra excited at 785nm , is shown in Figure 4.10. 
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Figure 4.10: SERS spectra at 785nm excitation of AuNP-Cy7SH dispersed in aqueous 
solution at nanomolar concentration. 
 
The two intense peaks between 500 and 600 cm-1 are the characteristic SERS 
signature of this dye. 
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Dithiolated Si-Naphthalocyanine 
Phthalocyanine and Naphthalocyanine are highly conjugated macrocyclics showing 
interesting optical properties widely explored in photodynamic therapies and electron 
or energy transfer.83, 84 
Li et al. reported that Si-phthalocyanine chloride undergo easily axial substitution 
with nucleophiles, especially with alkoxide ligands.85 Moreover, they reported that 
mercaptoethanol preferentially links to silicon through oxygen instead of sulphur, and 
that these axial thiol-functionalized phthalocyanines form well-oriented self-
assembled monolayers on gold surfaces.85 Following this suggestions Si-
naphthalocyanine di-chloride (NPCyCl2) was used for obtaining the bis-thiol 
derivative NPCy(SH)2 (briefly reported also as NPCySH) as reported in Figure 4.11. 
 
 
Figure 4.11: The synthetic route used to functionalize NPCyCl2.  
 
The product was characterized by MALDI-TOF mass spectrometry. In Figure 4.12 
the UV-vis-NIR absorption spectra of NPCy(SH)2 is shown.  
 
Figure 4.12: The UV-vis-NIR molar extinction cross section of NPCy(SH)2 in 
methanol. 
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Also in this case the main absorption band of NPCy(SH)2 at 780 nm is in resonance 
with the 785 nm laser line. 
The SERS spectra is reported in Figure 4.13. 
 
 
Figure 4.13: SERS spectra of about 3nM AuNP-NPCySH dispersed in aqueous 
solution at nanomolar concentration. 
 
The Raman signature of NPCy(SH)2 is the sharp intense peak at about 686 cm-1. 
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Raman reporters library 
Five Raman reporters are available for two different near infrared excitation 
wavelengths. Their optical behaviour clearly explains their high SERS performance 
with the occurrence of a resonance or a preresonance condition with the excitation 
wavelengths at 633 nm and 785 nm, as reported in Figure 4.14. 
 
Figure 4.14: Normalized absorption spectra for the five Raman reporters. 
 
Coupling of these molecules with AuNP allows to obtain what is called  surface 
enhanced resonance Raman scattering (SERRS), because the two resonance 
conditions  with the localized plasmon band of the AuNP and the absorption spectrum 
of the molecules occurs. 
The functionalization of the dyes with a thiol, or an equivalent group like a disulfide,  
guarantees a stronger interaction with AuNP, as just discussed in the introduction 
chapters. 
Moreover, one can observe that these Raman reporters have their own peculiar 
vibrational signatures which allows their simultaneous use for multiplexing analysis. 
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Figure 4.15: SERS spectra of the Raman reporters. Each dye has its own band 
signature, evidenced by the coloured circles.  
 
Figure 4.15 shows that TR-SH and MG-SH are optimized for the 633nm excitation, 
whereas Cy7-SH and NpCy-SH for the 785 nm one. LipNB shows high SERS signals 
with both excitations.  
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Processing of experimental SERS data 
In a typical experiment, a sample containing cells expressing different antigens are 
incubated with a series of nanostructures, each containing a different SERS reporter 
associated to a specific antibody. Cells, fixed on a glass slide, are then washed with 
PBS solution for removing all the nanostructures which have not recognized the cell 
antigens with their antibodies. SERS spectra are finally recorded for each cell.  
Recording all the spectra and their interpretation is usually a challenge task which 
must be faced with dedicated programs that were written during the period the present 
work was developed.  
To show the developed procedure I used the following nanostructures in a proof-of-
principle experiment : 
o AuNP + MG-SH + Ab1 
o AuNP + Cy7SH + Ab2 
o AuNP + NPCy(SH)2 + Ab3 
where “Abi” are the following antibodies: 
o Ab1 = mixture of antibodies specific for CD44 and NCad antigens 
o Ab2 = mixture of antibodies specific for PSCA and PSMA antigens 
o Ab3 = single antibody specific for EpCam antigen. 
These antigens were found to be important for cancer diagnosis. 45, 74, 86 
Two different cell populations were used to verify the targeting efficiency of such 
nanosystems: “HeLa” cells, which show both CD44 and NCad, and “LNCap/PSCA” 
cells which show PSCA and EpCam antigens. Some of these cells were also mixed 
together in the “mixed” sample. 
The experiment followed the scheme reported in Figure 4.16. 
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Figure 4.16: Key steps involved in a multiplexing analysis. Many of the analysis are 
obtained with home made programs. 
 
In the following paragraphs the programs will be introduced  for the different tasks. 
Identification of cells for recording the SERS spectra 
The number of cells of a typical sample can be very large (also several thousand of 
cells) and for this reason one needs an automated procedure for recording their 
coordinates on the slide.  These coordinates are then given to the Raman instrument 
for the automatic acquisition of the spectra of all the cells.  
A software was developed for the semi-automated localization of cells on a image 
acquired by the microscope camera of the micro-Raman instrument. 
The software, called Cell On the Floor is now at its fifth version (COF5). 
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Figure 4.17: COF5 acts in close synergy with the micro-Raman instrument, because  
it takes the white light image and returns a list of coordinates where the spectra have 
to be acquired. 
 
This software is written in MatLab® environment and it was developed for the 
identification, the localization and the counting of cells on a surface. 
The program code produces data readable by the WiRE4® software, which is the 
program which governs the inVia instrument of the Renishaw® company. 
The identification is based on the contrast difference between cells and the 
background. Therefore, a sufficiently clean glass surface and a high resolution image 
are important. 
 
 
Figure 4.18: At the left, a typical image usable with COF5. On the right, the 
coordinates and dimension of the sample are introduced. Into this example, the image 
extends by more than 1mm in length and about 0.8 mm in height. 
 
The image elaboration starts with the binary image into the bottom-right box and the 
real image at the central-left one (see Figure 4.19). 
Every red dots in the main box corresponds to a point which will be analysed. 
 
Micro-Raman Instrument 
MatLab® environment 
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Figure 4.19: The main windows of COF5. The cell searching results are shown into 
the main box at the centre-left of the window, as red dots. 
 
The code works by fixing a grey contrast value (Grey Limit Value) into the pristine 
image. Pixels brighter than the fixed value appear as white into the binary picture, 
while the other appear black. A red dot is reported at the centre of isle of nearby 
points and real coordinates are given to every red dots. 
The Parameters panel allows the user to change the values for the image elaboration, 
such as the Grey Limit Value or the Boundary Limit Value. The last one is extremely 
useful to avoid the identification of too much bigger or smaller isles, such as dust. For 
example, setting the Boundary Limit Value at Range mode within 10 and 30 !m, only 
the isles (cells) found into this dimension range will be selected, as you can see with 
the Show Histogram function. 
 
 
Figure 4.20: The graph shown using the Show Histogram function. A clear dimension 
distribution is found centered at about 13 !m. The larger elements are due to cell 
clusters or impurities. 
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As one can see in Figure 4.20, a distribution centered at about 13 µμm identifies the 
cells. Nevertheless, especially three elements have an unusual large dimension, close 
to  double of the average dimension. These elements can be identified as cell clusters, 
namely cells which are sticked together. The Check Clusters allows to edit manually 
the point of analysis, as in Figure 4.21. 
 
 
 
 
Figure 4.21: Top, the Check Clusters main window clearly shows the presence of a 
cell cluster recognized as a single bigger element. Below, the Edit Coordinate 
function allows to change manually the red dot with the green ones. The new 
coordinates are further uploaded into the main box of COF5. 
 
As a final step, a text log containing a list of coordinates, related to the points of 
analysis into the main box of COF5, is exported for uploading by the WiRE4® 
software. 
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Softwares for data analysis   
After recording the spectra of all the identified cells one has to analyse all the spectra 
for the presence of one or more SERS reporter.  
To make more easy and automatic this task, three different interactive graphical user 
interfaces were developed with the following aims: 
1. evaluation the presence/absence and signal intensity distribution of a particular 
SERS-tag, that is the presence of specific bands associated to the relative 
SERS reporter; 
2. evaluation the simultaneous occurrence of multiple SERS-tags in the same 
spectrum; 
3. comparison between different samples in order to understand the presence of 
different type of cells.  
The program for point 1 was called PicchiVeri4. In Figure 4.22 the main window with 
a representative dataset of cell is shown. The software works by selecting an user 
defined Raman Shift into the panel “Signal Selection”. Than a false colour map shows 
the cells distribution on the xy plane, while the z-elevation reflects the intensity found 
at the selected frequency. 
In “False-Positive Selection” the user can fix a lower intensity value, below which all 
signals are considered as noise. It is often a good practice to carefully check this value 
because of the occurrence of false positive or negative cases. To provide assistance to 
the user, all spectra can also be manually checked one-by-one, if needed. 
 
 
Figure 4.22: The main window of PicchiVeri4, a representative dataset is relative to 
cells targeted with a SERS-tag carrying LipNB. 
 
PicchiVeri4 also provides a couple of graphics for the analytic results. These are the 
intensity distribution of positive signals (left in Figure 4.23) and the overall counting 
of positive and negative elements (right in Figure 4.23). 
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Figure 4.23: Graphs provided by PicchiVeri4. The signal intensity distribution (left) 
reports how many elements show SERS signals, while the black bar reflect the spectra 
without signals. A pie graph (right) gives immediate information about the targeting 
efficiency. 
 
Returning to the proof of principle example reported above, with three types of 
nanostructures and two type of cells, the collected spectra have to be analysed by 
PicchiVeri4 three times for each type of cell, to obtain the results related to each 
Raman reporter.  
Now the simultaneous presence of more than one SERS-reporter is evaluated by 
another program, MultiplexingSERS, which unifies the results of the three runs of  
PicchiVeri4 for the three SERS-reporter. 
 
 
Figure 4.24: Main window of MultiplexingSERS. The signal related to the different 
SERS-tags are represented in different colours for each cell examined. 
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The main result provided by this program is the number of cells with the presence of 
single and multiple SERS-reporters. In Figure 4.25, one can see that 103 cells show 
only the signal related to MG-SH, 14 only that for Cy7SH and 17 cells that of  
NPCy(SH)2. Furthermore, 1 cells shows the presence of MG-SH and Cy7SH, 23 MG-
SH and NPCy(SH)2, and 5 Cy7SH and NPCy(SH)2. Finally 77 cells do not present 
any SERS-reporter signal. 
 
Figure 4.25: A graph representing the SERS-tag occurrence distribution found. Over 
the 40% of the overall cells express only the antigen for the SERS-tag associated to 
MG-SH. Nevertheless there are a consistent amount (>30%) of elements not 
recognized by any of the submitted SERS-tags. 
 
Finally the program MultiplexingPCA operates a PCA (Principal Component 
Analysis) to characterize the different type of cells present in a sample according to 
point 3 of the above list. In this case the comparison between sample with single type 
of cells and sample with mixed type of cells allow to identify, in the mixed samples  
the different cells.   
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Figure 4.26: The main window of MultiplexingPCA. In this software more cell 
samples are taken into account together. Under principal component analysis is 
possible to distinguish between heterogeneous populations. 
 
The principal component analysis (PCA) is a statistical method to find and represent 
similarities. Here, we applied PCA to the dataset composed by the signals recorded 
for the  HeLa,  LNCap/PSCA and mixed samples. 
In Figure 4.27 the score plot for the first two principal component is shown. 
“LNCap/PSCA” cell are represented in blue, “HeLa” in black and the “mixture” in 
red. The stars rapresent hypothetical samples in which the signal comes from only one 
Raman reporter. 
One observes that “LNCap/PSCA” are present in a cluster located close to the 100% 
of NPCy(SH)2, with a tail directed toward Cy7SH. 
At the other side, “HeLa” cells  are close to MG-SH and 50 elements are overlaped 
exactly at 100% of MG-SH. 
Some Mixed cells are close to the region of “LNCap/PSCA” and some others to that 
of “HeLa” making possible to identify HeLa and LNCap/PSCA cells in the sample.  
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a) 
 
 
b) 
 
 
Figure 4.27: Continue… 
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c) 
 
 
Figure 4.27: Score plots for the sample of HeLa, LNCap/PSCA and the mixed 
samples. In a) “LNCap/PSCA” cells cluster close to the NPCy(SH)2 flag (100% 
Naphthalocyanine) are highllighted. In b) “HeLa” are highlighted (100% 
MalachiteGreen). In c) the mixed cells sample is highlighted and divide into some 
clustering around “LNCap/PSCA” and some around “HeLa”. 
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Cultural Heritage applications 
Proteic matter characterization in artefacts 
In the field of cultural heritage, the characterization of the organic matter in artwork 
samples still remains a challenge due the physical and chemical changes with ageing 
of these materials. 
Nevertheless, due to the uniqueness and rarity of such a samples, the maximum 
information has to be obtained from the smaller amount of matter. This reflects into 
the preferential choice for non destructive analysis, and also toward the techniques 
providing information with the lowest number of measurements. 
In the following a comprehensive analytical approach is presented, based on the  
advantages provided by immunological protocols and SERS spectroscopy.49 
Traditional Raman spectroscopy is usually applied to the characterization of paint 
layers, and it provides chemical identification of Raman active compounds present in 
the artwork. However, the difficulty  to identify proteins like ovalbumin, suggested to 
use immunological protocols based on SERS nanostructures.  
The composition and synthesis of SERS-tag are similar to those used for the 
identification of tumour  associated antigens,74 and are sketched in Figure 4.28. 
 
 
Figure 4.28: a) Absorption spectra of AuNP before and after the aggregation and the 
functionalization with LipNB, antibody and PEG; b) a sketch representing the 
synthetic steps involved for the SERS-tag production: the aggregation of AuNP comes 
first, than the conjugation with the LipNB (I), with thiolated antibody (II) and with a 
long chain polyethylene glycol (III). From Ref.  49. 
 
We applied these nanostructures to a paint stratigraphic sample, obtained by a 
micrometric piece of the artefact. The micro-sample was embedded in polyester resin 
and cut to obtain a stratigraphy. Fine abrasive papers was used to polish the surface. 
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The stratigraphy was made by two layers, different in composition and 
physicochemical characteristics.  
Despite the synthesis of nanostructures are similar to the previously reported74, we 
functionalized AuNP with a secondary anti-rabbit IgG antibody.49 The immunologic 
protocol adopted consists on a non-competitive sandwich immunoassay. A primary 
anti-chicken egg albumin antibody was first added on the stratigraphy. The constant 
fraction of such antibodies are than recognized by our SERS-tags, due to the presence 
of secondary antibodies. In this way the SERS signals, related to the nanostructure, 
are enhanced because of the probability that multiple SERS-tags can recognize the 
same primary antibody. 
We tested our protocols with a standard sample presenting two layers with different 
proteins and pigments (sample 2L1, Figure 4.29). The sample was mapped acquiring 
572 spectra in a 52x11 !m2 area. 
Intensities at selected frequencies were used to reconstruct chemical false coloured 
maps. 
 
 
Figure 4.29: a) A image of 2L1 stratigraphic sample; the white box represent the 
mapped area. b), c), d) the false coloured chemical maps at the frequency of 592, 299 
and 400 cm-1, representing respectively ovalbumin (AuNP-LipNB SERS-tag), red 
ochre (Fe2O3) and azurite (Cu3(CO3)2(OH)2). e) a representative spectra by the layer 
1 in a). From Ref. 49. 
 
Finally, the proposed method was tested on a historical sample, collected from a 
Renaissance painting.  
The mapped area was 19x3 !m2 with a total of 57 acquired spectra. The unambiguous 
localization of our SERS-tag was found on the varnish layer (upper white area in 
Figure 4.30a), due to the presence of the characteristic band at 592 cm-1. 
It was also possible to localize the presence of azurite, with the Cu-O stretching at 
400 cm-1, and lead white, with the symmetric CO32- stretching at 1051 cm-1, into the 
pigment layer. 
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Figure 4.30: a) A image of a Renaissance stratigraphic paint sample, the white box 
represents the mapped area. b) the same image of a) under UV-light. c), d), e) the 
false coloured chemical maps at the frequency of 592, 400 and 1051 cm-1, 
representing respectively ovalbumin (AuNP-LipNB SERS-tag), azurite 
(Cu3(CO3)2(OH)2) and lead white ((PbCO3)2•Pb(OH)2). e) a representative spectra 
from the varnish layer. From Ref.  49. 
AuNPs for Surface Enhanced IR Absorption 
Identification of dyes in natural fibres is an interesting argument in Cultural Heritage 
because of the importance of characterizing artefacts with historical value. The 
identification of the dyes with Raman or SERS spectra can be a choice. However, 
when a molecule is adsorbed on rough metal surfaces, also its infrared absorptions 
appears more intense than it can be expected. This effect was named Surface 
Enhanced Infrared Absorption (SEIRA), to recall the analogy with SERS (Surface 
Enhanced Raman Scattering).87 
The enhancement factor of SEIRA is some order of magnitude lower than that of 
SERS.15, 87 Nevertheless, we investigated this effect using the laser ablated gold 
nanoparticle in infrared reflection absorption spectroscopy (RAS) for the 
measurements of the synthetic dye acid orange 7 (AO7) in whole wood.87 
To record a reference RAS-SEIRA spectra of AO7, we pre-mixed the colloidal 
solution of AuNPs with AO7, and then we dried a drop over of the solution on a glass 
slide. 
This method was found effective in measuring SEIRA spectra of a 5•10-5 M solution 
of AO7.  Figure 4.31 shows  the registered spectra. 
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Figure 4.31: RAS SEIRA spectra of AO7 mixed with AuNPs at 10-4M and 5•10-5 M 
concentration of the dye. From Ref.  87. 
 
The same measurement approach was used to evaluate the AO7 content into a wool 
fibre. Few mm of a single fibre was used, with a weight of less than 0.01 mg. 
The optimized micro extraction method consisted in washing the wool fibre with a 
small amount of methanol for 60 minutes, than the solvent was evaporated and the 
dye dissolved into 10 µL of water. 
The recorded RAS-SEIRA spectra are reported in Figure 4.32 and were characterized 
by weak signal intensities, which, however, made possible to identify the dye. 
 
Figure 4.32: RAS SEIRA spectra of AO7 extracted from a dyed wool and mixed with 
AuNPs (green) and the relative reference spectra (red). From Ref  87. 
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5. Advanced Diagnostic Tools, part 2 
In the field of diagnosis and prognosis of cancer, total-body screening and localization 
of tumour have crucial importance. 
In ideal application perspectives, adequate contrast agents (CAs) should be applied to 
localize not only the tumour but also the tumour margins during surgical removal. 
Both these challenges are extremely difficult to achieve within a single mono-modal 
contrast agent, that is usually optimized only for a single imaging technique. 
Nevertheless, nanotechnology offers the opportunity to merge multiple functionalities 
into the same nanoobject at nanometric scale. 
The so called multimodal contrast agents (MCAs) consist in a single material planned 
for providing signals for more than one imaging technique. In comparison to multiple 
administration of mono-modal CAs, MCAs provide contrasts coming from exactly the 
same points for each technique, while reducing the total amount of submitted agent 
and therefore, preventing high dose related side effects. 
In the following, a proposal for new, advanced, multimodal contrast agents are 
reported. In particular, two imaging technique like magnetic resonance imaging 
(MRI) and surface enhanced Raman spectroscopy (SERS), will be considered. Both 
techniques operate with safe radiations, namely magnetic fields and near infrared 
visible light.  MRI has high tissue penetration, whereas SERS provides spatial 
resolution down to microns. These properties make MRI and SERS complementary 
imaging techniques. 
AuFe nanoalloy nanoparticles for MRI-CT-Raman 
imaging 
For magnetic resonance imaging (MRI) contrast agents (CAs), a useful parameter for 
the comparison of effective image contrast is the molar relaxivity (r) related to T1 (r1) 
or T2 (r2): 
 1!!,!"#$%&$' = 1!!,!"##$% + !! ∙ !.!.  
… Equation 5.1, from Ref . 25. 
 
Where i = 1 or 2 and [C.A.] is the concentration of the relative contrast agent. Ti,tissue 
is the intrinsic relaxation time of the surrounding environment in the absence of 
contrast agents. 
Iron oxide nanoparticles is extensively used as CAs because of the large number of 
paramagnetic centres present in these nanoparticles, which provide a great magnetic 
susceptibility which is useful for obtaining a large r2.19 Their presence in multimodal 
CAs (MCAs) derives from the possibility of their coupling to other  nanometric 
structures, with complementary properties.19, 88-90 
The synthesis of nanostructures for multiple imaging detection, obtained by adding 
new functions in a layer-by-layer approach, has the disadvantage of a multiple 
production steps. 
The synthetic drawbacks can be reduced in case of MCAs made by a single phase, as 
in the case of alloy nanoparticles, which show all the planned properties. 
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We studied multimodal contrast agents based on Au-Fe alloy nanoparticles 
(AuFeNPs) 91which can be used for magnetic resonance imaging  (MRI), computed 
tomography (CT) and surface enhanced Raman scattering (SERS). 
Laser ablation synthesis in solution was used for the preparation of such MCAs, since 
it works far from thermodynamic equilibrium, where Au-Fe nanoalloy formation is 
favoured.  By contrast, using wet chemistry bottom-up  approaches, this kind of 
nanoparticles are not trivial to obtain. 
The optimal composition of AuFeNPs alloy was evaluated by considering the 
physical properties involved in good contrasts for MRI, CT and SERS. 
In Figure 5.1 every contributions to the determination of the best alloy composition 
are shown. 
 
 
Figure 5.1: The physical parameters involved on each imaging technique were 
evaluated to determine the best alloy composition. These are the magnetic momentum ! for MRI, the linear attenuation coefficient ! for CT and the enhancement factor at 
633 nm excitation GSERS for SERS. Each of these were rationalized with respect to the 
relative reference. The blue curve determines the most efficient composition to reach 
for optimal MCAs. From Ref . 91. 
 
Increasing Iron to Gold ratio favours the presence of a net magnetic moment (!)  
which grows at Fe atomic fraction higher than 5%. 
CT is based on absorption of X-rays, with energy in the 30-120 keV range. 
Heavier elements show higher X-ray absorption cross sections, therefore, Au has a X-
ray linear attenuation coefficient about 50 times larger than Fe.91 
SERS effect, due to electromagnetic enhancement, comes from plasmonic substrates 
and also in this case, higher a gold fraction is preferred.15, 18, 91 By DDA (discrete 
dipole approximation) calculations, SERS enhancement factor (GSERS) at the hot spots 
between two equal spheres can be calculated and one finds that it decays 
approximately 20 times for a Fe atomic fraction going from 0 to 15%. 
Taking into account all these composition dependent properties, the expected best 
performer nanoalloy composition was found to be at iron atomic content of about 
10%.  
Au89Fe11NPs were synthetized by LASiS in ethanol, of a bulk material with 
composition Au73Fe27.91 The nanoparticles were proved to be crystalline with Fe 
atoms homogeneously dispersed into the fcc lattice characteristic of AuNP.91 
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The nanoparticles were than conjugated with bis-thiolated SERS dyes (di-thiolated 
Texas Red, TR(SH)2, and di-thiolated naphthalocyanine, NPCy(SH)2) and a long 
chain of mercapto-polyethylene-glycol (PEG5000-SH). 
The bis-thiolated dyes favoured the formation of nanoparticle dimers and, as a 
consequence, the hot spot feature for greater SERS enhancements. In such a situation, 
the dye will stay at the nanoparticles junctions, the best position to fully benefit by the 
surface enhancement. 
By numerical calculations based on the DDA approach, we found that hot spots in 
such a representative MCA reach GSERS values as high as 106.91 
Magnetic relaxivity measurements were performed at 200 MHz.  AuFeNPs give a 
relaxivity of 60 mM-1  ∙  s−1 that is an interesting result if compared to the value obtain 
for the mono-modal commercial agent, Endorem™ (FeOxNPs), that is about 100 mM-
1  ∙  s−1. 
In X-ray absorption measurements, we found 225 HU (Hounsfield Units) for MCAs 
concentration of 5.5 mg/mL, that is close to the value obtained with pure gold 
nanoparticles dispersion at the same concentration. 
In Figure 5.2 are shown the magnetic resonance and CT results of AuFeNPs 
nanoalloy compared with reference samples. For MRI, the reference is Endorem™ 
and for CT a pure AuNP colloidal solution. 
 
 
Figure 5.2: The experimental responses for MRI (a) and CT (b) were reported as a 
function of Iron and nanoparticles concentration with respect to the relative reference 
sample. In (c) the good spatial resolution of SERS, better than 10 µm, appears clearly 
with respect to MRI and CT. From Ref. 91. 
 
In Figure 5.2c are also shown the differences in spatial resolution. 
The results show that such nanoparticles overcome the drawbacks of each single 
imaging technique. In fact, MRI and CT have higher tissue penetrations, but they lack 
in high spatial resolutions (0.15 x 0.15 mm2 for MRI). In contrast, SERS signal comes 
from the irradiated area and, therefore, they can be recorded with a spatial resolution 
determined by the optical objective. The typically found resolution is of the order of 
some microns or of hundreds of nanometres. The synthesized multimodal contrast 
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agents show all the pros useful for the considered techniques, and therefore they show 
high tissue penetration and high spatial resolution. 
AuFeNPs were tested with in in vivo experiments using Balb/c mice with established 
sub cute 4T1 tumours. The MCAs were injected intravenously into the tails and MR 
images were obtained over a period of 24 hours before the animals were sacrificed. 
In Figure 5.3 are reported the relaxation time T2 weighted with the same T2 measured 
before the MCAs injection, and the SERS signal intensities obtained with the main 
organs and tumour in ex vivo measurements. 
 
 
Figure 5.3: Normalized magnetic resonance relaxation time T2 measured at different 
times after injection of the MCAs (left) and the ex vivo bio-accumulation of such 
MCAs measured as Raman signal intensities at 633 nm excitation for TR-(SH)2 
functionalized AuFeNPs (right). From Ref. 91. 
 
Data show a fast presence of MCAs into the liver, since its T2 falls down in just 10 
minutes. However, at a time between 2 and 15 hours, the T2 value of tumour decrease 
by 10% from the original value. These timescales are compatible with the expected 
time for the effective accumulation in liver, due to the opsonization, and in tumour, 
due to the enhanced permeability and retention (EPR) effect.90 
The biodistribution of MCAs was investigated by Raman spectroscopy ex vivo on 
lysates of explanted organs. 
The intensity of Raman signals due to MCAs indicates a prevailing accumulation in 
liver, spleen, kidneys and tumor, while no signals are detected in lungs and blood. 
All these data prove the effective useful application of such a multimodal contrast 
agents in in vivo diagnosis and prognosis of tumour. 
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SuperDOTA(Gd) functionalized Gold 
Nanoparticles for multimodal imaging 
Magnetic resonance contrast agents with heavy metal cations, such as Gadolinium, 
provide positive contrasts in T1 weighted MRI imaging. 
However, Gd3+ is a toxic lantanide ion, with a size approximating calcium(II), but 
with a higher charge, which interferes with Ca(II)-required signalling.21 
Free Gadolinium is also known to bind serum proteins and accumulates within bone, 
where it becomes tightly and irreversibly associated.21 
For this reason much attention is dedicated to stable coordination of Gd3+.. Currently, 
all approved gadolinium(III) based MRI contrast agents are nine-coordinate 
complexes in which ligands occupy eight binding sites at the metal centre and the 
ninth coordination site is occupied by a solvent water molecule.21 
 
 
 
 
Figure 5.4: Gadolinium chelated compounds approved as MRI contrast agent from 
1999. From Ref. 21 
 
With respect to T2 MRI contrast agents, that are usually based on iron or iron oxides 
nanoparticles, gadolinium complexes are characterized by low sensitivity, due to their 
low magnetic relaxivity.19  
In Table 5.1 are reported some relaxivity values  for common gadolinium complexes. 
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Table 5.1: Relaxivity values for various gadolinium complexes. From Ref.  21. 
  
 
 
Strategies for enhancing such sensitivity for Gadolinium containing contrast agents 
are focused on the increasing the number of coordinated water molecules, although a 
consistent increase of the probability of cations release also occurs.21 
A second promising approach to the problem follows the synthesis of new classes of 
contrast agents, based on nanoparticles, where several, up to thousands, Gadolinium 
cations can be present on a single nanosystem. 
Planning the synthesis of new SuperDOTA polymer 
Within the second approach, namely the increase of number density of Gd3+ for a 
multimodal T1-MRI and SERS contrast agent, a new polymer able to coordinate up to 
three Gd3+ ions per single chain, using chelating groups like DOTA was planned and 
synthetized. This polymer can be also linked to AuNP with a thiol function. 
The polymer is called SuperDOTA, due to its enhanced cation loading capability.  
DOTA residues are bound to the polymer backbone, which, however, was planned to 
link also other imaging agents, or even drugs, using the same chemistry which is 
based on the click chemistry. The same DOTA can be used, however, for obtaining 
other complexes useful, for example, for radioimaging.20 
Sharpless at al. defined click chemistry the reactions that can be modular, wide in 
scope, with very high yields, which produces only inoffensive byproducts (removable 
preferentially by non chromatographic methods) and that can be also stereospecific.92 
The most popular click chemistry reaction was developed by Huisgen and is the the 
[3+2] cycloaddition between an azide and an acyclic alkyne.68, 92, 93 In its primary 
synthetic route, this reaction required high temperature to overcome the activation 
barrier needed for deforming the alkyne’s bond angle and forming the triazole.68, 92, 93 
The independent observation by Meldal and Sharpless that Cu(I) ions strongly 
catalysed the Huisgen reaction, results in a real breakthrough in triazole chemistry.68, 
93 
Despite Cu(I) makes the reaction possible in water at room temperature, the metal 
cytotoxicity limits its use in living systems or in biological sensitive environments.93 
Furthermore, considering the presence of DOTA in SuperDOTA, Cu cations are  
competitive coordinating ions with respect to Gd3+. 
A solution of this problem came from Bertozzi at al. that investigated the unusual 
reactivity between cyclooctyne and phenylazide.94 
The bond angles of the sp-hybridized carbons in cyclooctynes is ~160°, which is 
distorted toward the transition state of the cycloaddition reaction, resulting in a 
dramatic rate acceleration, without any Cu(I) ion.93 The reaction between a strained 
alkyne and an azide is actually known as Cu-free click chemistry. 
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For the coupling reaction between DOTA fragments and the polymer backbone, we 
chose dibenzocyclooctine (DBCO) as functional moiety for Cu-free click chemistry. 
The most peculiar feature of SuperDOTA molecule are resumed in Figure 5.5. 
 
 
 
Figure 5.5: A sketch (up) and the molecular structure (down) of the SuperDOTA-
Gd(III) polymer. The three fundamental moieties are indicated with different colours. 
 
The sulfhydryl group is present for the link to AuNP. The long polyethylene glycol 
chain (PEG) provides immunological stealth properties. It was reported that a 
nanosystem has to circulate, in vivo, at least for 6 hours, to have a consistent 
probability to accumulate to the tumour site due to the enhanced retention and 
permeability (EPR) effect.90 
In fact, over 30 different serum proteins are reported to bound to AuNP,90, 95 and the 
surface opsonization can effectively promotes their elimination from the circulating 
system between seconds to minutes.90 
To overcome this effect, the surface coverage of AuNP by over 1 kDa PEG was found 
effective in improving stealth properties.90, 95 The presence  of PEG reduces the serum 
protein adhesion to the nanoparticle surface.90, 95 In this way nor the macrophages nor 
the immune system recognise the presence of the so called complement components 
and biological cascade will not be activated. 
SuperDOTA, excluding the DOTA-DBCO couplings, was synthetized by solid phase 
peptide-like synthesis.  
The procedure consists of seven couplings and the name of the intermediate products 
recalls the number of the coupling in the sequence. Therefore, the intermediate 4c 
derives from four coupling reactions. 
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Solid phase synthesis of “7c” polymer 
The synthesis of the polymer 7c was carried out in solid phase according to the 
schematic procedure show in Figure 5.6. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.6: Schematic 
representation of the solid phase 
synthesis procedure for the 7c 
polymer. 
 
In 1963, Merrifield et al. developed the first protocol for the solid phase peptide 
synthesis.96 This approach had an impressive impact on the production of peptides 
and, at present, is an ubiquitous technique for this type of synthesis. 
The solid phase synthesis consists in coupling a selected sequence of monomers 
starting with the first one that is linked to an insoluble resin. All the buildings blocks 
are added and linked one-by-one. Every new coupling is carried out in a consistent 
excess of reagents to obtain products in quantitative yield. 
Since the sequence grows linked to an insoluble substrate, every step is easily 
purified, and the final product is cleaved from the resin. 
The most important implication is that the process is easily automated. 
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In the synthesis of 7c, the backbone of SuperDOTA, we used a 4-hydroxybenzylic 
alchol modified chloromethyl polystyrene resin (known as Wang resin), preloaded 
with cysteine, acting as first building block.  
We proceed from C-terminal toward N-terminal using the Fmoc 
(Fluorenylmethyloxycarbonyl) protecting group for amines, and Trityl 
(Triphenylmethyl) for thiols. 
The azide groups, due to the high selectivity of the click chemistry, don’t need any 
protection during the synthesis.92 
The other building blocks consist in a !-carbossyl-!-amino-PEG12 and in an (S)-5-
Azido-2-aminopentanoic acid. These two were alternated along the polymer chain. 
The last step involves the coupling of a carbossyl-PEG(2kDa)-OCH3. 
In the final product every building block is present three times, the chain starts with a 
cysteine and ends with a long polyethylene glycol chain. 
The solid phase synthesis was an efficient technique for the production of 7c. The 
mass spectroscopy and HPLC analysis of the 4c and 6c intermediates (see Appendix 
A9) confirm the quantitative yield for the coupling reactions. 
In Figure 5.7-8-9 are reported the MALDI-TOF mass spectra for the 6c intermediate, 
carbossyl-PEG(2kDa)-OCH3 and for the product 7c.  
 
 
Figure 5.7: Molecular structure (up) and MALDI-TOF mass spectra (down) of the 
product 6c, DHAP-TFA used as matrix. Theorical mass 2340.7Da, experimental 
2342.0 m/z ( [M+H]+); 2364.0 m/z ([M+Na]+). 
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Figure 5.8: Molecular structure (up) and MALDI-TOF mass spectra (down) of the 
carbossyl-PEG(2kDa)-OCH3, DHAP-TFA is used as matrix. Distribution peak 
centred at about 2050 m/z. The distribution of mass peaks is typical for heavy chain 
polymers. Every signal has a difference of 44 m/z in respect to the next or the 
previous one, that is the weight of the OCH2CH2 monomer unit in PEG. 
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Figure 5.9: Molecular structure (up) and MALDI-TOF mass spectra (down) of the 
product 7c, DHAP-TFA used as matrix. Theoretical mass distribution centered at 
4390 Da (2340 Da for 6c and 2050 Da for final PEG). Experimental mass 
distribution centered at about 4350 m/z. 
 
The mass spectra distribution for carbossyl-PEG(2kDa)-OCH3 shifts by more than 
two thousands mass units after the reaction with the intermediate product 6c. This 
result is compatible with the effective production of the final product 7c. The 
MALDI-TOF mass spectrum of 7c does not show peaks related neither to 6c nor to 
carbossyl-PEG(2kDa)-OCH3, in the zone of 2340-2365 m/z and 1500-3000 m/z 
respectively (data not shown). Therefore the distribution found at about 4350 m/z can 
be well attributed to the coupling product 7c. 
As a final proof, the reaction product was characterized with a series of mono- and bi-
dimensional nuclear magnetic resonance (NMR) experiments. 
In Figure 5.10 the hydrogen atoms of the molecular structure 7c were indicated with 
numbers according to the attributions reported in Table 5.2. 
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Figure 5.10: The molecular structure of 7c (up) with the hydrogen atoms enumerated 
as in the NMR attribution analysis and the 1H-NMR spectrum of 7c (down). 
 
 
Table 5.2: The NMR attribution for the hydrogens and the carbon atoms according to 
the numbers reported in Figure 5.10. 
Atom Index 
1H-NMR 
chemical shift 
(ppm) 
13C-NMR 
chemical shift 
(ppm) 
1H-NMR  
theorical area 
1H-NMR  
experimental area 
1 4.74 53.81 1 0.8 
2 2.97 26.49 2 1.3 
3 1.54 - 1 0.3 
4 7.38 - 1 0.8 
5 7.10 - - - 
6 4.39 52.47 3 2.9 
7 1.87 1.63 29.60 12 10.2 
8 1.58 25.00 
9 3.25 50.98 6 6.1 
10 7.04 - - - 
11 3.58 70.51 304 306.5 
12 3.31 58.97 3 3.0  (assigned value)  
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First, attributions come from the 1H-NMR spectra. Polymer amidic protons (4, 5, 10) 
fall between 6.70 and 7.40 ppm. The hydrogen number 4 develops a doublet centred 
at 7.38 ppm. For 5 and 10, the signals overlaps, but thanks to COSY and TOCSY 
bidimensional plots (see Figure 5.11) a reasonable attribution became possible at 7.10 
and 7.04 ppm respectively. 
The methoxy group protons (number 12) shows a singlet at 3.31ppm, as expected by 
looking at the molecular structure. 
The most intense signal at 3.58 ppm comes form the ethylene-glycol groups (11), 
since their protons are the most abundant in the molecule. 
Protons 1 and 6, being very close to carbonyl and amide electron withdrawing groups, 
have resonances at 4.30 and 4.80 ppm. 
Starting by this observation and thanks to COSY and TOCSY spectra, all other 
protons’ assignments were done. 
In particular, carbon at number 6 is a chiral centre. This fact makes pro-chiral points 
the other carbons 7, 8 and 9. Therefore, the hydrogen atoms bound to such a carbons 
are not magnetically equivalent and differences should be observed in their chemical 
shifts. However, the distance of the pro-chiral carbon from the chiral one reduces the 
inhomogeneity. Therefore, only for the protons 7 we observe two distinct signals at 
1.63 and 1.87 ppm, while for 8 and 9 only a single peak at 1.58 and 3.25 ppm . 
The peak areas were integrated and normalized to that of the methoxy group signal, 
which was assigned a value of 3. 
Since this functional group is only present in 7c and not in 6c, the close proximity of 
the theoretical areas with the experimental ones gives the final confirmation of the 
presence and purity of the molecule 7c. 
From the 1H13C-HMBC and 1H13C-HMQC bidimensional spectra also carbon 
chemical shifts were evaluated. 
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Figure 5.11: Continue… 
 
1H1H-COSY 1H1H-TOCSY 
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Figure 5.11: The bi-dimensional NMR specra of 7c in CDCl3 at ambient temperature.  
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The final steps on the synthesis of “SuperDOTA-Gd(III)” 
As just discussed before, we chose the Huisgen reaction to link DOTA residues to 7c. 
Dibenzocyclooctyne was used for the strained alkyne moiety that we linked to a 
DOTA derivative with an amide bond. The reaction scheme is reported in Figure 
5.12. 
 
 
 
 
Figure 5.12: The reaction scheme between DOTA and dibenzocyclooctyne-NHS. 
 
 
 
 
The different physicochemical properties of the two reagents allowed to obtain a 50-
60% reaction yield. In fact, DBCO-NHS is slightly polar while DOTA is water 
soluble. 
The final product DOTA-DBCO still remains soluble in water due to the polar 
properties of DOTA. This was also verified by the fact that when Gadolinium cations 
were added and the complex formed, a precipitation occurred. The solid obtained was 
no more soluble in a wide variety of solvents and its MALDI-TOF mass spectrometry 
revealed that the Gd complex was present. 
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Figure 5.13: MALDI-TOF mass spectra of Gd-DOTA-DBCO insoluble crystals (up), 
DHAP-TFA was used as matrix. Theoretical mass 959.1 Da; experimental 959.2 m/z 
([M]-). The mass spectra was obtained in negative ionization modality, since the total 
net charge of Gd-DOTA-DBCO is -1. The isotopic distribution follows the simulation 
provided for the same molecule (down), as a confirmation of its identity. 
 
The ability of DOTA-DBCO to coordinate Gd3+ ions was quantitatively evaluated 
adding a known excess of GdCl3. The unreacted Gd3+ was retro-titrated with EDTA 
and Xylenol Orange as indicator.97 Our results give a complexation yield of 98.6% 
over the total DOTA content. This evidence shows two crucial synthetic results: the 
coordination chemistry of DOTA still remains quantitative after the reaction and the 
synthesis was contaminant-free, maintaining the macrocycles empty. 
Due to the extremely low solubility of Gd-DOTA-DBCO, the Cu-free click chemistry 
between 7c and DOTA-DBCO was carried out first. The Gadolinium complexation 
becomes, therefore, the last step, as shown in Figure 5.14. 
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Figure 5.14: A schematic representation of the two final steps for the production of 
SuperDOTA-Gd. The Gd-DOTA-DBCO is extremely insoluble, so the click chemistry 
was operated before the complexation. 
 
The Huisgen cycloaddiction was performed simply mixing 7c and DOTA-DBCO in 
aqueous solution at room temperature for one day. 
Despite the click reaction gives quantitative yields, as proved by a test reaction 
between 6c and DBCO (data not shown), the complete characterization of the final 
SuperDOTA presented some not trivial complications. 
The reaction mixture was first purified by centrifugation, utilizing filtering 
membranes with 2000 Da molecular cut-off. 
The product stopped on the membrane was re-dissolved and analysed by reverse 
phase HPLC. Despite the chromatogram showed a single, quite broad, signal (see 
Figure 5.15), the reference chromatogram of 7c was not available because its polarity 
made its elution too fast. 
 
 
 
 
Figure 5.15: HPLC 
chromatogram of the 
purified reaction 
between 7c and 
DOTA-DBCO. The 
only, intense, signal 
is attributed to the 
SuperDOTA product. 
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In contrast, the MALDI-TOF mass spectra of 7c, just reported in Figure 5.9, shows 
clear signals, while the purified reaction product results only in the slightly broad 
band reported in Figure 5.16. 
 
 
Species Molecular Weight, g/mol 
7c 4350  (distribution centre) 
DOTA-DBCO 805 
7c + DOTA-DBCO 5155 
7c + 2 DOTA-DBCO 5960 
7c + 3 DOTA-DBCO 6765 
Figure 5.16: MALDI-TOF spectra of the purified reaction between 7c and DOTA-
DBCO (up), DHAP-TFA was used as matrix. The table (down) reported the predicted 
mass peaks for 7c, DBCO and for different grades of coupling yields between these 
two. 
 
The predicted mass centre distributions, reported in the table associated to Figure 
5.16, compared to the experimental mass spectra, seems to suggest that the number of 
DOTA-DBCO linked to the 7c chain could be less than three. The reason for such a 
result was not further investigated. 
After the coordination with Gadolinium ions, provided by an excess of GdCl3, the 
titration of thiol content gave us a SuperDOTA-Gd concentration value, since only 
one SH is present for each polymer chain. 
This quantitative titration was made using the 4,4’-dithiodipyridine, that develops 
high absorptions at 324 nm in presence of mercaptan groups.98-100 
The concentration of SuperDOTA-Gd obtained in water was found to be 35 !M. 
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The magnetic resonance T1 decay was than measured diluting the same solution and 
was than compared to an aqueous solution of GdCl3. 
The results, in term of 1/T1, reported in Table 5.3 show a relaxivity calculated value 
of  14.1 mM-1  ∙  s-1 per GdCl3 and 25.9 mM-1  ∙  s-1 per SuperDOTA-Gd. 
 
Table 5.3: Magnetic resonance relaxation times measured for aqueous solutions. The 
relaxivity values were calculated according to the Equation 5.1. Experimental 
magnetic field of 4.7T (200MHz). 
1/T1 (ms-1) Concentration (µμM) Relaxivity (mM-1  ∙  s-1) 
GdCl3 
0.00746 500 
14.1 
0.00372 250 
0.00103 50 
7.358∙10-4 25 
5.227∙10-4 10 
SuperDOTA-Gd 
8.613∙10-4 17.5 25.9 
Water 
4.087∙10-4 - - 
 
The relaxivity calculated for SuperDOTA-Gd was higher than that for a solution of 
free Gadolinium proving the characteristic of effective imaging contrast of the new 
polymer. 
Plotting the inverse of the relaxation time versus the gadolinium concentration, as in 
Figure 5.17, an estimation of the gadolinium content in SuperDOTA-Gd is possible. 
The comparison between the total polymer and the interpolated Gadolinium 
concentration gives an estimation of about 2 Gadolinium ions per polymer chain. The 
same result was previously found with MALDI-TOF mass spectrometry analysis. 
 
 
Figure 5.17: The inverse of the relaxation time T1 versus the concentration of Gd3+ 
for a solution of GdCl3, SuperDOTA-Gd and for pure water as reference.  
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Functionalization of gold nanoparticles and multimodal 
imaging characterization 
The same solutions of SuperDOTA-Gd used for the characterizations were than used 
for the synthesis of SERS-MRI multimodal contrast agents. 
Gold nanoparticles (AuNPs) obtained by laser ablation were first functionalized with 
lipoic Nile Blue (LipNB), namely one of the optimized SERS reporters. LipNB is able 
to develops high SERS signals both excited at 633 and at 785nm, as just reported in 
previous chapters. 
The presence of the dye molecules causes a little degree of aggregation, probably due 
to the reduction of free charges at the surface of nanoparticles. 
After a purification steps, performed by centrifugation, an excess of SuperDOTA-Gd 
is added and the functionalization reaction was carried out for one day, to guarantee 
the maximum coverage of the AuNPs surface. 
The reaction mixture was centrifuged to purify the nanoparticles, that were re-
dispersed in pure water. 
In Fig. 18 are reported the UV-vis and SERS spectra. The Uv-vis spectrum shows that 
the effective aggregation of the nanoparticles is not very high, whereas the Raman 
signals of LipNB, shows a very good SERS activity . 
 
 
 
Figure 5.18: UV-vis-NIR absorption spectra (left) and the SERS spectra (right) of  
AuNP-LipNB-SuperDOTA complex  in aqueous solution, Exciting line at 633 nm and 
7 mW laser power, with a 5x objective focused at the centre of the cuvette were used. 
 
The concentration of nanoparticles were evaluated by a fitting algorithm6 of their 
absorption spectra. The AuNPs concentration of the final colloidal solution was 
calculated to be about 10.4 nM. 
In Table 5.4 are reported the magnetic relaxation times and the relaxivity values for 
the synthesized SERS-MRI multimodal contrast agent. 
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Table 5.4: Magnetic resonance relaxation times measured for aqueous solutions. The 
relaxivity values were calculated according to the Equation 5.1. Experimental 
magnetic field of 4.7 T (200 MHz). 
1/T1 (ms-1) Concentration (nM) Relaxivity (mM-1  ∙  s-1) 
AuNP-LipNB-SuperDOTA-Gd complex 
4.435∙10-4 10.4 3340 
Water 
4.087∙10-4 - - 
 
The relaxivity value of 3340 mM-1  ∙  s-1, well reflects the high number of Gadolinium 
ions present on a single nanoparticle. 
It is an impressive value if compared to the relaxation properties of GdCl3 and to 
these reported in Table 5.1 obtained at 20 MHz field, also considering the 
approximations done for the nanoparticles concentration calculation. 
The estimation of the number of Gd ions per AuNP can be done in the same way just 
used for SuperDOTA. However, in this case, the long magnetic relaxation time shown 
for the 10.4 nM nanoparticle solution does not allow a direct interpolation with the 
reference GdCl3 solution, as seen in Figure 5.19. 
 
Figure 5.19: The inverse of the relaxation time T1 for AuNP-LipNB-SuperDOTA-Gd 
goes rapidly to values comparable to pure water. The direct graphical evaluation of 
the Gadolinium content with the reference solution of GdCl3 is no more possible. 
 
However, according to the Equation 5.1 and the relaxivity value for GdCl3 reported in 
Table 5.3, a Gd content of about 2.5 !M was found for the 10.4 nM AuNPs colloidal 
solution. This corresponds to an average content of about 240 Gd ions per AuNP, or 
an average value of 120 SuperDOTA molecules per AuNP. 
Despite the concentration of SuperDOTA chains are not very high, they are clearly 
sufficient for a good magnetic contrast and further experiments will show the degree 
of applicability of such SERS-MRI multimodal as contrast agents in vivo. 
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6. Summary and Conclusions 
The ability of modern science in exploiting the properties and dynamics of nanometre 
systems, opened the way to the development of a completely new class of materials.  
Between bulk materials and molecules, nanometre systems show properties with 
strong dependence on dimensions, still maintaining, in some cases, some order 
characteristic of a solid.  
Among nanostructures, metallic nanoparticles are interesting for their plasmonic 
properties and as new tools for spectroscopy. Free electrons of a metallic 
nanoparticles can be excited by an electromagnetic field and the resonance condition 
is called Localized Surface Plasmon Resonance (LSPR). Molecular species in close 
proximity to the surface of nanoparticles can feel the incident electromagnetic field 
enhanced by the LSPR. New spectroscopic techniques grew up exploiting this 
phenomenon, like Surface Enhanced Raman Spectroscopy (SERS)14, 15 and Surface 
Enhanced InfraRed Absorption (SEIRA).87 
Usually, molecules show low Raman cross sections, but near to a plasmonic surface 
they can show increased scattering efficiency, by 107 – 109  times,14, 15 making SERS 
an attractive new spectroscopic tool. 
In the present work, nanoparticles have been obtained with the Laser Ablation 
Synthesis in Solution (LASiS), a recent top-down technique for the production of 
nanomaterials, directly as colloidal solution without the need of any stabilizing 
molecule.26 A typical procedure consists in irradiating a pure metal target immersed in 
water or in an organic solvent. The irradiation is carried out with a nanosecond pulsed 
Nd:YAG Laser at the fundamental wavelength. Especially in case of noble metal 
nanoparticles in water, the synthesis allows to obtain indefinitely stable colloidal 
nanoparticles with bare surfaces.27 
AuNP from LASiS for Mass Spectrometry 
In recent years, much attention of oncologic clinical practice was focused on the 
personalization of therapies. At present, the best analytical performances for 
therapeutic drug monitoring and for a wide range of anticancer drugs are provided by 
chromatographic techniques, coupled with mass spectrometry.36 
Matrix Assisted Laser Desorption Ionization (MALDI) is a soft-ionization technique 
for mass spectrometry, frequently used in combination with a time-of-flight detection 
technique.101 Interesting studies in literature report the utility of MALDI for proteins 
and peptides characterization,5, 101, 102 also coupled with mapping and imaging of 
tissues.101, 102 The drawback of the technique is that the low mass region cannot be 
used because the organic matrix signals dominate.  
A systematic study on Laser Desorption Ionization (LDI) using gold nanoparticles as 
matrix is presented in the present thesis work.28 Five low mass molecules were 
considered: arginine (174 g/mol), fructose (180 g/mol), atrazine (216 g/mol), 
anthracene (178 g/mol) and paclitaxel (854 g/mol). Compared to both commercially 
available nanoparticles and DHAP (a widely used organic matrix), the LASiS 
produced AuNP with negligible background in the entire mass range. The influence of 
surface coverage versus particles dimension was also investigated. Although the large 
excess of surfactant present in commercial nanoparticles was removed by dialysis 
before the measurement, a consistent amount of these stabilizing molecules remained 
on the AuNP. This fact was clearly observed in the background associated with that 
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kind of particles. Two types,  LASiS and commercial AuNP, were used, with average 
size of 10 and 20 nm. In terms of signal-to-noise ratio, a stronger dependence on 
surface purity instead of dimensions was found.28 The results show that LASiS AuNP 
assisted LDI overcome the main limitation of this mass spectrometry technique, 
making it useful in the low mass region (<500 Da).28 
SERS for cancer drug detection  
There are excellent examples in the field of sensor devices based on plasmonic noble 
metal nanoparticles, which use the optical properties of the LSPR or related effects 
like SERS.5 SERS is attractive because it allows to use fingerprint information (from 
the vibrational spectra) with intensities comparable to fluorescence.14, 15 This 
characteristic makes it an excellent qualitative technique, although for quantitative 
analysis some care must be used, like fluorescence.13 The strongest field enhancement 
in a SERS substrate comes from only few hot-spots where the excited plasmons have 
positive interferences, like in junctions between particles or in tips.15 Moreover, the 
complete coverage of the nanoparticles causes saturation effects.13 In order to study 
limitations of SERS, the same amount of anticancer drugs (Sunitinib, Paclitaxel, 
Irinotecan and its active metabolite SN38) was spotted over different plasmonic 
substrates.12 . We also used a commercial SERS substrate (Klarite, Renishaw®) 
where drugs were spotted over fixed area by using a home-made viton mask. The 
measurements were obtained with different laser excitations: 488, 633 and 785 nm. 
Results show that LASiS AgNPs give the highest signals. This was expected since 
silver nanoparticles have very good SERS performances13-15 and the nanoparticles 
produced by laser ablation have a clean surface which favours hot-spots.28 However, 
Klarite was found to be a good SERS substrate for quantitative evaluation at 633 nm, 
because of the higher reproducibility of the SERS signals. The SERS signals intensity 
for the four drugs were found to be highly correlated to the distance of their maximum 
absorption wavelength to the laser excitation. Sunitinib showed the lowest limit of 
detection, being the wavelength of its absorption maximum near to the laser excitation 
at 633 nm. Paclitaxel was found the worst SERS performer at 633 nm over Klarite, 
since its maximum absorption is present near UV. It was also found that Sunitinib 
spectra show a linear intensity variation between 125 and 2657 pmol per millimetre 
square of SERS active area, and a detection limit (DL) between 26 and 37 pmol/mm2. 
Irinotecan has the same linear correlation between 191 and 3886 pmol/mm2, with a 
DL in the 58-68 pmol/mm2 range. SN-38 has linear intensity variation between 153 
and 1580 pmol/mm2 and a DL of 29-72 pmol/mm2.12 
Since the SN-38 is an active metabolite of Irinotecan, and can be present together in 
real samples, a procedure based on multivariate analysis was developed to distinguish 
between solutions of the pure substances and mixtures. 
The results showed that quantitative detection of anticancer drugs by SERS could be a 
realistic tool for clinical practice with sample volumes of few millilitres. 
One of the main problem of these analyses is the low SERS cross sections of some 
analytes which is an intrinsic limit for the technique. 
Reactive-SERS  
To overcome the problem of molecules with poor SERS performance, a reagent for 
specific molecular functional groups, showing, after reaction, different SERS 
signatures was found. Therefore, new SERS signatures increase in intensity with the 
analyte concentration. Such a protocol was called Reactive-SERS. The reagent is an 
aromatic azide functionalized with a thiol. In a polar aprotic solvent, the reaction 
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between the aromatic azide and a primary, or secondary, amine takes place by 
irradiating with a common UV lamp for 10 minutes.103 In a second step the adduct is 
linked to the surface of gold nanoparticles with the thiol group. The SERS spectra of 
the solution, or of some dried drops on a glass slide, were obtained, with a time 
exposure of few tens of seconds. The reaction and SERS quantitative measurements 
were verified by mass spectrometry with, as a model analyte, diethylamine (DEA). 
We found that the variations of the intensity of the SERS spectra changed linearly 
with  DEA concentration up to 8.65 mM. 
Tumour Cell antigens identification with SERS  
Since Raman spectroscopy provides sharp and characterizing vibrational signature of 
molecules, it is suitable for multiplexing analysis, that is the simultaneous detection of 
different analytes with a single measurement. In recent literature, some examples of 
the potentials of SERS for multiplexing can be found.5, 13, 16, 104 In the present thesis 
work the mutlplexing analysis of prostatic cancer cells, using SERS nanotags 
functionalized with selected dyes and antibodies is demonstrated with a very 
important result for the good targeting specificity of the two prostatic cancer antigens 
PSMA and PSCA.74 In a typical synthesis of the nanostructures, the first step is the 
aggregation of gold nanoparticles, obtained by a controlled centrifugation. These 
nanosystems still remain soluble and provide very efficient hot spot structures. Than 
the nanostructures are functionalized with a thiolated dye and an antibody for a 
specific targeting. 
The selection of dyes to associate to antibodies is a crucial step. A library of five dyes 
was selected with the following properties: 1. absorption spectrum in resonance with 
the excitation laser lines, 2. presence of a thiol for their strong linking to the 
nanoparticles surface and 3. characteristic SERS spectrum which allows their easy 
identification. In the first study, as recalled above, we used two nanosystems, the first 
associating TexasRed and anti-PSMA antibody, and the second Malachite Green and 
anti-PSCA antibody.74 After incubation of the nanosystems with tumour cells, we 
were able to recognize their antigen expression by the SERS signature recorded for 
every cell. At present, due to the extended dye library, is possible to perform 
multiplexing analysis in complex mixtures of cell cultures, using up to five different 
types of antibody-associated nanoparticles. 
SERS and Cultural Heritage  
The characterization of proteins content in samples, especially in cultural heritage is 
an open analytical issue, often faced by immunological protocols.105-108 Eggs, animal 
glue or other natural proteins were frequently used in ancient paints as binders for 
pigments or dyes.105, 106 In a stratigraphic sample of a tiny amount of such a paints, 
these organic moieties can be recognized by the antibody functionalized SERS tags. 
In addition, other interesting compounds, present in the paints, like for example 
inorganic crystals acting as pigments or simple degradation or aging products, can be 
recognized at the same time in the Raman spectrum. By mapping the stratigraphic 
sample, previously treated with SERS tag, a complete characterization of the 
inorganic and protein matter can be obtained. The methodology was applied for 
obtaining the presence of ovalbumin in a Renaissance artefact and, at the same time, 
for identifying the presence of inorganic materials, like azurite, and lead white.49 
 
6. Summary and Conclusions 
 114 
Processing and PCA of experimental SERS spectra  
The post processing and analysis of the recorded experimental spectra, for 
applications both in nanomedicine and in cultural heritage, is a challenge issue. At 
least hundreds of spectra had to be taken simultaneously into account and every 
interesting species had to be recognised by its signature. Every frequency in hundreds 
of vibrational spectra acts as a variable. Therefore, multivariate analysis becomes very 
useful to rationalize Raman mapping images.109 
For processing the experimental SERS spectra, several graphical interfaces based on 
MatLab® codes have been developed. For nanomedicine application, an interactive 
algorithm was also defined for the localization of cells on the samples. This allowed 
the automated recording of the spectra of hundreds or thousands of cells. Then, 
together with routines to manipulate the spectra, the codes for a complete analysis of 
the signals also with a PCA approach, have been developed. 
Engineered nanostructures were also used for mapping tumours in live organisms. 
Multifunctional nanostructures  
Magnetic Resonance Imaging (MRI) is a powerful technique for in vivo imaging, 
utilizing non-ionizing radiation.19 The image contrast is obtained with differences in 
protons relaxation times, so the efficiency of MRI is strongly related to proton 
density, but also to the presence of contrast agents (CAs).19 MRI is a good technique 
for the total body screening because the radiations used are safe. However, MRI lacks 
in spatial resolution and it is not suitable for intrasurgical imaging.19,22,91 
Nanotechnology offers the possibility to manage different functionalities into a single 
nanostructure.  
The ablation process used to synthesize nanoparticles works far from equilibrium, 
making possible to produce iron-gold alloy nanoparticles.91 The plasmonic and 
magnetic properties are still present in these nanomaterials. Nanoparticles were  
functionalized with two thiolated dyes, TexasRed (TRSH) for 633 nm and 
Naphthalocyanine (NPCySH) for 785 nm wavelength, and used as Multimodal 
Contrast Agents (MCAs).91 The magnetic relaxivity shown by the alloy nanoparticles 
was 60 mM-1•s-1 which compares well with commercial contrast agents. These MCAs 
were injected into a Balb/c mice with a tumour and the accumulation of the 
nanostructures was evidenced by the enhanced T2 relaxation time at the tumour site. 
The SERS spectra provided by TRSH, present on the AuFeNPs surface, was found 
ex-vivo in the liver, spleen, kidneys and tumour, while no signal was found in blood 
and lungs. 
Nanoparticles as T1 magnetic multifunctional contrast 
agents  
Despite magnetic contrast agents based on the relaxation time T2 are attractive, they 
provide negative imaging contrast.19, 91 More interesting are usually considered CAs 
which operate on the longitudinal T1 relaxation time which are positive contrast 
agents.   
Lanthanides, especially gadolinium ions, are used as positive magnetic CAs, since 
they influence the relaxation time T1.19, 22, 23 To improve the imaging properties of 
gold nanoparticles, a new chelating polymer, called  SuperDOTA was planned and 
synthesized. This new macromolecule is able to load up to three Gd3+ ions per single 
chain and have a thiol group that guarantees a stable bonding to the AuNP surface. 
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SuperDOTA was synthetized in solid phase using a cysteine pre-loaded Wang resin. It 
consists of a backbone made of three parts. The fist is a cysteine, for the binding to 
the gold surface. The second is a sequence, repeated three times, of 5-Azido-2-
(amino)pentanoic acid and H2N-PEG11-COOH, where the azido functional groups is 
used for further functionalization via click chemistry. The third is a H2N-PEG2000-
OCH3 for in vivo stealth purposes. The Huisgen azide-alkyne cycloaddition was used 
to bind DOTA-dibenzocyclooctyne residues to the polymer, before the loading with 
Gd3+. Gold nanoparticles were functionalized first with lipoic-acid-NileBlue, a SERS 
reporter, and then with the SuperDOTA-Gd. MRI measurements on these 
nanostructures show a magnetic relaxivity for AuNP-SuperDOTA-Gd of 3340 mM-
1•s-1 which is an interesting result also for in vivo applications.  
Future perspectives will consider the functionalization with targeting moieties, which 
will give further perspectives to these nanoystems. 
Conclusion 
In conclusion, plasmonic nanostructures based on gold nanoparticles were used with 
interesting results for qualitative and quantitative analysis in biomedical and cultural 
heritage applications. 
The laser ablation synthesis in solution allowed the production of gold nanoparticles 
which are particularly useful for these types of applications since their naked surface 
enhances SERS signals and allows their easy functionalization. 
SERS signals was optimized with derivative of dyes which allowed the registration of  
SERRS signals. These signals show cross section of the order of those of fluorescent 
molecules, but can be used for multiplexing experiments which are not simple or 
possible with fluorescent compounds.  
Engineering nanostructures opens many possible applications and some of them have 
been explored like for example targeting of antigens on tumour cells or the synthesis 
of multifunctional nanostructures combining particularly SERS and MRI, which are 
complementary techniques also for in vivo applications.  
The results presented in this thesis work show the high potentiality of nanotechnology 
in solving challenging tasks and open the ways to other new applications. 
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Appendixes, experimental details 
A1. Instrumentation 
o Laser for LASiS 
Nd:YAG laser (Quantel YG-981E-10), 9ns pulse duration, 10Hz repetition 
rate. 
 
o micro-Raman 
InVia micro-Raman (Renishaw), equipped with motorized stage, 5, 20 and 50x 
Leica objectives, 488nm Ar-Kr Laser, 633nm He-Ne Laser, 785nm diode 
Laser, CCD detector. 
 
o UV-vis-NIR spectrometer 
Varian UV-vis-NIR Cary 5 Spectrometer 
 
o MALDI-TOF 
AB SCIEX 4800 MALDI TOF/TOF Analyzer (AB SIEX Pte Ltd), equipped 
with a 355nm (3-7ns) pulses of a Nd:YAG laser at a repetition rate of 200Hz 
 
o ESI-TOF 
Applied Biosystem 5220 
Mariner ESI-TOF, Perspective Biosystem 
 
o NMR spectrometer 
Bruker Avance DMX 600, operating at 600 MHz 
 
o MRI spectrometer 
Biospec tomograph (Bruker, Karlsruhe, Germany) with a working field of 
4.7T 
 
o High Performance Liquid Chromatography 
Dionex P680 equipped with Dionex ASI-100 auto-sampler and Dionex 
UVD170U detector.  
Vydac C18 218TP104 reverse phase column (250 x 4.6 mm, 5µm particles) 
Elution profile: 10 to 90% of eluent B in 30 minutes. Where eluent A is H2O + 
0.1% TFA, eluent B is 10% H2O in CH3CN + 0.1% TFA. 
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A2. Laser Ablation Synthesis in Solution 
AuNP are synthesized by LASiS (laser ablation synthesis in solution) using 9 ns 
pulses at 1064 nm of a Nd:YAG laser.  
The laser beam is focused with a lens (10 cm focal length) on a Au target at the 
bottom of a cell (3x3x4 cm) filled with 15 ml of 10-5 M NaCl bidistilled water 
solution. Fluences of 10 J•cm-2 are used for obtaining nanoparticles with average 
diameters of 20 nm. 
The nanoparticle concentration was estimated by fitting their localised surface 
plasmon resonance absorption, according to the Mie-Gans model and the SPRFit 
algorithm.6 
An example of AuNPs colloidal solution is reported in Figure A.1. 
 
 
R  
(nm) 
Spheres  
% 1-RSS 
MaxSPA  
(m2) 
ε  
(cm-1M-1) 
Absb=2mm  
(520nm) 
AuNP conc.  
(mol/L) 
9.7 96 4.15E-04 3.14E-16 8.23E+08 0.4818 2.93E-09 
 
Figure A.1: The UV-vis-NIR absorption behaviour of a AuNP nanoparticle solution 
(up). The results obtained by the SPRFit algorithm, “R” is the average radius of 
nanoparticles, “Spheres” explain the percentage between spherical and spheroidal 
shaped nanoparticles, “1-RSS” is the residual sum of squares between the calculated 
and experimental spectra, “MaxSPA” is the AuNPs solution calculated extinction 
cross section and “ε” is the molar extinction coefficient, “Absb=2mm” is the maximum 
absorption location, “AuNP conc” is the estimated molar concentration of AuNPs. 
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A3. Gold nanoparticles for LDI (Laser Desorption 
Ionization) experiments 
Experimental procedure reported from Ref. 28. 
The following matrixes were used for MALDI-TOF mass spectrometry: 
o DHAP (2’,6’-dihydroxyacetophenone, Sigma Aldrich, CAS: 490-78-8) at 
40g/L solution in CH3CN, with also 0.1% of TFA (trifluoracetic acid) 
o AuNP by LASiS, 10.6nm±22%  (LASiS-AuNPs-I) 
o AuNP by LASiS, 18.6nm±35% (LASiS-AuNPs-II)  
o AuNP by Sigma Aldrich (G1527), 10.2nm±12% (citrate-AuNPs I)  
o AuNP by BBI International (EM.GC20), 19.6nm±8% (citrate-AuNPs II)  
To obtain the AuNP size  reported above, pristine AuNPs were selected by centrifugal 
cycles. 54 
Briefly, an Eppendrof centrifuge model 5430 equipped with a fixed angle rotor model 
FA-45-24-11-HS was used. The smallest LASiS-AuNPs (LASiS-AuNPs-I) were 
obtained by collecting the surnatant after centrifugation at 800 rcf for 60 minutes. The 
largest LASiS-AuNPs (LASiS-AuNPs-II) were obtained in two centrifugation steps: 
pristine LASiS-AuNPs were centrifuged for 1 hour at 100 rcf and the sediment 
discarded, then the remaining solution was centrifuged again for 1 hour at 500 rcf and 
the sediment collected to give LASiS-AuNPs-II. 
All nanoparticles were concentrated by dialysis concentration membranes with a cut 
off of 2000 Da (Sartorius Vivaspin) up to the same Au atoms concentration of about 
0.013M (2.6 mg/ml). The concentration was evaluated by optical absorption 
spectroscopy according to the protocol described in literature. 6 
L-Arginine (200 mg/L in water), D(-)fructose (200 mg/L in water), atrazine (50 mg/L 
in methanol:water 1:1), anthracene (350 mg/L in methanol:water 2:1), and paclitaxel 
(115 mg/L in methanol:water 1:1) from Sigma-Aldrich were used.  
Each spot on the stainless steel plate for the analysis consisted of 0.5µl of matrix 
solution and 0.5µl of analyte solution. For each analyte, we used two deposition 
methods: pre-mixing of the two solutions or sequential addition of the analyte 
solution on the dried drop of previously deposed AuNPs solution, and keeping the 
best result in terms of signal intensity for comparison with the other matrixes. 
Similarly, we considered the best result among LASiS-AuNPs I and II and we 
compared it with the best one among citrate-AuNPs I and II and with the organic 
matrix. This is because we did not observe big differences between samples I and II, 
while several differences exist between LASiS and citrate AuNPs matrixes. 
For the LDI measurements, we used 70% of maximum laser power, corresponding to 
<10 µJ/pulse, for all measurements. Each spectra was averaged over 400 laser shots 
and analyzed with the software provided by the instrument. Each measurement was 
carried out for a minimum of three times. Each of the six sets of measurements (i.e. 
one for the bare matrixes and five for the analytes) was collected within the same 
measurement session, in order to minimize the possible effects due to fluctuations in 
spectrometer settings (i.e. laser power) from one session to another or over different 
days. 
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A4. Quantitative SERS measurements 
Experimental procedure reported from Ref  12. 
Sunitinib malate, paclitaxel, irinotecan hydrochloride, SN-38, doxorubicin 
hydrochloride were purchased from Sigma-Aldrich. All drugs were dissolved in 
methanol (HPLC grade, from Sigma Aldrich). 
The following types of SERS-active plasmonic substrates were tested: gold 
nanoparticles in aqueous solution (AuNPs, average size of 30±13nm, 1.0mM in Au 
atoms) obtained by laser ablation synthesis in solution (LASiS), silver (Ag) NPs in 
aqueous solution (30±11nm, 1.0mM in Ag atoms) obtained by LASiS, commercial 
AuNPs in aqueous solution (BBI, 60±6nm, 1.0mM in Au atoms), commercial AgNPs 
in aqueous solution (Aldrich, 60±6nm, 1.0mM in Ag atoms) and commercial films of 
gold islands sputtered over silicon pyramids (Klarite, from Renishaw Diagnostics). 
For comparison, also crystalline silicon was used as a substrate.  
In case of plasmonic substrates of NPs, samples were obtained by mixing 6 µL of 
colloid at the concentration indicated above with 6 µL of drug solution at variable 
concentrations, and depositing the mixture in cylindrical wells (2 mm in diameter for 
4 mm height) obtained in a bulk aluminium plate. Then the liquid was evaporated 
prior to measurements. 
In case of Klarite substrates, a viton mask with a cylindrical hole (1.5 mm in diameter 
for 3 mm height) was placed on the active area of the substrate and filled with 6 µL of 
drug solution. After evaporation of the liquid, the mask was removed and the Klarite 
substrate used for Raman measurements. The mask was reversibly sealed on the 
substrate by applying a slight mechanical pressure on the viton mask.  
All the substrates were used only one time, i.e. they were not washed and recycled for 
another sample. 
Raman spectra were recorded using a 20X objective (NA 0.40, 56% coverage). The 
software Renishaw WiRE 4.1 was used for data acquisition. We used the 488 nm line 
of a Ar+/Kr+ laser, the 633 nm line of a He-Ne laser and the 785 nm line of a diode 
laser all three at the power of 1.3 mW.  
In our experimental set up, the noise level decreases with the 0.5th power of the 
acquisition time. A crystalline silicon reference was used before and after each 
measurement for power calibration to account for daily laser intensity fluctuations 
(less than 5%).  
Raman measurements were performed by homogeneously mapping the deposition 
area (1.8 mm2 for Klarite and 3.1 mm2 for NPs substrates) with 133 equally spaced 
collection points. The accumulation time for each spectrum was varied between 15 
and 120 seconds (i.e. from ~30’ to ~4h for each sample), depending on the signal to 
noise ratio. Baseline subtraction to the datasets of Raman spectra was performed with 
the Renishaw WiRE 4.1 software. 
Principal component analysis (PCA) was performed with a built in routine (princomp) 
running under MatLab R2012a. The PCA dataset consisted of ~1900 spectra acquired 
by mapping the 4x4 mm2 surface of a Klarite substrate with a resolution of less than 
100 µm between each acquisition. The PCA dataset was normalized on the 1385 cm-1 
band and spectra below 100 c.p.s. eliminated. 
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A5. Notes on Multivariate data analysis and 
Principal Component Analysis 
Spectroscopic imaging analysis needs to register huge multidimensional datasets. 
Even in bi-dimensional mapping, imaging techniques produces the so called data 
“hyper cubes”, in which in addiction to the spatial x and y coordinate, also exist 
spectral and intensity dimensions.109 
Usually, these four dimensional dataset are reduced to three dimensions, by 
expressing the intensities at single spectral coordinate, ea. the intensities at a single 
frequency for each xy point. 
Nevertheless, such a univariate data analysis provide only limited information toward 
the complete composition of sample. 
Taking into account the entire spectral range, instead of only a selected frequency, 
needs the use of a multivariate analysis. 
Zhang et al. reported the multivariate analysis of a pharmaceutical model tablet made 
of four different chemical substances.109 The authors analysed chemical micro-Raman 
imaging using different multivariate models and approaches. They also compared the 
final results in terms of quality and robustness of provided information. 
The models used in the study were:109 
o principal component analysis (PCA): it is a statistical procedure to transform 
possible correlated variable (ea. spectral features) into a set of new orthogonal 
ones, called principal components. It has the advantage to reduce the number 
of variable giving the maximum information on the system. 
o cluster analysis: it is a pattern recognition technique, which group objects as a 
function of similar characteristics. To do this, a feature extraction method is 
usually first applied to the original dataset, sometimes PCA. 
o direct classical least squares (DCLS): this approach can be applied only if 
reference spectra are available, because it is based on linear combination of 
such references. 
o multivariate curve resolution (MCR): it refers to a broad range of self-
modelling mixture analysis method. Often additional constrains are applied to 
avoid the so called rotational ambiguity, namely the possibility to represent 
the data by multiple possible solutions. 
PCA was extensively applied, because it doesn’t need any preliminary information 
about the sample and is operator independent. 
In a typical PCA, the four-dimensional dataset is expressed as a list of pixels, each 
one having its own spectral feature. In this way the dataset can be described with a 
matrix D made by M rows (number of spectra) and N columns (spectral frequencies). 
Each cell of the matrix D is an intensity value. 
PCA decomposes D in such a way that D = TPT+E, where T is the M×Q score matrix, 
P is the N×Q loading matrix, E is the M×N model residual matrix and Q is the number 
of principal components (PCs).109 The principal components are obtained with the 
highest possible variance in such a way that, usually, the firsts few PCs represent over 
the 95% of the total variance. 
The P loading matrix expresses the correlation between original variables 
(frequencies) and the principal components. So a PC loading usually appears with a 
spectral-like feature.  
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Figure A.2: PCA score images and loadings obtained by mapping a pharmaceutical 
tablet with Raman spectroscopy: PC1 (a - b), PC2 (c - d), PC3 (e - f), PC4 (g - h). 
The pixels in the score image with the higher score values are represented brighter. 
From Ref . 109. 
 
At the same time the T score matrix are related to the level of representation of every 
point of analysis along every principal component. So a false colour map is usually 
employed to enhance which image pixel expresses similar behaviour along a PC. For 
example, as shown in Figure A.2 from the study of Zhang et al., the largest amount of 
mapped surface are well represented by the first PC (Figure A.2a-b), while only other 
little areas are represented by PC 2 and 3 (Figure A.2c-d and e-f). 
If reference pure substances are available, quantitative evaluation of the correlation 
between each PC and real chemical species are possible by the correlation 
coefficients. For the spectra reported by Zhang et al., one can see in Table A.1 that 
PC1 results to be correlated largely to lactose and avicel, while PC2 almost 
exclusively to sodium benzoate and PC3 again to avicel. This explains why the same 
area appears the brightest in Figure A.2a and the darkest in Figure A.2e. 
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Table A.1: Correlation coefficient between PC loadings and pure reference spectra. 
From Ref . 109. 
 
 
 
Despite PCA often needs a certain level of interpretation, the huge quantity of 
information provided in such an automated and user independent procedure, makes it 
a potent multivariate analysis technique for chemometric imaging. 
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A6. Reactive SERS 
List of stock solutions used for the reactions: 
o Bis[2-(4-azidosalicylamido)ethyl] disulphide (ASAES2, Sigma Aldrich, CAS: 
199804-21-2) 3.15mM in CH3CN 
o Diethylamine (DEA, Sigma Aldrich, CAS: 109-89-7) 17.3mM in CH3CN 
o Tris(2-carboxyethyl)phosphine hydrochloride (TCEP, Sigma Aldrich, CAS: 
51805-45-9) 130mM in H2O 
o Gold nanoparticles (AuNP) obtaind by LASiS in 10-5M NaCl aqueous 
solution, average diameter 20nm, about 3nM in AuNP. 
 
Reduction of ASAES2 with TCEP 
The following reaction scheme (Figure A.4) were used to verify the ability of TCEP 
to selective reduce the di-sulphur group instead of the azide group. 
 
 
Reaction ID TCEP 130mM (µL) 
ASAES2 3.15mM 
(µL) 
Molar ratio 
TCEP / ASAES2 
1:20 0.5 410 0.05 
1:1 10 410 1 
10:1 100 410 10 
Figure A.3: Reaction scheme for the reduction of ASAES2 with TCEP and the amount 
of reactants used. 
 
The relative amounts of ASAES2 and TCEP were mixed together under mechanical 
stirring for 1 hour at room temperature. Then the reaction mixture was directly 
analysed by MALDI-TOF mass spectrometry using DHAP-TFA as matrix in positive 
ionization modality, as reported in Figure 3.25. 
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Quantification of diethylamine with ReactiveSERS 
 
 
 
Reaction 
ID 
ASAES2 3.15mM DEA 17.3mM CH3CN TCEP 130mM Molar ratio 
DEA / 
ASAES2 
Volume 
(µL) 
Mass 
(µmol) 
Volume 
(µL) 
Mass 
(µmol) 
Volume 
(µL) 
Volume 
(µL) 
Mass 
(µmol) 
A 500 1.57 0 0 200 15 1.95 0 
B 500 1.57 50 0.86 150 15 1.95 0.55 
C 500 1.57 100 1.73 100 15 1.95 1.10 
Figure A.4: Reactions scheme for the ReactiveSERS protocol adopted as preliminary 
proof of principle, and a table with the amounts of reactant used. 
 
Each reaction follows the same procedure. The relative amount of ASAES2 and DEA 
are mixed into a quartz cuvette with 2mm of optical path. It is then irradiated with a 
common laboratory UV-lamp for 10 minutes. 
Before the addition of TCEP, a little aliquot of the reaction mixture is removed and 
analysed by MALDI-TOF mass spectrometry, as reported in Figure 3.22. 
Then the TCEP is added and the reaction proceeds under mechanical stirring for 1 
hour. 
The amount of 100 µL of reaction mixture is removed and mixed with 1 mL of 
AuNPs (about 3nM, 3•10-12 mol). The reaction proceeds for 3 hours immersed into a 
sonication bath. 
The particles are then centrifuged at 30,000 RCF for 10 minutes, the supernatant is 
removed and the particles dispersed in pure water. The same purification procedure is 
repeated for three times. 
For Raman measurements, 20 µL of colloidal solution are dried on a glass slide and 
analysed with the 20x objective, 633 nm excitation wavelength at 0.3 mM of power 
for 10 seconds. 
Each sample is analysed on 16 different areas, then all acquisitions are baseline 
subtracted and averaged into the spectra reported in Figure 3.26. 
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A7. Synthesis of functionalized Raman Active 
Dyes 
Nile Blue 
The functionalization reaction uses the amidic bond formation between the aromatic 
amine of Nile Blue A (NB, Sigma Aldrich, CAS: 53340-16-2) and the lipoic acid (Ac. 
Lip., CAS: 1200-22-2). The reaction was obtained in dimethylformamide (DMF) in 
presence of the base 2,4,6-trimethylpyridine (Collidine, Sigma Aldrich, CAS: 108-75-
8) and 7-Aza-1H-benzotriazole-1-yl)-1,1,3,3-tetramethyluronium hexafluoro-
phosphate (HATU, Sigma Aldrich, CAS: 148893-10-1). 
 
 Density [g/cm3] 
Volume 
[ml] 
MW 
[g/mol] 
Weight 
[mg] 
Weight 
[µmol] Equivalents 
NB - - 417,85 20,75 49,7 1 
Ac.Lip. - - 206,33 20,33 98,5 2 
Collidine 0,92 0,065 121,18 59,8 493,5 9,9 
HATU - - 380,23 38,34 100,8 2 
DMF 0,94 1,5 - - - - 
Figure A.5: The reaction scheme for the Nile Blue functionalization (up) and the 
reagents used (down). 
 
The reaction was followed by normal phase TLC using the eluent composed by 
CHCl3 (87%): MeOH (13%). NB and LipNB show a blue colour whereas HATU and 
Collidine can be revealed under UV lamp. Lipoic acid was developed by the Kaiser 
test. 
After about 6 hours the solvent was evaporated and the residue dissolved into the 
minimum amount of CH3CN with 5% of MeOH. The mixture was then purified by 
normal phase chromatography using CH3CN with 10% MeOH  as eluent. 
The final product was characterized by ESI-TOF mass spectrometry with positive 
ionization modality (theorical mass [M]+ = 506.1930 Da, experimental mass [M+] = 
506.1899 m/z). 
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Figure A.6: ESI-TOF mass spectra of the final product LipNB obtained in positive 
modality. 
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Cy7SH 
The commercial available IR783 dye (Sigma Aldrich, CAS: 115970-66-6) is well 
soluble in water, methanol and dimethylformamide, but slightly in dichloromethane 
(DCM). Nevertheless, its solubility in DCM is sufficient for the following reaction 
and DCM allows further liquid/liquid extraction with water. 
 
 MW, g/mol 
Weight,  
mg 
Weight, 
moli 
Volum, 
uL 
Density, 
g/mL 
Conc, 
mol/L Equivalents 
IR783 749.35 12.3 1.64E-05 - - 5.47E-03 1.00 
DTT 154.25 2.7 1.75E-05 - - 5.83E-03 1.07 
DCM - - - 3000 1.33 - - 
TEA 101.19 7.3 7.18E-05 10 0.727 2.39E-02 4.38 
Figure A.7: The reaction scheme for the IR783 functionalization (up) and the 
reagents used (down). 
 
IR783 are solubilized in DCM under magnetic stirring, then dithiothreitol (DTT, 
Sigma Aldrich, CAS: 3483-12-3) and triethylamine (TEA, Sigma Aldrich, CAS: 121-
44-8) are added. The reaction proceeds for one day and is purified by liquid/liquid 
extraction using NaCl saturated aqueous solution. The aqueous phase is removed and, 
after two days, abundant precipitation occured. 
A little fraction of the dark green solid is solubilized with methanol and characterized 
with MALDI-TOF mass spectrometry, showing the desired Cy7SH product (theoric 
mass [M+H]+ = 867Da; experimental [M+H]+ = 866.9m/z). 
On the same MALDI-TOF analysis, a consistent signal from the reactant IR783 is 
present at 784.9m/z ([IR783+H]+). 
Analytical high pressure liquid chromatography, using a reverse phase C18 column, 
showed a reaction yield of about 50%. 
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Figure A.8: MALDI-TOF mass spectra of the final product Cy7SH obtained in 
positive modality. DHAP-TFA was used as matrix. 
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NPCy(SH)2 
For the synthesis of mercaptoethanol substituted Silicon 2,3-naphthalocyanine 
dichloride (Sigma, CAS: 92396-91-3) 49.5mg of NPCyCl2 were dissolved in 3mL of 
mercaptoethanol (Sigma) and a drop of triethilamine (TEA).  
 
 
Figure A.9: The reaction scheme used for the synthesis of NPCy(SH)2 
 
The solution was stirred at 90°C under reflux for 4 hours and then the solvent was 
evaporated. The product was purified by a liquid-liquid extraction using 
dichloromethane and sodium chloride saturated aqueous solution. The final organic 
fraction was dried with MgSO4 and the solvent evaporated. The product NPCy(SH)2 
was dissolved in methanol and characterized by UV-vis-NIR absorption (most intense 
band at 780 nm) and MALDI-TOF/TOF mass spectrometry with positive ionization 
mode and 2,4-dihydroxyacetophenone as matrix (theoretical 895,2015 m/z; 
experimental 894,9735 m/z). 
 
Figure A.10: UV-vis-NIR absorption spectra of NPCy(SH)2 showing the 
characteristic band at 780 nm. 
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Figure A.11: MALDI-TOF mass spectra of the final product NPCy(SH)2 obtained in 
positive modality. DHAP-TFA was used as matrix. 
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A8. Typical Synthesis of SERRS tags 
In the following, a typical procedure used to synthesize SERS and SERRS tags is 
presented.49, 74 
The entire protocol can be sketched as in Figure A.12. 
 
Figure A.12: A sketch representing the general steps involved in SERS and SERRS 
tag synthesis. a) AuNPs are synthesized by LASiS; b) centrifugation procedures allow 
to controlled aggregation of AuNPs; c) one of the Raman reporters is bound to 
nanoparticles; d) a previously thiolated antibody is added; e) long chains of 
mercapto-polyethylen glycol guarantee the complete surface coverage. From Ref . 74. 
Antibody functionalization 
Antibodies (Ab) are functionalized with a thiol group using 2-iminothiolane (2-IT). 
150 µl of 1M solution of NaHCO3 are mixed with a solution of 2-IT•HCl (0.5 g/L ) 
and 0.7 mg of Ab. The reaction proceeds for two hours at room temperature and then 
overnight at 4 °C. The antibody is purified by centrifugal ultrafiltration (5000 Da, 
Vivaspin 500 Sartorius) and washed for three times with a PBS solution. 
The degree of functionalization was obtained with the Ellman test, giving the average 
value of 1 new thiol group per Ab. 
AuNPs aggregation and functionalization 
4 ml of colloidal solution of gold nanoparticles obtained by LASiS (3 nM in water) 
are centrifuged at 30,000 RCF for 10 minutes and the aggregated nanoparticles are 
dispersed in bidistilled water by mild sonication.  
About 100 µL of Raman reporter solution (always 50 µM) are stirred with the 
colloidal solution of the aggregated AuNP for 1 hour and are purified by 
centrifugation at 30,000 g . These nanoparticles are mixed with the solution of the 
thiol functionalized antibody. The reaction continues for 6 hours at room temperature 
and then overnight at 4° C.  
The prepared nanostructures are purified by centrifugation at 30,000 g and then mixed 
with 100 µL of a solution of mercapto-Polyethylen glycol (5,000 Da, Rapp Polymere) 
(0.5 g/L). The reaction proceeds for 3 hours at room temperature. Purification of the 
nanostructures is obtained by centrifugation at 30,000 g. The precipitated 
nanoparticles are finally dissolved with a PBS solution and mixed with 5mg of BSA 
(bovine serum albumin) per mL of SERS tag.  
UV-vis-NIR absorption and Raman spectroscopy are used to characterize the final 
product and the intermediate steps. 
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Figure A.13: TEM images of aggregated Au nanoparticles included in PVA to avoid 
their clustering after the solvent evaporation on TEM grids. From Ref. 74. 
 
 
 
Figure A.14: UV-vis-NIR spectra (a1 and b1), and the relative SERS spectra (a2 and 
b2), of two representative SERRS tags during the main synthetic steps. The 
nanoparticles absorption shows broader bands after the antibody is added, but the 
SERS signals still remain intense and characterizing. From Ref . 74. 
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A9. SuperDOTA 
A list of the reagents used for the solid phase and solution synthesis of the 
SuperDOTA and SuperDOTA-Gd(III) polymer: 
o Fmoc-Cys(Trt)-Wang resin LL (100-200 mesh), Cys content of 0.30mmol/g, 
(Wang resin) Merk Millipore 
o Fmoc-NH-PEG12-COOH, (PEG12) Iris Biotech, CAS: 867062-95-1 
o (S)-5-Azido-2-(Fmoc-amino)pentanoic acid, (AAN3) Sigma Aldrich, CAS: 
1097192-04-5 
o CH3O-PEG-NHCO-C2H4-COOH, (mPEG2000) Rapp Polymer, MW≈2,000 Da 
o Dibenzocyclooctyne-N-hydroxysuccinimidyl ester, (DBCO-NHS) Sigma 
Aldrich 
o NH2-DOTA-GA, (DOTA) CheMatech, CAS: 306776-79-4 
o GdCl3•6H2O, (GdCl3) Sigma Aldrich, CAS: 1350-84-5 
Synthesis of 7c and characterization 
100mg of Wang resin and 2mL of dimethylformamide (DMF) are mixed together for 
1 hour to make the resin swelling. 
The entire polymer chain is obtained by the repetition of seven analogue coupling 
reactions. In the first six, PEG12 and AAN3 are added alternatively, while the 7th 
coupling is obtained with mPEG2000, as in Figure 5.6. 
Each step occurs with the same following procedure. 
The resins is treated for 5 minutes with a solution of 20% of piperidine in DMF, then 
the solvent is filtered and another aliquot of the same solution is added for 20 
minutes. The solvent is removed again and the solid washed six times with 2mL of 
pure DMF. Then 80 µmol of reactant (PEG12, AAN3 or mPEG2000) is added with 
HBTU/HOBT solution (2 - (1H - Benzotriazole - 1 - yl) - 1,1,3,3 - tetramethyluronium 
hexafluorophosphate and 1 – Hydroxybenzotriazole, 150µL, 0.5M), DIPEA (N,N-
diisopropylethylamine, 150µL, 1M) and DMF (700µL). 
The reaction proceeds under mechanical stirring for 90 minutes, then the solvent is 
filtered and the resin washed six times with 2mL of pure DMF. 
During the synthesis, little amounts of 4c and 6c intermediate (means after 4 and 6 
coupling reactions) are extracted and analysed. 
This procedure is repeated until the 7th coupling and then the polymer is removed 
from the resin. Two treatments with piperidine 20% in DMF are performed. Then the 
resin is washed with DCM (dichloromethane) and dried for about 10 minutes. A 
solution of 95% TFA (trifluoroacetic acid), 2.5% TIS (triisopropylsilane) and 2.5% 
H2O is added and the reaction proceeds for 90 minutes. 
The solution is separated by the solid and evaporated under nitrogen gas flow. 
The residue is purified by crystallization in cold ethylic ether for three times. 
The final light yellow solid and the intermediate products 4c and 6c are characterized 
by mass spectrometry and HPLC (only 4c and 6c). 
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Figure A.15: Reverse phase HPLC of 4c intermediate solutions. 
 
 
Figure A.16: Reverse phase HPLC of 6c intermediate solution. 
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Figure A.17: MALDI-TOF mass spectra of intermediate 4c with positive ionization 
modality. DHAP-TFA was used as matrix. Theoretical MW = 1600.75 Da; 
experimental [M+H]+ = 1601.34 m/z 
 
 
 
 
 
 
Figure A.18: ESI-TOF mass spectra of intermediate 4c with positive ionization 
modality. Theoretical MW = 1600.75 Da; experimental [M+H]+ = 1601.86 m/z 
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Figure A.19: MALDI-TOF mass spectra of intermediate 6c with positive ionization 
modality. DHAP-TFA was used as matrix. Theoretical MW = 2340.73 Da; 
experimental [M+H]+ = 2342.01 m/z 
 
 
 
Figure A.20: ESI-TOF mass spectra of intermediate 6c with positive ionization 
modality. Theoretical MW = 2340.73 Da; experimental [M+H]+ = 2341.43 m/z 
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Synthesis of SuperDOTA-Gd(III) 
50.1 mg of DOTA (96.6 µmol) and 32.8 mg of DBCO-NHS (81.5 µmol) are mixed 
with 8mL of anhydrous DMF and 75 µL of DIPEA (diisopropylethylamine, 438 
µmol), as in Figure 5.12. 
The reaction proceeds for 5 days and then the solvent is evaporated and the residue re-
dissolved in methanol. 
The desired product was separated by water/ethyl acetate liquid phase extraction, 
washing the organic fraction four times. Nitrogen gas is then gurgled into the final 
aqueous solution to complete remove the ethyl acetate. 
By ESI-TOF mass spectrometry and HPLC analysis, DOTA and DOTA-DBCO are 
found in the aqueous fraction (Figures A.21 and A.23), while DBCO-OH, DBCO-
OCH3 and DBCO-NHS in the organic fraction (Figure A.22 and A.23). 
 
 
Figure A.21: ESI-TOF mass spectra of extracted aqueous fraction with positive 
ionization modality. Experimental [DOTA-DBCO+H]+ = 806.36 m/z; [DOTA+H]+ = 
519.30 m/z 
 
 
 
 
Figure A.22: ESI-TOF mass spectra of extracted organic fraction with positive 
ionization modality. Experimental [DBCO-NHS+H]+ = 403.15 m/z; [DBCO-
OH+H]+ = 306.14 m/z; [DBCO-OCH3+H]+ = 320.14 m/z 
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Figure A.23: Continue… 
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Figure A.23: Reverse phase HPLC of the DOTA-DBCO reaction mixture (top), the 
extracted aqueous solution (middle) and the extracted organic solution (down). The 
signal at about 14 minutes correspond to DOTA-DBCO. 
 
Considering an approximate reaction yield of 50% between the total DOTA and the 
DOTA-DBCO, we estimated a DOTA-DBCO concentration in the aqueous phase of 
2.4 mM. 
2mL of such a solution (about 4.9 µmol of DOTA-DBCO) are mixed with 5.2 mg of 
7c polymer (about 1.2 µmol). The reaction proceeds under mechanical stirring for one 
day. The reaction product (SuperDOTA) is purified by filtration on 2,000 Da cut-off 
membrane (Vivaspin, Sartorius) and re-dispersed in water. The product is 
characterized by HPLC and MALDI-TOF mass spectrometry (see Figure 5.15 and 
5.16). 
The SuperDOTA concentration is calculated by quantitative evaluation of free thiol 
content, following the Ellman and DTDP test procedures reported in literature.100  We 
found 39 µM of thiols. 
Then, 90 µL of SuperDOTA solution were mixed with a 10 fold excess of GdCl3 (215 
µL, 164 µM) in pure water, for one day under stirring. The gadolinium excess were 
then removed by osmosis using a 2,000 Da cut-off membrane (Vivaspin, Sartorius) 
for one day. 
Then, the solution are recovered and directly used for the conjugation to AuNPs and 
magnetic resonance characterization (see Figure 5.17). 
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Synthesis of AuNP functionalized with SuperDOTA-
Gd(III) 
Gold nanoparticles are synthetized by LASiS in NaCl 10-5 M and characterized by 
UV-vis-NIR absorption using the Mie-Gans model as reported in literature.6 
 
 
R (nm) Spheres % 1-RSS MaxSPA (m2) ε (cm-1M-1) Absb=2mm (519nm) C (mol/L) 
9.6 97% 4.13E-04 3.03E-16 7.94E+08 0.4213 2.65E-09 
Figure A.24: UV-vis-NIR spectra of AuNPs synthetized by LASiS and the relative 
properties calculated. 
 
3 mL of such AuNPs solution are mixed with 30 µL of LipNB 50 µM for 2 hours 
under sonication. 
The colloidal solution is then centrifuged for 30 seconds at 30,000 RCF. The 
supernatant was eliminated and the particle dispersed in pure water by sonication. The 
solution was centrifuged again for 30 seconds at 30,000 RCF, the supernatant 
eliminated and the particles re-dispersed with 250 µL of the SuperDOTA-Gd(III) 
solution. 
The reaction proceeded for one day and then the colloidal solution was purified by 
centrifugation (5 minutes at 30,000 RCF) for three times. 
The final pellet is dispersed in 500 µL of pure water and characterized by UV-vis-
NIR, Raman and magnetic resonance spectroscopy (see Figures 5.18 and 5.19). 
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